Register
Medicines reference
Active substance

Fipronil

Phenylpyrazole ectoparasiticide. Registered in Georgia: 68 veterinary products. Forms: aerosol / spray, drops (oral), spot-on, topical (unspecified).

Dose and use

Doses

Each dose comes with its source. Check the label of the product you use.

Active substance Fipronil
Before use

Safety information

Known Contraindications

  • Critical
    Do not use in cases of hypersensitivity to the active substances or to any of the excipients.
    Sources: VMD SPC · VMD
  • Critical
    Do not use on sick (e.g. systemic diseases, fever) or convalescent animals.
    Sources: VMD SPC · VMD
  • Warning (Dog)
    In the absence of available data, the veterinary medicinal product should not be used on puppies less than 8 weeks old and/or weighing less than 2 kg. Puppies and kittens from 2 days of age may be safely treated. Nepoužívat u štěňat do 3 dnů stáří.
    Sources: VMD SPC · VMD
  • Warning (Cat)
    In the absence of available data, the veterinary medicinal product should not be used on kittens less than 8 weeks old and/or weighing less than 1 kg. Nepoužívat u koťat do 8 týdnů stáří. Puppies and kittens from 2 days of age may be safely treated.
    Sources: VMD SPC · VMD
  • Caution (Cat)
    The potential toxicity of the veterinary medicinal product for kittens of less than 8 weeks of age in contact with a treated queen is not documented. Special care should be taken in this case. Data are not available on treatment of pregnant queens or nursing queens. Přípravek může být podán chovným, březím i laktujícím kočkám.
    Sources: VMD SPC · VMD
Latin name
Fipronil
Georgian name
ფიპრონილი
Authorisation status
Authorised veterinary medicine
An authorised veterinary medicine containing this substance exists. Whether a particular use is on-label depends on the species and the indication - see each dose rule.
Registered in Georgia
68 of 70 forms
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
All forms and registration70

Registration in Georgia and abroad: the register, number, validity and source are behind (i).

vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label from 8 weeks: otodectic otitis treated with fipronil 0.1%, diphenhydramine and diflubenzuron ear drops, plus local application to mite skin lesions
Not rateable
No numerical score assigned
vetman assessment

Amit Forte

1/5/0.5 mg/ml external solution, 20 ml for dogs and cats
Assessed clinical scopeDog · Full dog label from 8 weeks: otodectic otitis treated with fipronil 0.1%, diphenhydramine and diflubenzuron ear drops, plus local application to mite skin lesions · otic,topical
Care settingVeterinary-confirmed ear mites with an intact eardrum, ear cleaning and follow-up cytology
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, veterinary · № 000743 · Verified on 21 Oct 2026 Off-label use
Not rateable

Not rateable until the exact Georgian pack resolves the formulation and strength conflict: the register uses an invalid fipronil strength unit and the product identity may refer to an older amitraz formulation.

No numerical score until the exact active composition and strength are verified from the Georgian pack or an authoritative exact-product leaflet.

Important safety and use flags

  • Do not use with a perforated eardrum; examine the ear first.
  • Do not use in puppies under 8 weeks, during pregnancy or lactation, or in infectious, weakened or convalescent dogs.
  • Despite the name, the current formula contains fipronil, not amitraz; check the pack composition.
  • Do not combine with another acaricide.
  • Treat both ears and all in-contact animals, and recheck ear cytology after the course.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Full cat label from 8 weeks: otodectic otitis treated with fipronil 0.1%, diphenhydramine and diflubenzuron ear drops, plus local application to mite skin lesions
Not rateable
No numerical score assigned
vetman assessment

Amit Forte

1/5/0.5 mg/ml external solution, 20 ml for dogs and cats
Assessed clinical scopeCat · Full cat label from 8 weeks: otodectic otitis treated with fipronil 0.1%, diphenhydramine and diflubenzuron ear drops, plus local application to mite skin lesions · otic,topical
Care settingVeterinary-confirmed ear mites with an intact eardrum, ear cleaning and treatment of in-contact animals
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, veterinary · № 000743 · Verified on 21 Oct 2026 Off-label use
Not rateable

Not rateable until the exact Georgian pack resolves the formulation and strength conflict: the register uses an invalid fipronil strength unit and the product identity may refer to an older amitraz formulation.

No numerical score until the exact active composition and strength are verified from the Georgian pack or an authoritative exact-product leaflet.

Important safety and use flags

  • Do not use with a perforated eardrum; examine the ear first.
  • Do not use in kittens under 8 weeks, during pregnancy or lactation, or in infectious, weakened or convalescent cats.
  • Despite the name, the current formula contains fipronil, not amitraz; never use older amitraz stock of this brand on cats.
  • Do not combine with another acaricide.
  • Treat both ears and all in-contact animals, and recheck ear cytology after the course.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Fipronil1 mg/ml Diphenhydramine5 mg/ml Diflubenzuron0.5 mg/ml
Formulation Type
Drops (oral)
Administration route
Into the ear, On the skin
Manufacturer
AVZ S-P · Russia
Manufacturer (register)
AVZ S-P, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1239, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 13 Nov 2029
Veterinary (National Food Agency)
In the register: ამიტ ფორტე
№ 000743
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

Barrier Super, Topical (unspecified)

fipronil 40 mg/g collar, 32.5 +/- 2.5 cm for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
5.0/10
Weak evidence support
vetman assessment

Barrier Super

fipronil 40 mg/g collar, 32.5 +/- 2.5 cm for cats
Assessed clinical scopeCat · Full cat label from 10 weeks: prevention and control of flea and tick infestation with a fipronil 40 mg/g collar worn for up to 6 months · On the skin
Care settingOwner-applied preventive collar for a healthy adult cat, with attention to collar fit and entrapment risk
vetman score 5.0/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000391 · Verified on 22 Oct 2026

A weak option for cats: fipronil itself is cat-safe, but the collar claim is unproven and entrapment and chewing risks remain. A cat-authorised spot-on is better supported.

Regulatory and scientific credibility4.0/10

The exact collar is registered in Georgia (000391, valid to 2028) with a current Ukrainian manufacturer instruction, but no EU, UK or US authorisation was documented in the reviewed evidence and no public efficacy dossier.

Clinical efficacy4.0/10

Fipronil works well in cats as a spot-on or spray, but no independent study supports 6-month flea and tick control from a fipronil collar.

Safety and tolerability6.0/10

Fipronil is safe in cats at label doses, but the label warns of neurological signs after chewing or ingestion, and no breakaway release is described for this cat collar.

Clinical practicality6.5/10

A single collar is easy to fit, but cats may lose or chew it and wetting reduces efficacy.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in kittens under 10 weeks, sick, convalescent, debilitated or old cats, or during pregnancy and lactation.
  • If the collar is chewed or swallowed by the cat, another pet or a child, remove it and seek urgent care: ataxia, tremor, seizures and vomiting are possible.
  • No breakaway release is described: check the fit regularly so a jaw or leg cannot get caught.
  • Remove the collar if local hair loss, itching or skin irritation develops.
  • Wetting may reduce efficacy; wash hands after handling.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil40 mg/g
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer (register)
Private Enterprise Barrier-Profi, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 870, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 17 Jul 2028
Veterinary (National Food Agency)
In the register: ბარიერ სუპერი ინსექტოაკარიციდული საყელო კატებისთვის
№ 000391
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Barrier Super, Topical (unspecified)

fipronil 40 mg/g collar, 65 +/- 5 cm for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.1/10
Weak evidence support
vetman assessment

Barrier Super

fipronil 40 mg/g collar, 65 +/- 5 cm for dogs
Assessed clinical scopeDog · Full dog label from 10 weeks: prevention and control of flea and tick infestation with a fipronil 40 mg/g collar worn for up to 6 months · On the skin
Care settingOwner-applied preventive collar for a healthy adult dog, after veterinary advice on tick-borne disease risk
vetman score 5.1/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000404 · Verified on 22 Oct 2026

A weak option: an easy collar, but the 6-month fipronil collar claim has no independent support. EU-authorised collars or fipronil spot-ons are better documented.

Regulatory and scientific credibility4.0/10

The exact collar is registered in Georgia (000404, valid to 2028) with a current Ukrainian manufacturer instruction, but no EU, UK or US authorisation was documented in the reviewed evidence and no public efficacy dossier.

Clinical efficacy4.0/10

Fipronil is well proven as a spot-on and spray, but no independent study shows that a fipronil collar matrix releases enough drug to kill fleas and ticks for the claimed 6 months.

Safety and tolerability6.5/10

Fipronil is well tolerated by dogs, but the label lists neurological signs after chewing or swallowing the collar and excludes puppies under 10 weeks, sick, old, pregnant and lactating dogs.

Clinical practicality6.5/10

One collar fitted with a 1-1.5 cm gap is simple, but wetting reduces efficacy and the end of protection cannot be checked.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in puppies under 10 weeks, sick, convalescent, debilitated or old dogs, or during pregnancy and lactation.
  • If the collar is chewed or swallowed by the dog, another pet or a child, remove it and seek urgent care: ataxia, tremor, seizures and vomiting are possible.
  • Remove the collar if local hair loss, itching or skin irritation develops.
  • Swimming and bathing may reduce efficacy; in tick-borne disease areas add or prefer a product with proven tick efficacy.
  • Wash hands after handling and open the pouch just before use.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil40 mg/g
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer (register)
Private Enterprise Barrier-Profi, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 871, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 17 Jul 2028
Veterinary (National Food Agency)
In the register: ბარიერ სუპერი ინსექტოაკარიციდული საყელო ძაღლებისთვის
№ 000404
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Barrier Super, Spot-on

fipronil 80 mg/ml drops, 3 x 1 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal
4.4/10
Weak evidence support
vetman assessment

Barrier Super

fipronil 80 mg/ml drops, 3 x 1 ml for dogs and cats
Assessed clinical scopeDog · Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal · auricular
Care settingVeterinary diagnosis after otoscopy and microscopy; clean the external canal, verify tympanic membrane integrity and reassess before repetition.
vetman score 4.4/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000369 · Verified on 22 Oct 2026

A weak, low-confidence label-supported otic option: the regimen is stated, but exact-formulation efficacy and ototoxicity evidence are absent. Prefer a product with regulator-reviewed otic data and always confirm an intact tympanum.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current manufacturer instruction identifies the exact 3 x 1 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy3.5/10

The exact instruction provides an otic regimen, but no exact-product controlled auricular efficacy study was found. Evidence for fipronil spot-on control of fleas and ticks is not direct evidence for this solvent, concentration and repeated ear-canal regimen.

Safety and tolerability3.5/10

Exact-formulation ear-canal safety and ototoxicity data were not found. Use only after confirming an intact tympanic membrane; stop for pain, neurologic signs, marked irritation or hearing change. Class safety from dermal spot-on use cannot be assumed to prove otic safety.

Clinical practicality6.5/10

Two to three drops per ear repeated two or three times at 8-10 day intervals is measurable, but requires cleaning, bilateral dosing, massage, restraint and reassessment. The dropper presentation is workable but not a one-step spot-on regimen.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Confirm otodectosis by otoscopy/microscopy and verify an intact tympanic membrane before use. Do not apply into a perforated, unvisualised, severely inflamed or neurologically abnormal ear.
  • Clean both external canals, treat both ears even with unilateral signs and massage the ear base as directed. Stop and reassess for pain, head tilt, nystagmus, ataxia, hearing change or marked irritation.
  • Spot-on flea/tick efficacy and dermal safety studies do not establish efficacy or ototoxicity safety for this exact repeated ear-canal regimen. Evidence confidence is low.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The exact instruction excludes pregnancy and lactation. Record reproductive status and choose another product for pregnant, breeding or nursing animals.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Dog Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them
5.3/10
Weak evidence support
vetman assessment

Barrier Super

fipronil 80 mg/ml drops, 3 x 1 ml for dogs and cats
Assessed clinical scopeDog · Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them · On the skin
Care settingHome topical administration after veterinary selection of parasite target, weight band and retreatment interval; environmental control and household coverage as clinically indicated.
vetman score 5.3/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000369 · Verified on 22 Oct 2026

A weak exact-presentation option: fipronil class efficacy is credible, but dose design, broad claims or formulation-specific evidence are less convincing than current regulator-reviewed comparators. Use only within the exact label and reassess control rather than assuming class equivalence.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current manufacturer instruction identifies the exact 3 x 1 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy4.5/10

Fipronil spot-on has controlled dog/cat evidence for fleas and ticks, but the exact 80 mg/ml product has no independent outcome study. The claimed 1.5-2 month protection and broad mite scope exceed or differ from current authorised comparator durations and therefore remain manufacturer-supported claims.

Safety and tolerability5.0/10

The instruction excludes young, sick, debilitated, old, pregnant or lactating animals and describes local alopecia, pruritus, irritation and systemic overdose signs. Exact-formulation frequency and margin are not independently characterised, and the fixed 1 ml feline dose exceeds the 0.5 ml authorised comparator volume.

Clinical practicality7.5/10

One-millilitre ampoules are simple for an adult cat or 2-10 kg dog, but larger dogs require two to four ampoules. The claimed 1.5-2 month interval is convenient but should not substitute for parasite- and exposure-based reassessment.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only on dry, intact skin in an area the animal cannot lick. Weigh the patient, select the exact label band and do not extrapolate between products, concentrations or pipette sizes.
  • Fipronil does not reliably prevent tick attachment or pathogen transmission. Examine the patient after exposure and use an integrated parasite plan based on local epidemiology and lifestyle.
  • The exact product has no independent controlled outcome trial or public regulator assessment dossier. Class evidence supports fipronil, not every broader mite, repellent or persistence claim on this formulation.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The exact instruction excludes pregnancy and lactation. Record reproductive status and choose another product for pregnant, breeding or nursing animals.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal
4.4/10
Weak evidence support
vetman assessment

Barrier Super

fipronil 80 mg/ml drops, 3 x 1 ml for dogs and cats
Assessed clinical scopeCat · Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal · auricular
Care settingVeterinary diagnosis after otoscopy and microscopy; clean the external canal, verify tympanic membrane integrity and reassess before repetition.
vetman score 4.4/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000369 · Verified on 22 Oct 2026

A weak, low-confidence label-supported otic option: the regimen is stated, but exact-formulation efficacy and ototoxicity evidence are absent. Prefer a product with regulator-reviewed otic data and always confirm an intact tympanum.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current manufacturer instruction identifies the exact 3 x 1 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy3.5/10

The exact instruction provides an otic regimen, but no exact-product controlled auricular efficacy study was found. Evidence for fipronil spot-on control of fleas and ticks is not direct evidence for this solvent, concentration and repeated ear-canal regimen.

Safety and tolerability3.5/10

Exact-formulation ear-canal safety and ototoxicity data were not found. Use only after confirming an intact tympanic membrane; stop for pain, neurologic signs, marked irritation or hearing change. Class safety from dermal spot-on use cannot be assumed to prove otic safety.

Clinical practicality6.5/10

Two to three drops per ear repeated two or three times at 8-10 day intervals is measurable, but requires cleaning, bilateral dosing, massage, restraint and reassessment. The dropper presentation is workable but not a one-step spot-on regimen.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Confirm otodectosis by otoscopy/microscopy and verify an intact tympanic membrane before use. Do not apply into a perforated, unvisualised, severely inflamed or neurologically abnormal ear.
  • Clean both external canals, treat both ears even with unilateral signs and massage the ear base as directed. Stop and reassess for pain, head tilt, nystagmus, ataxia, hearing change or marked irritation.
  • Spot-on flea/tick efficacy and dermal safety studies do not establish efficacy or ototoxicity safety for this exact repeated ear-canal regimen. Evidence confidence is low.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The exact instruction excludes pregnancy and lactation. Record reproductive status and choose another product for pregnant, breeding or nursing animals.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them
5.1/10
Weak evidence support
vetman assessment

Barrier Super

fipronil 80 mg/ml drops, 3 x 1 ml for dogs and cats
Assessed clinical scopeCat · Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them · On the skin
Care settingHome topical administration after veterinary selection of parasite target, weight band and retreatment interval; environmental control and household coverage as clinically indicated.
vetman score 5.1/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000369 · Verified on 22 Oct 2026

A weak exact-presentation option: fipronil class efficacy is credible, but dose design, broad claims or formulation-specific evidence are less convincing than current regulator-reviewed comparators. Use only within the exact label and reassess control rather than assuming class equivalence.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current manufacturer instruction identifies the exact 3 x 1 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy4.5/10

Fipronil spot-on has controlled dog/cat evidence for fleas and ticks, but the exact 80 mg/ml product has no independent outcome study. The claimed 1.5-2 month protection and broad mite scope exceed or differ from current authorised comparator durations and therefore remain manufacturer-supported claims.

Safety and tolerability4.5/10

The instruction excludes young, sick, debilitated, old, pregnant or lactating animals and describes local alopecia, pruritus, irritation and systemic overdose signs. Exact-formulation frequency and margin are not independently characterised, and the fixed 1 ml feline dose exceeds the 0.5 ml authorised comparator volume.

Clinical practicality7.5/10

One-millilitre ampoules are simple for an adult cat or 2-10 kg dog, but larger dogs require two to four ampoules. The claimed 1.5-2 month interval is convenient but should not substitute for parasite- and exposure-based reassessment.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only on dry, intact skin in an area the animal cannot lick. Weigh the patient, select the exact label band and do not extrapolate between products, concentrations or pipette sizes.
  • Fipronil does not reliably prevent tick attachment or pathogen transmission. Examine the patient after exposure and use an integrated parasite plan based on local epidemiology and lifestyle.
  • The exact product has no independent controlled outcome trial or public regulator assessment dossier. Class evidence supports fipronil, not every broader mite, repellent or persistence claim on this formulation.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The exact instruction excludes pregnancy and lactation. Record reproductive status and choose another product for pregnant, breeding or nursing animals.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil80 mg/ml
Formulation Type
Spot-on
Administration route
On the skin, auricular
Manufacturer (register)
Private Enterprise Barrier-Profi, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 860, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 21 Jun 2028
Veterinary (National Food Agency)
In the register: ინსექტოაკარიციდული წვეთები ბარიერი სუპერი
№ 000369
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

BARS, Spot-on

insectoacaricidal drops 0.5 ml, 2 pipettes for cats 5-10 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
5.5/10
Weak evidence support
vetman assessment

BARS

insectoacaricidal drops 0.5 ml, 2 pipettes for cats 5-10 kg
Assessed clinical scopeCat · Full labelled feline ectoparasite scope of the fixed fipronil/cyfluthrin/piperonyl-butoxide/diflubenzuron spot-on, including labelled fleas, ticks, lice and mites · On the skin
Care settingVeterinary-selected feline ectoparasite treatment with strict prevention of licking and cross-exposure
vetman score 5.5/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000800 · Verified on 21 Oct 2026

A poorly substantiated four-component feline ectoparasiticide whose pyrethroid component and limited independent evidence warrant more caution than established cat-specific alternatives.

Regulatory and scientific credibility5.5/10

The exact feline presentation is registered in Georgia and has a Russian registration-labelled instruction, but no transparent EMA, FDA or VMD assessment dossier for this exact four-component feline combination was identified.

Clinical efficacy5.5/10

Small comparative studies report flea and tick efficacy, but the evidence is limited, substantially manufacturer-associated and not sufficient to establish broad comparative effectiveness across every labelled mite indication.

Safety and tolerability4.0/10

A small repeated-dose tolerance study reported no major abnormalities, but cats are intrinsically vulnerable to pyrethroid toxicity; the exact cyfluthrin-containing formulation lacks large independent safety and pharmacovigilance datasets.

Clinical practicality8.0/10

One pipette is simple to apply, but feline grooming behaviour makes exact skin placement, drying and separation from other animals especially important.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Evidence for this exact fixed combination is limited to small studies with substantial manufacturer involvement; do not infer the evidence depth of established fipronil-only or internationally assessed products.
  • Keep away from rabbits and other non-target species; never interchange the canine and feline presentations or weight bands.
  • Apply only to dry intact skin where licking is impossible, separate animals until fully dry and monitor for salivation, vomiting, tremor, ataxia, skin irritation or other neurologic signs.
  • Do not use in sick, convalescent, pregnant, lactating, very young or underweight animals unless the exact label explicitly permits it and an individual veterinary assessment supports use.
  • Prevent environmental contamination and entry into water; the fipronil/pyrethroid/insect-growth-regulator combination is hazardous to non-target arthropods and aquatic organisms.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil100 mg/ml Cyfluthrin2.5 mg/ml Piperonyl butoxide0.5 mg/ml Diflubenzuron1 mg/ml
Formulation Type
Spot-on
Administration route
TOPICAL
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1318, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
Unknown

BARS, Spot-on

insectoacaricidal drops 0.67 ml, 4 pipettes for dogs up to 10 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.8/10
Weak evidence support
vetman assessment

BARS

insectoacaricidal drops 0.67 ml, 4 pipettes for dogs up to 10 kg
Assessed clinical scopeDog · Full labelled canine ectoparasite scope of the fixed fipronil/cyfluthrin/piperonyl-butoxide/diflubenzuron spot-on, including labelled fleas, ticks, lice and mites · On the skin
Care settingVeterinary-selected ectoparasite treatment using the exact canine weight-band pipette after species and risk review
vetman score 5.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000744 · Verified on 21 Oct 2026

A convenient but weakly substantiated four-component canine ectoparasiticide: limited manufacturer-associated studies do not provide the regulatory and independent-evidence depth available for better documented alternatives.

Regulatory and scientific credibility5.5/10

The exact presentations are registered in Georgia and have a Russian registration-labelled instruction, but no transparent EMA, FDA or VMD assessment dossier for this exact four-component combination was identified.

Clinical efficacy5.5/10

Small comparative and field studies report flea, tick and repellent efficacy, but they are limited in size, narrow in endpoints and substantially manufacturer-associated; robust independent multicentre evidence for the complete combination is lacking.

Safety and tolerability5.0/10

The labelled topical use can be tolerated, but combining fipronil with a pyrethroid, synergist and insect-growth regulator increases exposure complexity; independent target-animal safety and postmarketing transparency are limited.

Clinical practicality8.0/10

A single weight-banded spot-on is operationally simple, but correct dry-skin placement, prevention of licking and strict separation from cats and other animals until dry are essential.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Evidence for this exact fixed combination is limited to small studies with substantial manufacturer involvement; do not infer the evidence depth of established fipronil-only or internationally assessed products.
  • Keep away from rabbits and other non-target species; never interchange the canine and feline presentations or weight bands.
  • Apply only to dry intact skin where licking is impossible, separate animals until fully dry and monitor for salivation, vomiting, tremor, ataxia, skin irritation or other neurologic signs.
  • Do not use in sick, convalescent, pregnant, lactating, very young or underweight animals unless the exact label explicitly permits it and an individual veterinary assessment supports use.
  • Prevent environmental contamination and entry into water; the fipronil/pyrethroid/insect-growth-regulator combination is hazardous to non-target arthropods and aquatic organisms.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil150 mg/ml Cyfluthrin5 mg/ml Piperonyl butoxide1 mg/ml Diflubenzuron1 mg/ml
Formulation Type
Spot-on
Administration route
TOPICAL
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1240, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
Unknown

BARS, Spot-on

insectoacaricidal drops 1.34 ml for dogs over 10-20 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.8/10
Weak evidence support
vetman assessment

BARS

insectoacaricidal drops 1.34 ml for dogs over 10-20 kg
Assessed clinical scopeDog · Full labelled canine ectoparasite scope of the fixed fipronil/cyfluthrin/piperonyl-butoxide/diflubenzuron spot-on, including labelled fleas, ticks, lice and mites · On the skin
Care settingVeterinary-selected ectoparasite treatment using the exact canine weight-band pipette after species and risk review
vetman score 5.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000741 · Verified on 21 Oct 2026

A convenient but weakly substantiated four-component canine ectoparasiticide: limited manufacturer-associated studies do not provide the regulatory and independent-evidence depth available for better documented alternatives.

Regulatory and scientific credibility5.5/10

The exact presentations are registered in Georgia and have a Russian registration-labelled instruction, but no transparent EMA, FDA or VMD assessment dossier for this exact four-component combination was identified.

Clinical efficacy5.5/10

Small comparative and field studies report flea, tick and repellent efficacy, but they are limited in size, narrow in endpoints and substantially manufacturer-associated; robust independent multicentre evidence for the complete combination is lacking.

Safety and tolerability5.0/10

The labelled topical use can be tolerated, but combining fipronil with a pyrethroid, synergist and insect-growth regulator increases exposure complexity; independent target-animal safety and postmarketing transparency are limited.

Clinical practicality8.0/10

A single weight-banded spot-on is operationally simple, but correct dry-skin placement, prevention of licking and strict separation from cats and other animals until dry are essential.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Evidence for this exact fixed combination is limited to small studies with substantial manufacturer involvement; do not infer the evidence depth of established fipronil-only or internationally assessed products.
  • Keep away from rabbits and other non-target species; never interchange the canine and feline presentations or weight bands.
  • Apply only to dry intact skin where licking is impossible, separate animals until fully dry and monitor for salivation, vomiting, tremor, ataxia, skin irritation or other neurologic signs.
  • Do not use in sick, convalescent, pregnant, lactating, very young or underweight animals unless the exact label explicitly permits it and an individual veterinary assessment supports use.
  • Prevent environmental contamination and entry into water; the fipronil/pyrethroid/insect-growth-regulator combination is hazardous to non-target arthropods and aquatic organisms.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil150 mg/ml Cyfluthrin5 mg/ml Piperonyl butoxide1 mg/ml Diflubenzuron1 mg/ml
Formulation Type
Spot-on
Administration route
TOPICAL
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1237, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
Unknown

BARS, Spot-on

insectoacaricidal drops 2.68 ml for dogs over 20-40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.8/10
Weak evidence support
vetman assessment

BARS

insectoacaricidal drops 2.68 ml for dogs over 20-40 kg
Assessed clinical scopeDog · Full labelled canine ectoparasite scope of the fixed fipronil/cyfluthrin/piperonyl-butoxide/diflubenzuron spot-on, including labelled fleas, ticks, lice and mites · On the skin
Care settingVeterinary-selected ectoparasite treatment using the exact canine weight-band pipette after species and risk review
vetman score 5.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000699 · Verified on 21 Oct 2026

A convenient but weakly substantiated four-component canine ectoparasiticide: limited manufacturer-associated studies do not provide the regulatory and independent-evidence depth available for better documented alternatives.

Regulatory and scientific credibility5.5/10

The exact presentations are registered in Georgia and have a Russian registration-labelled instruction, but no transparent EMA, FDA or VMD assessment dossier for this exact four-component combination was identified.

Clinical efficacy5.5/10

Small comparative and field studies report flea, tick and repellent efficacy, but they are limited in size, narrow in endpoints and substantially manufacturer-associated; robust independent multicentre evidence for the complete combination is lacking.

Safety and tolerability5.0/10

The labelled topical use can be tolerated, but combining fipronil with a pyrethroid, synergist and insect-growth regulator increases exposure complexity; independent target-animal safety and postmarketing transparency are limited.

Clinical practicality8.0/10

A single weight-banded spot-on is operationally simple, but correct dry-skin placement, prevention of licking and strict separation from cats and other animals until dry are essential.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Evidence for this exact fixed combination is limited to small studies with substantial manufacturer involvement; do not infer the evidence depth of established fipronil-only or internationally assessed products.
  • Keep away from rabbits and other non-target species; never interchange the canine and feline presentations or weight bands.
  • Apply only to dry intact skin where licking is impossible, separate animals until fully dry and monitor for salivation, vomiting, tremor, ataxia, skin irritation or other neurologic signs.
  • Do not use in sick, convalescent, pregnant, lactating, very young or underweight animals unless the exact label explicitly permits it and an individual veterinary assessment supports use.
  • Prevent environmental contamination and entry into water; the fipronil/pyrethroid/insect-growth-regulator combination is hazardous to non-target arthropods and aquatic organisms.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil150 mg/ml Cyfluthrin5 mg/ml Piperonyl butoxide1 mg/ml Diflubenzuron1 mg/ml
Formulation Type
Spot-on
Administration route
TOPICAL
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1188, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
Unknown

BARS, Spot-on

insectoacaricidal drops 4.02 ml for dogs over 40-60 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.8/10
Weak evidence support
vetman assessment

BARS

insectoacaricidal drops 4.02 ml for dogs over 40-60 kg
Assessed clinical scopeDog · Full labelled canine ectoparasite scope of the fixed fipronil/cyfluthrin/piperonyl-butoxide/diflubenzuron spot-on, including labelled fleas, ticks, lice and mites · On the skin
Care settingVeterinary-selected ectoparasite treatment using the exact canine weight-band pipette after species and risk review
vetman score 5.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000750 · Verified on 21 Oct 2026

A convenient but weakly substantiated four-component canine ectoparasiticide: limited manufacturer-associated studies do not provide the regulatory and independent-evidence depth available for better documented alternatives.

Regulatory and scientific credibility5.5/10

The exact presentations are registered in Georgia and have a Russian registration-labelled instruction, but no transparent EMA, FDA or VMD assessment dossier for this exact four-component combination was identified.

Clinical efficacy5.5/10

Small comparative and field studies report flea, tick and repellent efficacy, but they are limited in size, narrow in endpoints and substantially manufacturer-associated; robust independent multicentre evidence for the complete combination is lacking.

Safety and tolerability5.0/10

The labelled topical use can be tolerated, but combining fipronil with a pyrethroid, synergist and insect-growth regulator increases exposure complexity; independent target-animal safety and postmarketing transparency are limited.

Clinical practicality8.0/10

A single weight-banded spot-on is operationally simple, but correct dry-skin placement, prevention of licking and strict separation from cats and other animals until dry are essential.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Evidence for this exact fixed combination is limited to small studies with substantial manufacturer involvement; do not infer the evidence depth of established fipronil-only or internationally assessed products.
  • Keep away from rabbits and other non-target species; never interchange the canine and feline presentations or weight bands.
  • Apply only to dry intact skin where licking is impossible, separate animals until fully dry and monitor for salivation, vomiting, tremor, ataxia, skin irritation or other neurologic signs.
  • Do not use in sick, convalescent, pregnant, lactating, very young or underweight animals unless the exact label explicitly permits it and an individual veterinary assessment supports use.
  • Prevent environmental contamination and entry into water; the fipronil/pyrethroid/insect-growth-regulator combination is hazardous to non-target arthropods and aquatic organisms.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil150 mg/ml Cyfluthrin5 mg/ml Piperonyl butoxide1 mg/ml Diflubenzuron1 mg/ml
Formulation Type
Spot-on
Administration route
TOPICAL
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1246, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
Unknown
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
5.6/10
Weak evidence support
vetman assessment

BARS Classic

10/1/1 mg/ml drops, 3 x 1 ml for cats
Assessed clinical scopeCat · Full cat label from 8 weeks: monthly treatment and prevention of flea, tick and louse infestation with a fipronil 1%, diflubenzuron and MGK-264 spot-on · On the skin
Care settingOwner-applied monthly ectoparasite control for a healthy cat
vetman score 5.6/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 001237 · Verified on 21 Oct 2026

A weak option for cats: fipronil is cat-safe, but this product gives a much lower dose than proven fipronil spot-ons and has no independent data.

Regulatory and scientific credibility4.5/10

The exact product is registered in Georgia (001237, valid to 2031) with a current Russian manufacturer instruction, but there is no EU, UK or US dossier.

Clinical efficacy4.5/10

The cat bands deliver only 3-10 mg fipronil per cat (often 2-3 mg/kg), well below the 50 mg per cat of EU-authorised fipronil spot-ons, and no study supports this lower dose.

Safety and tolerability7.0/10

Fipronil is safe in cats; the label excludes pregnancy, lactation, kittens under 8 weeks and sick or convalescent cats.

Clinical practicality7.0/10

A weight-banded dose of 0.3, 0.6 or 1 ml monthly from the 1 ml pipettes is simple, but partial pipettes must be measured for small cats.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use during pregnancy or lactation, in kittens under 8 weeks, or in infectious, weakened or convalescent cats.
  • The fipronil dose per cat is about one fifth of EU-authorised spot-ons; check for live fleas and ticks and switch product if control is poor.
  • Apply to dry intact skin where the cat cannot lick, and do not bathe for 3 days before or after.
  • Do not use the dog pipettes on cats, and do not repeat more often than monthly.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil10 mg/ml Diflubenzuron1 mg/ml Dicarboximide (MGK-264)1 mg/ml
Formulation Type
Spot-on
Administration route
On the skin, auricular
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P LTD, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1842, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 Aug 2031
Veterinary (National Food Agency)
In the register: ბარსი® კლასიკი რწყილებისა და ტკიპების საწინააღმდეგო წვეთები
№ 001237
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
6.2/10
Situational / acceptable
vetman assessment

BARS Classic

50/1/5 mg/ml drops, 4 x 1.4 ml for dogs
Assessed clinical scopeDog · Full dog label from 8 weeks and 2 kg: monthly treatment and prevention of flea, tick and louse infestation with a fipronil 5%, diflubenzuron and MGK-264 spot-on · On the skin
Care settingOwner-applied monthly ectoparasite control for a healthy dog, with a tick check after outdoor exposure
vetman score 6.2/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 000824 · Verified on 21 Oct 2026

A situational fipronil spot-on for dogs: the dose matches proven fipronil products, but the exact formulation has no independent study or major-regulator dossier.

Regulatory and scientific credibility5.0/10

The exact product is registered in Georgia (000824, valid to 2028) with a current Russian manufacturer instruction; fipronil spot-ons are authorised in the EU, but this exact product has no EU, UK or US dossier.

Clinical efficacy6.0/10

The labelled bands give at least about 7 mg/kg fipronil, in line with EU-authorised spot-ons, and diflubenzuron adds flea growth regulation; there is no independent study of this formulation.

Safety and tolerability7.0/10

Fipronil is well tolerated by dogs; the label excludes pregnancy, lactation, puppies under 8 weeks and sick or convalescent dogs.

Clinical practicality7.0/10

One pipette monthly for 2-20 kg, or 0.14 ml/kg above 20 kg, is simple, though no bathing is allowed for 3 days before and after.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use during pregnancy or lactation, in puppies under 8 weeks or 2 kg, or in infectious, weakened or convalescent dogs.
  • Do not use on rabbits: fipronil is toxic to them.
  • Fipronil kills ticks after attachment and does not repel them; in tick-borne disease areas consider a repellent or faster-killing product.
  • Apply to dry intact skin where the dog cannot lick, and do not bathe for 3 days before or after.
  • Do not repeat more often than monthly.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil50 mg/ml Diflubenzuron1 mg/ml Dicarboximide (MGK-264)5 mg/ml
Formulation Type
Spot-on
Administration route
On the skin, auricular
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1355, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 01 Apr 2028
Veterinary (National Food Agency)
In the register: ბარსი® კლასიკი
№ 000824
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

BARS spray, Aerosol / spray

BARS insectoacaricidal spray 3 mg/ml, 100 ml for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
5.7/10
Weak evidence support
vetman assessment

BARS spray

BARS insectoacaricidal spray 3 mg/ml, 100 ml for cats
Assessed clinical scopeCat · Full cat label from 10 weeks: treatment and prevention of flea, tick and louse infestation with a fipronil 0.3% whole-coat spray · On the skin
Care settingClinic or owner treatment in a ventilated room for kittens and cats where a measured coat dose is wanted
vetman score 5.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000314 · Verified on 21 Oct 2026

A weak option for cats: a correctly dosed fipronil spray, but hard to apply and without independent product evidence. A cat-authorised spot-on is easier.

Regulatory and scientific credibility5.0/10

The spray is registered in Georgia for cats (000314, valid to 2028) with a current Russian manufacturer instruction, but it has no EU, UK or US dossier.

Clinical efficacy6.0/10

At 3-5 ml/kg the spray gives 9-15 mg/kg fipronil, similar to EU-authorised fipronil sprays, but this formulation has no independent study.

Safety and tolerability6.5/10

Fipronil is safe in cats, but grooming of a wet coat raises oral exposure; the label excludes kittens under 10 weeks and sick cats.

Clinical practicality5.0/10

Spraying a cat to skin level against the hair is poorly tolerated and needs restraint until dry.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in kittens under 10 weeks or in infectious, weakened or convalescent cats; pregnancy and lactation need veterinary supervision.
  • Never use on rabbits: fipronil is toxic to them.
  • Prevent licking until fully dry; hypersalivation can follow if the cat licks the wet coat.
  • Use the cat spray, not the dog spray, and apply in a ventilated area.
  • Toxic to bees, fish and aquatic organisms.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil3 mg/ml
Formulation Type
Aerosol / spray
Administration route
On the skin
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 819, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 07 Apr 2028
Veterinary (National Food Agency)
In the register: ბარსი - ინსექტოაკარიციდული სპრეი კატებისთვის
№ 000314
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

BARS spray, Aerosol / spray

BARS insectoacaricidal spray 3 mg/ml, 100 ml for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.8/10
Weak evidence support
vetman assessment

BARS spray

BARS insectoacaricidal spray 3 mg/ml, 100 ml for dogs
Assessed clinical scopeDog · Full dog label from 10 weeks: treatment and prevention of flea, tick and louse infestation with a fipronil 0.3% whole-coat spray · On the skin
Care settingClinic or owner treatment outdoors or in a ventilated room, useful for puppies and small dogs where a measured coat dose is wanted
vetman score 5.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000924 · Verified on 21 Oct 2026

A weak option: the fipronil dose matches proven sprays, but the large volume and missing product evidence keep it well below EU-authorised fipronil sprays.

Regulatory and scientific credibility5.0/10

The spray is registered in Georgia (000924, valid to 2030) with a current Russian manufacturer instruction; fipronil sprays are authorised in the EU, but this product has no EU, UK or US dossier.

Clinical efficacy6.0/10

At 3-5 ml/kg the spray gives 9-15 mg/kg fipronil, similar to EU-authorised fipronil sprays, but this formulation has no independent study.

Safety and tolerability6.5/10

Fipronil is well tolerated by dogs, but whole-coat spraying increases inhalation and licking exposure; the label excludes puppies under 10 weeks and sick dogs.

Clinical practicality5.5/10

Wetting the coat to the skin with 3-5 ml/kg means large volumes for big dogs, and a 100 ml bottle treats one 20-30 kg dog.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in puppies under 10 weeks or in infectious, weakened or convalescent dogs; pregnancy and lactation need veterinary supervision.
  • Never use on rabbits: fipronil is toxic to them.
  • Spray outdoors or in a ventilated area, prevent licking until fully dry and comb after 20 minutes.
  • Fipronil kills ticks after attachment and does not repel them.
  • Toxic to bees, fish and aquatic organisms.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil3 mg/ml
Formulation Type
Aerosol / spray
Administration route
On the skin
Manufacturer
AVZ S-P Ltd · Russia
Manufacturer (register)
AVZ S-P Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1468, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Blochnet, Aerosol / spray

spray 5/56/60/1 mg/ml, 125 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label from 10 weeks and 2 kg: treatment and prevention of flea, tick and louse infestation with a fipronil, benzyl benzoate, DEET and S-methoprene spray
5.2/10
Weak evidence support
vetman assessment

Blochnet

spray 5/56/60/1 mg/ml, 125 ml for dogs and cats
Assessed clinical scopeDog · Full dog label from 10 weeks and 2 kg: treatment and prevention of flea, tick and louse infestation with a fipronil, benzyl benzoate, DEET and S-methoprene spray · On the skin
Care settingOwner or clinic spray treatment of a healthy dog with licking prevented until dry, away from cats
vetman score 5.2/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000286 · Verified on 21 Oct 2026

A weak option: an easy multi-ingredient spray with a low fipronil dose, added DEET and no independent data. A proven fipronil spray or spot-on is preferable.

Regulatory and scientific credibility4.5/10

The spray is registered in Georgia (000286, valid to 2028) with a current Russian manufacturer instruction, but it has no EU, UK or US authorisation documented in the reviewed evidence and its four-ingredient mix has no public dossier.

Clinical efficacy5.0/10

At 1-2 ml/kg the dog receives 5-10 mg/kg fipronil, at or below the lower end of proven fipronil sprays, plus an insect growth regulator; there is no product study.

Safety and tolerability5.5/10

Fipronil is well tolerated, but DEET can cause vomiting, tremor and seizures if licked, and the label excludes pregnancy, lactation, puppies under 10 weeks and recently operated dogs.

Clinical practicality6.0/10

The 1-2 ml/kg volume is smaller than most fipronil sprays and the trigger sprayer is easy to use.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use below 2 kg, in puppies under 10 weeks, during pregnancy or lactation, or in infectious, convalescent or recently operated dogs.
  • Prevent licking until dry: DEET and benzyl benzoate can cause salivation, vomiting, tremor or seizures if swallowed.
  • Do not combine with another insectoacaricide.
  • The fipronil dose is at the low end of proven sprays; check for live ticks and fleas.
  • Never use on rabbits; toxic to bees, fish and aquatic organisms.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label from 12 weeks and 2 kg: treatment and prevention of flea, tick and louse infestation with a fipronil, benzyl benzoate, DEET and S-methoprene spray
4.6/10
Weak evidence support
vetman assessment

Blochnet

spray 5/56/60/1 mg/ml, 125 ml for dogs and cats
Assessed clinical scopeCat · Full cat label from 12 weeks and 2 kg: treatment and prevention of flea, tick and louse infestation with a fipronil, benzyl benzoate, DEET and S-methoprene spray · On the skin
Care settingNot recommended for cats; prefer a cat-authorised product without benzyl benzoate or DEET
vetman score 4.6/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000286 · Verified on 21 Oct 2026

A weak option for cats: it contains benzyl benzoate and DEET, both hazardous to cats, with a low fipronil dose. Choose a cat-authorised fipronil product instead.

Regulatory and scientific credibility4.5/10

The spray is registered in Georgia for cats and dogs (000286, valid to 2028), but it has no EU, UK or US authorisation documented in the reviewed evidence or public dossier.

Clinical efficacy4.5/10

At 1 ml/kg the cat receives about 5 mg/kg fipronil, below proven fipronil sprays, and no product study exists.

Safety and tolerability4.0/10

Benzyl benzoate is a recognised feline toxin and cats are also sensitive to DEET; grooming after spraying makes oral exposure likely.

Clinical practicality6.0/10

A 1 ml/kg dose from a trigger sprayer is quick, but licking must be prevented until the coat is dry.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Benzyl benzoate and DEET are hazardous to cats: watch for salivation, vomiting, tremor, ataxia or seizures, wash the coat and seek urgent care if they occur.
  • Do not use below 2 kg, in kittens under 12 weeks, during pregnancy or lactation, or in infectious, convalescent or recently operated cats.
  • Do not combine with another insectoacaricide.
  • Prevent licking until the coat is completely dry.
  • Never use on rabbits; toxic to bees, fish and aquatic organisms.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil5 mg/ml Benzyl benzoate56 mg/ml Diethyltoluamide60 mg/ml S-methoprene1 mg/ml
Formulation Type
Aerosol / spray
Administration route
On the skin
Manufacturer
Astrafarm · Russia
Manufacturer (register)
Scientific Innovative Enterprise Astrafarm Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 805, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 Apr 2028
Veterinary (National Food Agency)
In the register: ბლოხნეტ ® სპრეი
№ 000286
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

Broadline, Spot-on

fipronil 24.9 mg + (S)-methoprene 30.0 mg + eprinomectin 1.20 mg + praziquantel 24.9 mg, spot-on solution for cats <2.5 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
8.3/10
Very good
vetman assessment

Broadline

fipronil 24.9 mg + (S)-methoprene 30.0 mg + eprinomectin 1.20 mg + praziquantel 24.9 mg, spot-on solution for cats <2.5 kg
Assessed clinical scopeCat · Full feline EU label when ectoparasites, nematodes and cestodes are all targeted: fleas/FAD, Ixodes ricinus, Notoedres cati, listed tapeworms, gastrointestinal, lung and vesical worms, and heartworm prevention · On the skin
Care settingVeterinary-prescribed feline multiparasite treatment after individual clinical, lifestyle and epidemiological assessment
vetman score 8.3/10 Very good
Evidence confidence: High Georgia: No · Verified on 15 Oct 2026

A highly effective, unusually broad feline endectoparasiticide when all three parasite groups genuinely need concurrent treatment. Its strong EU evidence does not change its absence from the Georgian register, and broad coverage should not replace narrower first-line therapy when mixed risk is absent.

Regulatory and scientific credibility8.2/10

The exact presentation has a valid central EU authorisation and a current UPD record, supported by detailed official product information and a mature EPAR. It is not registered in Georgia or the US; the separate GB national authorisation expired on 3 July 2026, while EU authorisation including Northern Ireland remains valid.

Clinical efficacy9.0/10

Controlled and multicentre field evidence supports high activity across fleas, major gastrointestinal helminths, lungworms, eyeworm and heartworm prevention. The label is deliberately restricted to simultaneous three-group need; tick protection is shorter than flea protection, and some parasite-specific follow-up or repeat dosing remains necessary.

Safety and tolerability7.5/10

Correct topical use is generally well tolerated and has a wide experimental safety margin, but common local coat or skin changes and salivation can occur. Accidental licking can cause gastrointestinal or transient neurological signs; very rare tremor or visual impairment, reproductive uncertainty and important species and health restrictions require counselling.

Clinical practicality8.4/10

One whole applicator gives broad single-dose coverage and is easier than several separate products, but it must reach the skin at an inaccessible neck site, the cat must not be bathed for two days, exact weight-band selection is required and cats above 7.5 kg need a veterinarian-selected applicator combination.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in sick or convalescent animals, rabbits, or with hypersensitivity to an ingredient. This feline product is not intended for dogs; prevent oral exposure, especially in Collies, Old English Sheepdogs and related breeds.
  • Do not use below 0.6 kg or under 7 weeks of age. Safety in pregnancy and lactation is not established; use only after veterinary benefit-risk assessment. Safety at intervals shorter than two weeks has not been tested.
  • Counsel for common transient coat clumping, local itching or hair loss and salivation. Accidental licking can cause vomiting, hypersalivation, ataxia, disorientation, apathy or pupil dilation; tremor and transient blindness or impaired vision are very rare. Reassess signs persisting beyond 24 hours.
  • Use only for confirmed mixed infestation or substantial concurrent risk involving ectoparasites, nematodes and cestodes. If three-group risk is absent, choose a narrower first-line parasiticide; avoid unnecessary frequent use and underdosing that can select resistance.
  • Flea treatment and environmental-stage control last at least one month, while Ixodes ricinus protection lasts up to three weeks. Tick attachment and pathogen transmission cannot be completely excluded; treat household animals and the environment when clinically indicated.
  • For heartworm prevention, test cats aged at least 6 months in endemic areas because adult Dirofilaria is not treated. Aelurostrongylus may need a second dose after one month; Joyeuxiella needs post-treatment follow-up, and tapeworm control requires management of fleas, rodents and other intermediate hosts.
  • Weigh exactly and empty the whole applicator onto visible skin at the midline of the neck where licking is prevented. Use 0.3 ml below 2.5 kg and 0.9 ml at 2.5-7.5 kg; above 7.5 kg use a veterinarian-selected applicator combination. Avoid bathing for two days, wear gloves, limit handling until dry and keep product or containers out of watercourses.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Registration
Georgia No
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Expired
Expired on 03 Jul 2026, not renewed yet
№ 61700/5085
Verified on: 22 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Broadline, Spot-on

fipronil 74.7 mg + (S)-methoprene 90.0 mg + eprinomectin 3.60 mg + praziquantel 74.7 mg, spot-on solution for cats 2.5-7.5 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
8.3/10
Very good
vetman assessment

Broadline

fipronil 74.7 mg + (S)-methoprene 90.0 mg + eprinomectin 3.60 mg + praziquantel 74.7 mg, spot-on solution for cats 2.5-7.5 kg
Assessed clinical scopeCat · Full feline EU label when ectoparasites, nematodes and cestodes are all targeted: fleas/FAD, Ixodes ricinus, Notoedres cati, listed tapeworms, gastrointestinal, lung and vesical worms, and heartworm prevention · On the skin
Care settingVeterinary-prescribed feline multiparasite treatment after individual clinical, lifestyle and epidemiological assessment
vetman score 8.3/10 Very good
Evidence confidence: High Georgia: No · Verified on 15 Oct 2026

A highly effective, unusually broad feline endectoparasiticide when all three parasite groups genuinely need concurrent treatment. Its strong EU evidence does not change its absence from the Georgian register, and broad coverage should not replace narrower first-line therapy when mixed risk is absent.

Regulatory and scientific credibility8.2/10

The exact presentation has a valid central EU authorisation and a current UPD record, supported by detailed official product information and a mature EPAR. It is not registered in Georgia or the US; the separate GB national authorisation expired on 3 July 2026, while EU authorisation including Northern Ireland remains valid.

Clinical efficacy9.0/10

Controlled and multicentre field evidence supports high activity across fleas, major gastrointestinal helminths, lungworms, eyeworm and heartworm prevention. The label is deliberately restricted to simultaneous three-group need; tick protection is shorter than flea protection, and some parasite-specific follow-up or repeat dosing remains necessary.

Safety and tolerability7.5/10

Correct topical use is generally well tolerated and has a wide experimental safety margin, but common local coat or skin changes and salivation can occur. Accidental licking can cause gastrointestinal or transient neurological signs; very rare tremor or visual impairment, reproductive uncertainty and important species and health restrictions require counselling.

Clinical practicality8.4/10

One whole applicator gives broad single-dose coverage and is easier than several separate products, but it must reach the skin at an inaccessible neck site, the cat must not be bathed for two days, exact weight-band selection is required and cats above 7.5 kg need a veterinarian-selected applicator combination.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in sick or convalescent animals, rabbits, or with hypersensitivity to an ingredient. This feline product is not intended for dogs; prevent oral exposure, especially in Collies, Old English Sheepdogs and related breeds.
  • Do not use below 0.6 kg or under 7 weeks of age. Safety in pregnancy and lactation is not established; use only after veterinary benefit-risk assessment. Safety at intervals shorter than two weeks has not been tested.
  • Counsel for common transient coat clumping, local itching or hair loss and salivation. Accidental licking can cause vomiting, hypersalivation, ataxia, disorientation, apathy or pupil dilation; tremor and transient blindness or impaired vision are very rare. Reassess signs persisting beyond 24 hours.
  • Use only for confirmed mixed infestation or substantial concurrent risk involving ectoparasites, nematodes and cestodes. If three-group risk is absent, choose a narrower first-line parasiticide; avoid unnecessary frequent use and underdosing that can select resistance.
  • Flea treatment and environmental-stage control last at least one month, while Ixodes ricinus protection lasts up to three weeks. Tick attachment and pathogen transmission cannot be completely excluded; treat household animals and the environment when clinically indicated.
  • For heartworm prevention, test cats aged at least 6 months in endemic areas because adult Dirofilaria is not treated. Aelurostrongylus may need a second dose after one month; Joyeuxiella needs post-treatment follow-up, and tapeworm control requires management of fleas, rodents and other intermediate hosts.
  • Weigh exactly and empty the whole applicator onto visible skin at the midline of the neck where licking is prevented. Use 0.3 ml below 2.5 kg and 0.9 ml at 2.5-7.5 kg; above 7.5 kg use a veterinarian-selected applicator combination. Avoid bathing for two days, wear gloves, limit handling until dry and keep product or containers out of watercourses.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Registration
Georgia No
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Expired
Expired on 03 Jul 2026, not renewed yet
№ 61700/5084
Verified on: 22 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Chistotel Maximum 47.5/9.5 mg/ml, Spot-on

spot-on drops 4 x 1 ml for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
4.9/10
Weak evidence support
vetman assessment

Chistotel Maximum

47.5/9.5 mg/ml, spot-on drops 4 x 1 ml for dogs
Assessed clinical scopeDog · Complete dog label: fleas, sucking and biting lice, ixodid ticks, otodectosis, canine sarcoptic mange and prevention of ectoparasite attack across the labelled skin, ear and attached-tick regimens · On the skin
Care settingOwner-applied dog-only spot-on after accurate weighing and veterinarian/product selection; ear and mange regimens require diagnostic veterinary supervision
vetman score 4.9/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 001232 · Verified on 23 Oct 2026

A locally authorised dog spot-on with a plausible fipronil ectoparasite core, but no exact outcome programme and a very low permethrin exposure relative to regulated fipronil-permethrin controls. Broad ear/mange claims, severe cat-contact risk and pack insufficiency above 40 kg make the complete-label practical value weak.

Regulatory and scientific credibility6.5/10

The exact four-pipette dog pack has current Georgian authorisation through 2031, an approved manufacturer instruction and a current Russian umbrella registration. Exact identity is verifiable, but there is no EU/GB/US authorisation or public exact-product regulator assessment; the umbrella feline wording is not accepted as feline evidence.

Clinical efficacy4.0/10

Fipronil supports a plausible flea/tick/lice core, but no exact-product outcomes support the two-month insect, mite, ear or mange breadth. At the label rule, permethrin is about 0.95 mg/kg versus roughly 60-120 mg/kg in authorised comparators, so their repellency/acaricidal trial results cannot validate Chistotel.

Safety and tolerability3.5/10

Dog irritation, salivation/lacrimation and ingestion-related neurologic toxicity are material, and repeated bilateral ear-canal use lacks a tympanic/ototoxicity boundary. Permethrin creates potentially fatal household-cat risk. Exact quantified dog target-animal, reproductive and repeated-course safety data are absent.

Clinical practicality6.0/10

Monthly skin dosing and clear weight bands are workable, but the 4 ml carton is insufficient for one dose above 40 kg and a 0.5 ml small-dog dose requires partial use of a 1 ml tube. Multi-site large-dog application, 48-hour contact/water controls and complex ear/mange repeats add burden.

Full-course cost-effectiveness-

Current Georgian per-treatment price was unavailable; price is excluded from the denominator.

Important safety and use flags

  • Complete dog-scope boundary: this score covers skin prevention/treatment for fleas, lice and ixodid ticks, bilateral ear drops for otodectosis, repeated canine sarcoptic-mange treatment and direct attached-tick application. It does not transfer the umbrella instruction to cats or include feline notoedrosis.
  • Evidence/exposure conflict: the label rule supplies about 4.75 mg/kg fipronil and 0.95 mg/kg permethrin. Authorised fipronil-permethrin controls use about 6.7-13.4 and 60-120 mg/kg respectively; their quantified one-month repellency/kill cannot validate this 63-126-fold lower permethrin exposure.
  • Exact skin dose: under 2 kg 0.5 ml; 2-10 kg 1 ml; 10-20 kg 2 ml; 20-30 kg 3 ml; 30-40 kg 4 ml; 40-50 kg 5 ml; over 50 kg 0.1 ml/kg across 3-4 sites. Apply only to dry intact skin inaccessible to licking; do not round down because the carton is short.
  • Pack practicality: the exact carton contains four 1 ml tubes. It covers one label dose only through 40 kg; 40-50 kg needs 5 ml and over 50 kg needs more than one carton. The 0.5 ml dose partially uses a tube without validated reclosure/storage—measure accurately and discard remainder safely.
  • Dog only—cat emergency: never use this presentation on a cat despite the umbrella manufacturer instruction. Permethrin exposure or grooming a treated dog may be fatal; separate household cats for at least 48 hours and seek emergency veterinary toxicology care after any cat contact/licking.
  • Ear boundary: diagnose otodectosis and examine both canals/tympanic membranes before instilling 1-3 drops bilaterally. Do not use in an ulcerated canal, ruptured/unknown tympanum or nonspecific otitis; repeated 3-5-day dosing lacks an exact public ototoxicity dossier.
  • Mange/tick boundary: confirm canine sarcoptic mange and use 2-4 treatments 7-10 days apart until clinical recovery plus two negative acarologic checks. One drop on an attached tick is not whole-patient prevention; remove it mechanically after 20 minutes if still attached.
  • Do not use under 3 months, during pregnancy/lactation, infectious disease or convalescence, on damaged/wet skin, or with another insectoacaricide. Prevent licking; stop, wash with mild detergent/water and reassess for salivation, lacrimation, dermatitis, vomiting, weakness, ataxia, tremor or seizure.
  • Flea/environment control: treat every suitable household animal with its own species-safe product and manage bedding/environment. Repeat general application only when indicated and no more often than monthly; investigate bathing, reinfestation, adherence and resistance before stacking products.
  • Handler/water control: wear gloves, wash hands, prevent petting and small-child contact, and do not bathe or allow swimming for 48 hours. Fipronil/permethrin are hazardous to aquatic organisms; keep from watercourses and dispose of opened tubes, remainder and packaging safely.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil47.5 mg/ml Permethrin9.5 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1666, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 30 Mar 2031
Veterinary (National Food Agency)
In the register: ჩისტოტელ მაქსიმუმი 47.5/9.5 მგ/მლ, 4 × 1 მლ ძაღლისთვის
№ 001232
Verified on: 23 Oct 2026
EU No
UK No
US No
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified Dog-only complete label: fleas, sucking/biting lice, ixodid ticks, otodectosis and canine sarcoptic mange. Apply the exact weight-band volume to dry intact skin inaccessible to licking; repeat general treatment only when indicated and no more often than monthly. The carton contains 4 ml, so one labelled dose above 40 kg requires more than one carton. Exact-product controlled outcomes were not found.

DIXIE, Spot-on

Fipronil 50 mg/0.5 ml spot-on solution for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
8.3/10
Very good
vetman assessment

DIXIE

Fipronil 50 mg/0.5 ml spot-on solution for cats
Assessed clinical scopeCat · Full cat label: treatment and four-week prevention of Ctenocephalides felis flea and Rhipicephalus turanicus tick infestations with one fipronil spot-on pipette · On the skin
Care settingHome topical ectoparasite treatment after confirming species, age, weight and parasite-control plan
vetman score 8.3/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 139-11 · Verified on 20 Oct 2026

A strong exact cat fipronil spot-on for its named flea and tick targets, with simple monthly use and solid regulatory support. It does not guarantee prevention of tick attachment or vector transmission and is not a broad substitute for every ectoparasite plan.

Regulatory and scientific credibility9.0/10

The exact 50 mg/0.5 ml cat pipette is actively registered in Georgia and has a transparent current UK VMD SPC; independent studies support the same active ingredient and presentation class.

Clinical efficacy8.0/10

The exact label supports flea and R. turanicus tick kill and four-week persistence, while controlled and household studies support fipronil spot-on performance. Coverage is species-specific, occasional tick attachment can occur and pathogen transmission is not excluded.

Safety and tolerability7.8/10

Systemic absorption is low and target-animal margin is useful, but local reactions, drooling, gastrointestinal, neurologic or respiratory signs can occur. Rabbits may die after exposure, reproductive safety is unestablished and handler contact needs control.

Clinical practicality8.5/10

One complete monthly pipette applied at one or two sites is simple and avoids dose calculation. Accurate weighing, preventing licking, keeping children away until dry and avoiding poorly studied bathing around treatment remain necessary.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use below 9 weeks or 1 kg, in sick or convalescent cats, on damaged skin or with hypersensitivity.
  • Never use in rabbits: serious adverse reactions and death can occur.
  • Ticks can still attach; infectious-disease transmission cannot be excluded despite treatment.
  • Prevent licking and animal-to-animal licking; avoid eyes and keep children away until the site is dry.
  • Pregnancy and lactation safety is not established; use only after veterinary benefit-risk assessment.
  • Bathing, immersion or shampooing effects are unstudied; avoid especially within two days of treatment.
  • Monitor application-site change, pruritus, drooling, vomiting, neurologic or respiratory signs; reassess persistent signs promptly.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil50 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer (register)
QUIMICA DE MUNGUÍA. S.A. (QUIMUNSA), Spain
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1748, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: დიქსი 50 მგ დასაწვეთებელი ხსნარი კატებისთვის
№ 139-11
Verified on: 20 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effipro Duo 50 mg/60 mg, Spot-on

fipronil 50 mg + pyriproxyfen 60 mg, spot-on solution for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
8.1/10
Very good
vetman assessment

Effipro Duo

50 mg/60 mg, fipronil 50 mg + pyriproxyfen 60 mg, spot-on solution for cats
Assessed clinical scopeCat · Full feline flea-centred label: flea treatment/prevention, 12-week inhibition of flea development, FAD strategy, and tick treatment when fleas are present or also require control · On the skin
Care settingOne exact species/weight-band pipette on intact dry skin after weighing and parasite assessment, with environmental flea control when needed
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 76-11 · Verified on 15 Oct 2026

A well-regulated flea-centred fixed combination with useful 12-week immature-stage control and labelled tick activity. It is a strong exact-form option when both components fit the clinical goal, but it is not a repellent and tick protection is not uniform across species.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Clinical efficacy7.5/10

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Safety and tolerability8.0/10

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

Clinical practicality8.0/10

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The fixed combination is flea-centred: use against fleas alone or fleas associated with ticks. Do not choose it for a tick-only problem when the pyriproxyfen flea-life-cycle component is not clinically justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use in known hypersensitivity to either active substance or an excipient.
  • Apply directly to intact skin and prevent licking or mutual grooming until dry. Licking may cause brief salivation; rinse accidental eye or human skin exposure promptly.
  • The product is not a repellent. Ticks may attach before dying and infection transmission cannot be completely excluded; cats have only one week of labelled persistent tick efficacy.
  • Do not use below the exact label minimum: cats under 10 weeks or 1 kg, and dogs under 10 weeks or 2 kg. Use only the correct species and weight-band pipette.
  • Safety during pregnancy and lactation is not established; use only after the veterinarian’s benefit-risk assessment. Keep treated animals and discarded pipettes away from watercourses.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1047, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფფიპრო® დუო 50მგ/60მგ დასაწვეთებელი ხსნარი კატებისათვის
№ 76-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effipro Duo 67 mg/20 mg, Spot-on

fipronil 67 mg + pyriproxyfen 20.1 mg, spot-on solution for dogs 2-10 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.1/10
Very good
vetman assessment

Effipro Duo

67 mg/20 mg, fipronil 67 mg + pyriproxyfen 20.1 mg, spot-on solution for dogs 2-10 kg
Assessed clinical scopeDog · Full canine flea-centred label: flea treatment/prevention, 12-week inhibition of flea development, FAD strategy, and tick treatment when fleas are present or also require control · On the skin
Care settingOne exact species/weight-band pipette on intact dry skin after weighing and parasite assessment, with environmental flea control when needed
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 84-11 · Verified on 15 Oct 2026

A well-regulated flea-centred fixed combination with useful 12-week immature-stage control and labelled tick activity. It is a strong exact-form option when both components fit the clinical goal, but it is not a repellent and tick protection is not uniform across species.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Clinical efficacy7.5/10

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Safety and tolerability8.0/10

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

Clinical practicality8.0/10

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The fixed combination is flea-centred: use against fleas alone or fleas associated with ticks. Do not choose it for a tick-only problem when the pyriproxyfen flea-life-cycle component is not clinically justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use in known hypersensitivity to either active substance or an excipient.
  • Apply directly to intact skin and prevent licking or mutual grooming until dry. Licking may cause brief salivation; rinse accidental eye or human skin exposure promptly.
  • The product is not a repellent. Ticks may attach before dying and infection transmission cannot be completely excluded; cats have only one week of labelled persistent tick efficacy.
  • Do not use below the exact label minimum: cats under 10 weeks or 1 kg, and dogs under 10 weeks or 2 kg. Use only the correct species and weight-band pipette.
  • Safety during pregnancy and lactation is not established; use only after the veterinarian’s benefit-risk assessment. Keep treated animals and discarded pipettes away from watercourses.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil67 mg Pyriproxyfen20.1 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფფიპრო® დუო 67მგ/20მგ დასაწვეთებელი ხსნარი პატარა ძაღლებისთვის (2-10კგ)
№ 84-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effipro Duo 134 mg/40 mg, Spot-on

fipronil 134 mg + pyriproxyfen 40.2 mg, spot-on solution for dogs 10-20 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.1/10
Very good
vetman assessment

Effipro Duo

134 mg/40 mg, fipronil 134 mg + pyriproxyfen 40.2 mg, spot-on solution for dogs 10-20 kg
Assessed clinical scopeDog · Full canine flea-centred label: flea treatment/prevention, 12-week inhibition of flea development, FAD strategy, and tick treatment when fleas are present or also require control · On the skin
Care settingOne exact species/weight-band pipette on intact dry skin after weighing and parasite assessment, with environmental flea control when needed
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 81-11 · Verified on 15 Oct 2026

A well-regulated flea-centred fixed combination with useful 12-week immature-stage control and labelled tick activity. It is a strong exact-form option when both components fit the clinical goal, but it is not a repellent and tick protection is not uniform across species.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Clinical efficacy7.5/10

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Safety and tolerability8.0/10

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

Clinical practicality8.0/10

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The fixed combination is flea-centred: use against fleas alone or fleas associated with ticks. Do not choose it for a tick-only problem when the pyriproxyfen flea-life-cycle component is not clinically justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use in known hypersensitivity to either active substance or an excipient.
  • Apply directly to intact skin and prevent licking or mutual grooming until dry. Licking may cause brief salivation; rinse accidental eye or human skin exposure promptly.
  • The product is not a repellent. Ticks may attach before dying and infection transmission cannot be completely excluded; cats have only one week of labelled persistent tick efficacy.
  • Do not use below the exact label minimum: cats under 10 weeks or 1 kg, and dogs under 10 weeks or 2 kg. Use only the correct species and weight-band pipette.
  • Safety during pregnancy and lactation is not established; use only after the veterinarian’s benefit-risk assessment. Keep treated animals and discarded pipettes away from watercourses.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil134 mg Pyriproxyfen40.2 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1050, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფფიპრო® დუო 134მგ/40მგ დასაწვეთებელი ხსნარი საშუალო ზომის ძაღლებისთვის(10-20კგ)
№ 81-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effipro Duo 268 mg/80 mg, Spot-on

fipronil 268 mg + pyriproxyfen 80.4 mg, spot-on solution for dogs 20-40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.1/10
Very good
vetman assessment

Effipro Duo

268 mg/80 mg, fipronil 268 mg + pyriproxyfen 80.4 mg, spot-on solution for dogs 20-40 kg
Assessed clinical scopeDog · Full canine flea-centred label: flea treatment/prevention, 12-week inhibition of flea development, FAD strategy, and tick treatment when fleas are present or also require control · On the skin
Care settingOne exact species/weight-band pipette on intact dry skin after weighing and parasite assessment, with environmental flea control when needed
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 89-11 · Verified on 15 Oct 2026

A well-regulated flea-centred fixed combination with useful 12-week immature-stage control and labelled tick activity. It is a strong exact-form option when both components fit the clinical goal, but it is not a repellent and tick protection is not uniform across species.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Clinical efficacy7.5/10

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Safety and tolerability8.0/10

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

Clinical practicality8.0/10

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The fixed combination is flea-centred: use against fleas alone or fleas associated with ticks. Do not choose it for a tick-only problem when the pyriproxyfen flea-life-cycle component is not clinically justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use in known hypersensitivity to either active substance or an excipient.
  • Apply directly to intact skin and prevent licking or mutual grooming until dry. Licking may cause brief salivation; rinse accidental eye or human skin exposure promptly.
  • The product is not a repellent. Ticks may attach before dying and infection transmission cannot be completely excluded; cats have only one week of labelled persistent tick efficacy.
  • Do not use below the exact label minimum: cats under 10 weeks or 1 kg, and dogs under 10 weeks or 2 kg. Use only the correct species and weight-band pipette.
  • Safety during pregnancy and lactation is not established; use only after the veterinarian’s benefit-risk assessment. Keep treated animals and discarded pipettes away from watercourses.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil268 mg Pyriproxyfen80.4 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1058, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფფიპრო® დუო 268მგ/80მგ დასაწვეთებელი ხსნარი დიდი ზომის ძაღლებისთვის (20-40კგ)
№ 89-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effipro Duo 402 mg/120 mg, Spot-on

fipronil 402 mg + pyriproxyfen 120.6 mg, spot-on solution for dogs 40-60 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.1/10
Very good
vetman assessment

Effipro Duo

402 mg/120 mg, fipronil 402 mg + pyriproxyfen 120.6 mg, spot-on solution for dogs 40-60 kg
Assessed clinical scopeDog · Full canine flea-centred label: flea treatment/prevention, 12-week inhibition of flea development, FAD strategy, and tick treatment when fleas are present or also require control · On the skin
Care settingOne exact species/weight-band pipette on intact dry skin after weighing and parasite assessment, with environmental flea control when needed
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 105-11 · Verified on 15 Oct 2026

A well-regulated flea-centred fixed combination with useful 12-week immature-stage control and labelled tick activity. It is a strong exact-form option when both components fit the clinical goal, but it is not a repellent and tick protection is not uniform across species.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Clinical efficacy7.5/10

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Safety and tolerability8.0/10

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

Clinical practicality8.0/10

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The fixed combination is flea-centred: use against fleas alone or fleas associated with ticks. Do not choose it for a tick-only problem when the pyriproxyfen flea-life-cycle component is not clinically justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use in known hypersensitivity to either active substance or an excipient.
  • Apply directly to intact skin and prevent licking or mutual grooming until dry. Licking may cause brief salivation; rinse accidental eye or human skin exposure promptly.
  • The product is not a repellent. Ticks may attach before dying and infection transmission cannot be completely excluded; cats have only one week of labelled persistent tick efficacy.
  • Do not use below the exact label minimum: cats under 10 weeks or 1 kg, and dogs under 10 weeks or 2 kg. Use only the correct species and weight-band pipette.
  • Safety during pregnancy and lactation is not established; use only after the veterinarian’s benefit-risk assessment. Keep treated animals and discarded pipettes away from watercourses.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil402 mg Pyriproxyfen120.6 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1071, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფფიპრო® დუო 402მგ/120მგ დასაწვეთებელი ხსნარი ძალიან დიდი ზომის ძაღლებისათვის (40-60კგ)
№ 105-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effitix 26.8 mg/240 mg, Spot-on

fipronil 26.84 mg + permethrin 239.8 mg, spot-on solution for dogs 1.5-4 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.2/10
Very good
vetman assessment

Effitix

26.8 mg/240 mg, fipronil 26.84 mg + permethrin 239.8 mg, spot-on solution for dogs 1.5-4 kg
Assessed clinical scopeDog · Full canine label: flea treatment/prevention and FAD strategy, tick treatment and four-week control, with four-week sand-fly and mosquito repellency when that combined role is clinically required · On the skin
Care settingExact weight-band pipette after weighing and parasite-risk assessment; apply to two to four skin sites, prevent licking, and separate treated dogs from cats until fully dry
vetman score 8.2/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 313-11 · Verified on 15 Oct 2026

A strongly supported four-week flea, tick and vector-repellency option for dogs when the combined role is actually needed. Its value is limited by strict cat-exposure precautions and a more involved application process, not by weak canine efficacy.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

Clinical efficacy8.5/10

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Safety and tolerability7.5/10

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Clinical practicality7.5/10

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats or rabbits. Permethrin exposure is extremely poisonous and may be fatal to cats; keep treated dogs away until the site is fully dry and urgently wash and seek veterinary help after accidental exposure.
  • Do not use in sick, febrile or convalescent dogs or in known hypersensitivity to either active substance or an excipient.
  • Use this fixed combination for confirmed or credible flea and/or tick risk when sand-fly or mosquito repellency is also needed; do not add the permethrin component without a coherent clinical purpose.
  • Do not use below 12 weeks of age or 1.5 kg. Weigh accurately and use the exact weight-band pipette; overdose can increase adverse reactions.
  • Very rare canine reactions include application-site pruritus, erythema or alopecia, vomiting, agitation and neurologic signs. Prevent licking; transient hypersalivation may follow oral exposure.
  • Single ticks or bites by sand flies or mosquitoes may still occur, so pathogen transmission cannot be excluded; some Dermacentor or Rhipicephalus present at application may remain alive for 48 hours.
  • Frequent swimming or shampooing may reduce persistence. Keep dogs out of watercourses for two days, minimise human contact for about 12 hours, and use in pregnancy or lactation only after veterinary benefit-risk assessment.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil26.84 mg Permethrin239.8 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
Virbac, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 949, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფიტიქსი 26,8მგ/240მგ დასაწვეთებელი ხსნარი ძალიან პატარა ჯიშის ძაღლებისათვის (1.5-4კგ)
№ 313-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effitix 67 mg/600 mg, Spot-on

fipronil 67.1 mg + permethrin 599.5 mg, spot-on solution for dogs 4-10 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.2/10
Very good
vetman assessment

Effitix

67 mg/600 mg, fipronil 67.1 mg + permethrin 599.5 mg, spot-on solution for dogs 4-10 kg
Assessed clinical scopeDog · Full canine label: flea treatment/prevention and FAD strategy, tick treatment and four-week control, with four-week sand-fly and mosquito repellency when that combined role is clinically required · On the skin
Care settingExact weight-band pipette after weighing and parasite-risk assessment; apply to two to four skin sites, prevent licking, and separate treated dogs from cats until fully dry
vetman score 8.2/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 316-11 · Verified on 15 Oct 2026

A strongly supported four-week flea, tick and vector-repellency option for dogs when the combined role is actually needed. Its value is limited by strict cat-exposure precautions and a more involved application process, not by weak canine efficacy.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

Clinical efficacy8.5/10

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Safety and tolerability7.5/10

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Clinical practicality7.5/10

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats or rabbits. Permethrin exposure is extremely poisonous and may be fatal to cats; keep treated dogs away until the site is fully dry and urgently wash and seek veterinary help after accidental exposure.
  • Do not use in sick, febrile or convalescent dogs or in known hypersensitivity to either active substance or an excipient.
  • Use this fixed combination for confirmed or credible flea and/or tick risk when sand-fly or mosquito repellency is also needed; do not add the permethrin component without a coherent clinical purpose.
  • Do not use below 12 weeks of age or 1.5 kg. Weigh accurately and use the exact weight-band pipette; overdose can increase adverse reactions.
  • Very rare canine reactions include application-site pruritus, erythema or alopecia, vomiting, agitation and neurologic signs. Prevent licking; transient hypersalivation may follow oral exposure.
  • Single ticks or bites by sand flies or mosquitoes may still occur, so pathogen transmission cannot be excluded; some Dermacentor or Rhipicephalus present at application may remain alive for 48 hours.
  • Frequent swimming or shampooing may reduce persistence. Keep dogs out of watercourses for two days, minimise human contact for about 12 hours, and use in pregnancy or lactation only after veterinary benefit-risk assessment.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil67.1 mg Permethrin599.5 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Manufacturer (register)
Virbac, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 952, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფიტიქსი 67მგ/600მგ დასაწვეთებელი ხსნარი პატარა ჯიშის ძაღლებისათვის (4-10კგ)
№ 316-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effitix 134 mg/1200 mg, Spot-on

fipronil 134.2 mg + permethrin 1199 mg, spot-on solution for dogs 10-20 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.2/10
Very good
vetman assessment

Effitix

134 mg/1200 mg, fipronil 134.2 mg + permethrin 1199 mg, spot-on solution for dogs 10-20 kg
Assessed clinical scopeDog · Full canine label: flea treatment/prevention and FAD strategy, tick treatment and four-week control, with four-week sand-fly and mosquito repellency when that combined role is clinically required · On the skin
Care settingExact weight-band pipette after weighing and parasite-risk assessment; apply to two to four skin sites, prevent licking, and separate treated dogs from cats until fully dry
vetman score 8.2/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 317-11 · Verified on 15 Oct 2026

A strongly supported four-week flea, tick and vector-repellency option for dogs when the combined role is actually needed. Its value is limited by strict cat-exposure precautions and a more involved application process, not by weak canine efficacy.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

Clinical efficacy8.5/10

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Safety and tolerability7.5/10

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Clinical practicality7.5/10

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats or rabbits. Permethrin exposure is extremely poisonous and may be fatal to cats; keep treated dogs away until the site is fully dry and urgently wash and seek veterinary help after accidental exposure.
  • Do not use in sick, febrile or convalescent dogs or in known hypersensitivity to either active substance or an excipient.
  • Use this fixed combination for confirmed or credible flea and/or tick risk when sand-fly or mosquito repellency is also needed; do not add the permethrin component without a coherent clinical purpose.
  • Do not use below 12 weeks of age or 1.5 kg. Weigh accurately and use the exact weight-band pipette; overdose can increase adverse reactions.
  • Very rare canine reactions include application-site pruritus, erythema or alopecia, vomiting, agitation and neurologic signs. Prevent licking; transient hypersalivation may follow oral exposure.
  • Single ticks or bites by sand flies or mosquitoes may still occur, so pathogen transmission cannot be excluded; some Dermacentor or Rhipicephalus present at application may remain alive for 48 hours.
  • Frequent swimming or shampooing may reduce persistence. Keep dogs out of watercourses for two days, minimise human contact for about 12 hours, and use in pregnancy or lactation only after veterinary benefit-risk assessment.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil134.2 mg Permethrin1199 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფიტიქსი 134მგ/1200მგ დასაწვეთებელი ხსნარი საშუალო ჯიშის ძაღლებისათვის (10-20კგ)
№ 317-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effitix 268 mg/2400 mg, Spot-on

fipronil 268.4 mg + permethrin 2398 mg, spot-on solution for dogs 20-40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.2/10
Very good
vetman assessment

Effitix

268 mg/2400 mg, fipronil 268.4 mg + permethrin 2398 mg, spot-on solution for dogs 20-40 kg
Assessed clinical scopeDog · Full canine label: flea treatment/prevention and FAD strategy, tick treatment and four-week control, with four-week sand-fly and mosquito repellency when that combined role is clinically required · On the skin
Care settingExact weight-band pipette after weighing and parasite-risk assessment; apply to two to four skin sites, prevent licking, and separate treated dogs from cats until fully dry
vetman score 8.2/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 315-11 · Verified on 15 Oct 2026

A strongly supported four-week flea, tick and vector-repellency option for dogs when the combined role is actually needed. Its value is limited by strict cat-exposure precautions and a more involved application process, not by weak canine efficacy.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

Clinical efficacy8.5/10

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Safety and tolerability7.5/10

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Clinical practicality7.5/10

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats or rabbits. Permethrin exposure is extremely poisonous and may be fatal to cats; keep treated dogs away until the site is fully dry and urgently wash and seek veterinary help after accidental exposure.
  • Do not use in sick, febrile or convalescent dogs or in known hypersensitivity to either active substance or an excipient.
  • Use this fixed combination for confirmed or credible flea and/or tick risk when sand-fly or mosquito repellency is also needed; do not add the permethrin component without a coherent clinical purpose.
  • Do not use below 12 weeks of age or 1.5 kg. Weigh accurately and use the exact weight-band pipette; overdose can increase adverse reactions.
  • Very rare canine reactions include application-site pruritus, erythema or alopecia, vomiting, agitation and neurologic signs. Prevent licking; transient hypersalivation may follow oral exposure.
  • Single ticks or bites by sand flies or mosquitoes may still occur, so pathogen transmission cannot be excluded; some Dermacentor or Rhipicephalus present at application may remain alive for 48 hours.
  • Frequent swimming or shampooing may reduce persistence. Keep dogs out of watercourses for two days, minimise human contact for about 12 hours, and use in pregnancy or lactation only after veterinary benefit-risk assessment.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil268.4 mg Permethrin2398 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფიტიქსი 268მგ/2400მგ დასაწვეთებელი ხსნარი დიდი ჯიშის ძაღლებისათვის (20-40კგ)
№ 315-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Effitix 402 mg/3600 mg, Spot-on

fipronil 402.6 mg + permethrin 3597 mg, spot-on solution for dogs 40-60 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.2/10
Very good
vetman assessment

Effitix

402 mg/3600 mg, fipronil 402.6 mg + permethrin 3597 mg, spot-on solution for dogs 40-60 kg
Assessed clinical scopeDog · Full canine label: flea treatment/prevention and FAD strategy, tick treatment and four-week control, with four-week sand-fly and mosquito repellency when that combined role is clinically required · On the skin
Care settingExact weight-band pipette after weighing and parasite-risk assessment; apply to two to four skin sites, prevent licking, and separate treated dogs from cats until fully dry
vetman score 8.2/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 314-11 · Verified on 15 Oct 2026

A strongly supported four-week flea, tick and vector-repellency option for dogs when the combined role is actually needed. Its value is limited by strict cat-exposure precautions and a more involved application process, not by weak canine efficacy.

Regulatory and scientific credibility9.0/10

All five exact presentations are currently registered in Georgia, with a current regulator-hosted product-line leaflet, a transparent assessment dossier and exact-form evidence.

Clinical efficacy8.5/10

The regulatory dossier and several exact-product controlled or field studies consistently support four-week flea and tick activity plus anti-feeding activity against labelled sand flies and mosquitoes. Some studies are sponsor-linked and bites or attachment are not completely prevented.

Safety and tolerability7.5/10

Correctly selected dogs generally tolerate the label dose well and canine reactions are very rare, but neurologic signs are possible and permethrin exposure can be fatal to cats. Strict species separation, age, weight, illness and reproductive-use restrictions materially shape safe use.

Clinical practicality7.5/10

Monthly weight-band dosing is workable, but application to two to four skin sites, drying time, cat separation, licking prevention and swimming or shampoo restrictions create more handling burden than a simple single-site ectoparasiticide.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on cats or rabbits. Permethrin exposure is extremely poisonous and may be fatal to cats; keep treated dogs away until the site is fully dry and urgently wash and seek veterinary help after accidental exposure.
  • Do not use in sick, febrile or convalescent dogs or in known hypersensitivity to either active substance or an excipient.
  • Use this fixed combination for confirmed or credible flea and/or tick risk when sand-fly or mosquito repellency is also needed; do not add the permethrin component without a coherent clinical purpose.
  • Do not use below 12 weeks of age or 1.5 kg. Weigh accurately and use the exact weight-band pipette; overdose can increase adverse reactions.
  • Very rare canine reactions include application-site pruritus, erythema or alopecia, vomiting, agitation and neurologic signs. Prevent licking; transient hypersalivation may follow oral exposure.
  • Single ticks or bites by sand flies or mosquitoes may still occur, so pathogen transmission cannot be excluded; some Dermacentor or Rhipicephalus present at application may remain alive for 48 hours.
  • Frequent swimming or shampooing may reduce persistence. Keep dogs out of watercourses for two days, minimise human contact for about 12 hours, and use in pregnancy or lactation only after veterinary benefit-risk assessment.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil402.6 mg Permethrin3597 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Virbac · France
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ეფიტიქსი 402გ/3600მგ დასაწვეთებელი ხსნარი ძალიან დიდი ჯიშის ძაღლებისათვის (40-60კგ)
№ 314-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Fipron 2.5 mg/ml, Topical (unspecified)

fipronil 2.5 mg/ml, cutaneous spray for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full labelled canine cutaneous-spray scope for flea, tick and biting-louse control, including labelled flea-allergy-dermatitis support
7.2/10
Good
vetman assessment

Fipron

2.5 mg/ml, fipronil 2.5 mg/ml, cutaneous spray for dogs and cats
Assessed clinical scopeDog · Full labelled canine cutaneous-spray scope for flea, tick and biting-louse control, including labelled flea-allergy-dermatitis support · On the skin
Care settingVeterinary-directed whole-coat ectoparasite treatment with dose calculated by body weight and coat length
vetman score 7.2/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 223-11 · Verified on 15 Oct 2026

An established broad-coverage fipronil spray for dogs and cats, useful when whole-coat treatment is appropriate, but notably less convenient and more exposure-prone than a pipette.

Regulatory and scientific credibility7.5/10

The exact Bioveta spray is registered in Georgia and supported by manufacturer product information plus current official EU information for the same strength, form and target species; exact-product regulatory transparency is less complete than for the spot-ons.

Clinical efficacy7.5/10

Fipronil has established activity against labelled fleas, ticks and lice, but the spray presentation has less direct modern product-specific clinical evidence and performance depends strongly on complete coat coverage and dose accuracy.

Safety and tolerability7.0/10

Usually tolerated, but whole-coat application increases handler and animal exposure; prevent inhalation and licking, avoid eyes and damaged skin, and observe the strict rabbit and environmental warnings.

Clinical practicality6.5/10

Weight- and coat-length dosing requires many pump actuations, full coat wetting, gloves, ventilation and drying time; this is materially more demanding than a single pipette.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in rabbits; serious adverse reactions and death can occur. Use only in the target species stated on the exact presentation.
  • Do not use in sick, systemically ill or convalescent animals; observe the product-specific minimum age and body-weight limits.
  • Apply to intact skin, prevent licking and animal-to-animal grooming until dry, and monitor for local skin reactions or transient hypersalivation.
  • Fipronil is hazardous to aquatic organisms; prevent entry into watercourses and follow label restrictions on bathing and swimming.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full labelled feline cutaneous-spray scope for flea, tick and biting-louse control, including labelled flea-allergy-dermatitis support
7.2/10
Good
vetman assessment

Fipron

2.5 mg/ml, fipronil 2.5 mg/ml, cutaneous spray for dogs and cats
Assessed clinical scopeCat · Full labelled feline cutaneous-spray scope for flea, tick and biting-louse control, including labelled flea-allergy-dermatitis support · On the skin
Care settingVeterinary-directed whole-coat ectoparasite treatment with dose calculated by body weight and coat length
vetman score 7.2/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 223-11 · Verified on 15 Oct 2026

An established broad-coverage fipronil spray for dogs and cats, useful when whole-coat treatment is appropriate, but notably less convenient and more exposure-prone than a pipette.

Regulatory and scientific credibility7.5/10

The exact Bioveta spray is registered in Georgia and supported by manufacturer product information plus current official EU information for the same strength, form and target species; exact-product regulatory transparency is less complete than for the spot-ons.

Clinical efficacy7.5/10

Fipronil has established activity against labelled fleas, ticks and lice, but the spray presentation has less direct modern product-specific clinical evidence and performance depends strongly on complete coat coverage and dose accuracy.

Safety and tolerability7.0/10

Usually tolerated, but whole-coat application increases handler and animal exposure; prevent inhalation and licking, avoid eyes and damaged skin, and observe the strict rabbit and environmental warnings.

Clinical practicality6.5/10

Weight- and coat-length dosing requires many pump actuations, full coat wetting, gloves, ventilation and drying time; this is materially more demanding than a single pipette.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in rabbits; serious adverse reactions and death can occur. Use only in the target species stated on the exact presentation.
  • Do not use in sick, systemically ill or convalescent animals; observe the product-specific minimum age and body-weight limits.
  • Apply to intact skin, prevent licking and animal-to-animal grooming until dry, and monitor for local skin reactions or transient hypersalivation.
  • Fipronil is hazardous to aquatic organisms; prevent entry into watercourses and follow label restrictions on bathing and swimming.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil2.5 mg/ml
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer
Bioveta · Czechia
Registration
Georgia Yes, veterinary
EU Yes, veterinary
Verified on: 15 Oct 2026
UK No
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Fipron 50 mg, Spot-on

fipronil 50 mg, spot-on solution for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
7.9/10
Good
vetman assessment

Fipron

50 mg, fipronil 50 mg, spot-on solution for cats
Assessed clinical scopeCat · Full labelled feline spot-on scope for flea, tick and biting-louse control, including labelled flea-allergy-dermatitis support · On the skin
Care settingVeterinary-selected ectoparasite treatment and prevention using the exact species and weight-band pipette
vetman score 7.9/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 222-11 · Verified on 15 Oct 2026

A practical established fipronil spot-on for labelled ectoparasites when the exact species and weight band are respected; expectations should account for parasite- and environment-dependent residual efficacy.

Regulatory and scientific credibility8.0/10

The exact Bioveta presentations are registered in Georgia and have current or closely matched official EU product information; the evidence base is mature but mostly formulation- and active-level rather than product-specific clinical trials.

Clinical efficacy8.0/10

Controlled and field studies support strong flea, tick and chewing-louse efficacy for correctly dosed fipronil spot-ons, while speed and residual performance vary by parasite, environment, bathing and local susceptibility.

Safety and tolerability7.5/10

Generally well tolerated on intact skin, but licking, local reactions, use in sick or very young animals, species/weight-band errors, rabbit toxicity and aquatic environmental hazard require attention.

Clinical practicality8.5/10

A single whole pipette is simple and the weight bands are clear, but correct skin placement, prevention of licking and avoiding bathing around treatment remain important.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in rabbits; serious adverse reactions and death can occur. Use only in the target species stated on the exact presentation.
  • Do not use in sick, systemically ill or convalescent animals; observe the product-specific minimum age and body-weight limits.
  • Apply to intact skin, prevent licking and animal-to-animal grooming until dry, and monitor for local skin reactions or transient hypersalivation.
  • Fipronil is hazardous to aquatic organisms; prevent entry into watercourses and follow label restrictions on bathing and swimming.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil50 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Bioveta · Czechia
Manufacturer (register)
Bioveta a.s., Czechia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 290, 19 Oct 2026.
Registration
Georgia Yes, veterinary
EU Yes, veterinary
Verified on: 15 Oct 2026
UK No
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Fipron, Spot-on

L 268 mg, fipronil 268 mg, spot-on solution for dogs 20-40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.9/10
Good
vetman assessment

Fipron

L 268 mg, fipronil 268 mg, spot-on solution for dogs 20-40 kg
Assessed clinical scopeDog · Full labelled canine spot-on scope for flea, tick and biting-louse control, including labelled flea-allergy-dermatitis support · On the skin
Care settingVeterinary-selected ectoparasite treatment and prevention using the exact species and weight-band pipette
vetman score 7.9/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 256-11 · Verified on 15 Oct 2026

A practical established fipronil spot-on for labelled ectoparasites when the exact species and weight band are respected; expectations should account for parasite- and environment-dependent residual efficacy.

Regulatory and scientific credibility8.0/10

The exact Bioveta presentations are registered in Georgia and have current or closely matched official EU product information; the evidence base is mature but mostly formulation- and active-level rather than product-specific clinical trials.

Clinical efficacy8.0/10

Controlled and field studies support strong flea, tick and chewing-louse efficacy for correctly dosed fipronil spot-ons, while speed and residual performance vary by parasite, environment, bathing and local susceptibility.

Safety and tolerability7.5/10

Generally well tolerated on intact skin, but licking, local reactions, use in sick or very young animals, species/weight-band errors, rabbit toxicity and aquatic environmental hazard require attention.

Clinical practicality8.5/10

A single whole pipette is simple and the weight bands are clear, but correct skin placement, prevention of licking and avoiding bathing around treatment remain important.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in rabbits; serious adverse reactions and death can occur. Use only in the target species stated on the exact presentation.
  • Do not use in sick, systemically ill or convalescent animals; observe the product-specific minimum age and body-weight limits.
  • Apply to intact skin, prevent licking and animal-to-animal grooming until dry, and monitor for local skin reactions or transient hypersalivation.
  • Fipronil is hazardous to aquatic organisms; prevent entry into watercourses and follow label restrictions on bathing and swimming.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil268 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Bioveta · Czechia
Manufacturer (register)
Bioveta a.s., Czechia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 289, 19 Oct 2026.
Registration
Georgia Yes, veterinary
EU Yes, veterinary
Verified on: 15 Oct 2026
UK No
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Fipron, Spot-on

M 134 mg, fipronil 134 mg, spot-on solution for medium dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.9/10
Good
vetman assessment

Fipron

M 134 mg, fipronil 134 mg, spot-on solution for medium dogs
Assessed clinical scopeDog · Full labelled canine spot-on scope for flea, tick and biting-louse control, including labelled flea-allergy-dermatitis support · On the skin
Care settingVeterinary-selected ectoparasite treatment and prevention using the exact species and weight-band pipette
vetman score 7.9/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 231-11 · Verified on 15 Oct 2026

A practical established fipronil spot-on for labelled ectoparasites when the exact species and weight band are respected; expectations should account for parasite- and environment-dependent residual efficacy.

Regulatory and scientific credibility8.0/10

The exact Bioveta presentations are registered in Georgia and have current or closely matched official EU product information; the evidence base is mature but mostly formulation- and active-level rather than product-specific clinical trials.

Clinical efficacy8.0/10

Controlled and field studies support strong flea, tick and chewing-louse efficacy for correctly dosed fipronil spot-ons, while speed and residual performance vary by parasite, environment, bathing and local susceptibility.

Safety and tolerability7.5/10

Generally well tolerated on intact skin, but licking, local reactions, use in sick or very young animals, species/weight-band errors, rabbit toxicity and aquatic environmental hazard require attention.

Clinical practicality8.5/10

A single whole pipette is simple and the weight bands are clear, but correct skin placement, prevention of licking and avoiding bathing around treatment remain important.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in rabbits; serious adverse reactions and death can occur. Use only in the target species stated on the exact presentation.
  • Do not use in sick, systemically ill or convalescent animals; observe the product-specific minimum age and body-weight limits.
  • Apply to intact skin, prevent licking and animal-to-animal grooming until dry, and monitor for local skin reactions or transient hypersalivation.
  • Fipronil is hazardous to aquatic organisms; prevent entry into watercourses and follow label restrictions on bathing and swimming.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil134 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Bioveta · Czechia
Registration
Georgia Yes, veterinary
EU Yes, veterinary
Verified on: 15 Oct 2026
UK No
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Fipron, Spot-on

S 67 mg, fipronil 67 mg, spot-on solution for small dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.9/10
Good
vetman assessment

Fipron

S 67 mg, fipronil 67 mg, spot-on solution for small dogs
Assessed clinical scopeDog · Full labelled canine spot-on scope for flea, tick and biting-louse control, including labelled flea-allergy-dermatitis support · On the skin
Care settingVeterinary-selected ectoparasite treatment and prevention using the exact species and weight-band pipette
vetman score 7.9/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 221-11 · Verified on 15 Oct 2026

A practical established fipronil spot-on for labelled ectoparasites when the exact species and weight band are respected; expectations should account for parasite- and environment-dependent residual efficacy.

Regulatory and scientific credibility8.0/10

The exact Bioveta presentations are registered in Georgia and have current or closely matched official EU product information; the evidence base is mature but mostly formulation- and active-level rather than product-specific clinical trials.

Clinical efficacy8.0/10

Controlled and field studies support strong flea, tick and chewing-louse efficacy for correctly dosed fipronil spot-ons, while speed and residual performance vary by parasite, environment, bathing and local susceptibility.

Safety and tolerability7.5/10

Generally well tolerated on intact skin, but licking, local reactions, use in sick or very young animals, species/weight-band errors, rabbit toxicity and aquatic environmental hazard require attention.

Clinical practicality8.5/10

A single whole pipette is simple and the weight bands are clear, but correct skin placement, prevention of licking and avoiding bathing around treatment remain important.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in rabbits; serious adverse reactions and death can occur. Use only in the target species stated on the exact presentation.
  • Do not use in sick, systemically ill or convalescent animals; observe the product-specific minimum age and body-weight limits.
  • Apply to intact skin, prevent licking and animal-to-animal grooming until dry, and monitor for local skin reactions or transient hypersalivation.
  • Fipronil is hazardous to aquatic organisms; prevent entry into watercourses and follow label restrictions on bathing and swimming.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil67 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Bioveta · Czechia
Manufacturer (register)
Bioveta a.s., Czechia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 289, 19 Oct 2026.
Registration
Georgia Yes, veterinary
EU Yes, veterinary
Verified on: 15 Oct 2026
UK No
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Fipron, Spot-on

XL 402 mg, fipronil 402 mg, spot-on solution for dogs over 40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.9/10
Good
vetman assessment

Fipron

XL 402 mg, fipronil 402 mg, spot-on solution for dogs over 40 kg
Assessed clinical scopeDog · Full labelled canine spot-on scope for flea, tick and biting-louse control, including labelled flea-allergy-dermatitis support · On the skin
Care settingVeterinary-selected ectoparasite treatment and prevention using the exact species and weight-band pipette
vetman score 7.9/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 255-11 · Verified on 15 Oct 2026

A practical established fipronil spot-on for labelled ectoparasites when the exact species and weight band are respected; expectations should account for parasite- and environment-dependent residual efficacy.

Regulatory and scientific credibility8.0/10

The exact Bioveta presentations are registered in Georgia and have current or closely matched official EU product information; the evidence base is mature but mostly formulation- and active-level rather than product-specific clinical trials.

Clinical efficacy8.0/10

Controlled and field studies support strong flea, tick and chewing-louse efficacy for correctly dosed fipronil spot-ons, while speed and residual performance vary by parasite, environment, bathing and local susceptibility.

Safety and tolerability7.5/10

Generally well tolerated on intact skin, but licking, local reactions, use in sick or very young animals, species/weight-band errors, rabbit toxicity and aquatic environmental hazard require attention.

Clinical practicality8.5/10

A single whole pipette is simple and the weight bands are clear, but correct skin placement, prevention of licking and avoiding bathing around treatment remain important.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use in rabbits; serious adverse reactions and death can occur. Use only in the target species stated on the exact presentation.
  • Do not use in sick, systemically ill or convalescent animals; observe the product-specific minimum age and body-weight limits.
  • Apply to intact skin, prevent licking and animal-to-animal grooming until dry, and monitor for local skin reactions or transient hypersalivation.
  • Fipronil is hazardous to aquatic organisms; prevent entry into watercourses and follow label restrictions on bathing and swimming.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil402 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Bioveta · Czechia
Registration
Georgia Yes, veterinary
EU Yes, veterinary
Verified on: 15 Oct 2026
UK No
Verified on: 15 Oct 2026
US No
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Frontline Combo 50 mg/60 mg, Spot-on

fipronil 50 mg + (S)-methoprene 60 mg, spot-on solution for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
8.1/10
Very good
vetman assessment

Frontline Combo

50 mg/60 mg, fipronil 50 mg + (S)-methoprene 60 mg, spot-on solution for cats
Assessed clinical scopeCat · Full feline label scope: flea infestation, alone or with labelled tick and biting-louse infestations, flea life-cycle suppression and use within a flea-allergy-dermatitis control strategy · On the skin
Care settingSingle correctly matched pipette applied to intact, dry skin after weighing and parasite assessment, alongside environmental flea control when infestation is established
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 182-11, 24-11 · Verified on 15 Oct 2026

A mature, well-documented and locally registered flea-centred ectoparasiticide with useful life-cycle control. It remains a strong option when the exact species and weight pipette is used, but is not a repellent and should not be treated as guaranteed prevention of vector attachment or transmission.

Regulatory and scientific credibility9.0/10

Every exact presentation is currently registered in Georgia and remains authorised in the UK, with current official product records, exact SPCs and more than two decades of regulatory history.

Clinical efficacy7.5/10

Controlled and household field studies support adult-flea control and the added inhibition of eggs and immature stages; labelled tick and biting-louse efficacy is established, but performance depends on correct skin application, parasite species, bathing and local susceptibility.

Safety and tolerability8.0/10

Systemic exposure is low and labelled-dose tolerability is generally favourable, but application-site reactions, transient hypersalivation after licking and rare reversible neurologic or systemic signs can occur. Rabbits must not be treated, and age, weight and illness restrictions apply.

Clinical practicality8.0/10

Monthly weight-band pipettes are straightforward and cover adult fleas plus environmental life stages, but the coat must be parted to reach skin, the site must stay dry, grooming and cross-licking must be prevented, and heavy household infestations require environmental management.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The combined label is flea-centred: use for fleas alone or when fleas occur with labelled ticks and/or biting lice. Do not use the fixed combination for a tick-only or louse-only problem when the added flea life-cycle component is not justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use on sick, febrile or convalescent animals, and observe the exact minimum age and weight limits.
  • Apply directly to intact skin where the animal cannot lick it; separate treated animals until dry. Licking can cause brief marked salivation, and accidental eye or human skin exposure should be rinsed promptly.
  • This product kills after exposure and is not a repellent. Parasites may attach before they die, so transmission of vector-borne infection cannot be completely excluded.
  • Avoid bathing or shampooing around treatment as directed by the exact label, keep the animal away from watercourses during the restricted period, and combine animal treatment with environmental flea control when needed.
  • Use only the feline pipette in cats; dog pipettes are not interchangeable. Confirm body weight and avoid use in kittens younger than 8 weeks or below the exact label minimum weight.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფრონტლაინ კომბო სპოტ-ონ ქეთ
№ 182-11, 24-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
№ EPA 65331-4, 65331-5
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Frontline Combo 67 mg/60.3 mg, Spot-on

fipronil 67 mg + (S)-methoprene 60.3 mg, spot-on solution for dogs 2-10 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.1/10
Very good
vetman assessment

Frontline Combo

67 mg/60.3 mg, fipronil 67 mg + (S)-methoprene 60.3 mg, spot-on solution for dogs 2-10 kg
Assessed clinical scopeDog · Full canine label scope: flea infestation, alone or with labelled tick and biting-louse infestations, flea life-cycle suppression and use within a flea-allergy-dermatitis control strategy · On the skin
Care settingSingle correctly matched pipette applied to intact, dry skin after weighing and parasite assessment, alongside environmental flea control when infestation is established
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 180-11, 21-11 · Verified on 15 Oct 2026

A mature, well-documented and locally registered flea-centred ectoparasiticide with useful life-cycle control. It remains a strong option when the exact species and weight pipette is used, but is not a repellent and should not be treated as guaranteed prevention of vector attachment or transmission.

Regulatory and scientific credibility9.0/10

Every exact presentation is currently registered in Georgia and remains authorised in the UK, with current official product records, exact SPCs and more than two decades of regulatory history.

Clinical efficacy7.5/10

Controlled and household field studies support adult-flea control and the added inhibition of eggs and immature stages; labelled tick and biting-louse efficacy is established, but performance depends on correct skin application, parasite species, bathing and local susceptibility.

Safety and tolerability8.0/10

Systemic exposure is low and labelled-dose tolerability is generally favourable, but application-site reactions, transient hypersalivation after licking and rare reversible neurologic or systemic signs can occur. Rabbits must not be treated, and age, weight and illness restrictions apply.

Clinical practicality8.0/10

Monthly weight-band pipettes are straightforward and cover adult fleas plus environmental life stages, but the coat must be parted to reach skin, the site must stay dry, grooming and cross-licking must be prevented, and heavy household infestations require environmental management.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The combined label is flea-centred: use for fleas alone or when fleas occur with labelled ticks and/or biting lice. Do not use the fixed combination for a tick-only or louse-only problem when the added flea life-cycle component is not justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use on sick, febrile or convalescent animals, and observe the exact minimum age and weight limits.
  • Apply directly to intact skin where the animal cannot lick it; separate treated animals until dry. Licking can cause brief marked salivation, and accidental eye or human skin exposure should be rinsed promptly.
  • This product kills after exposure and is not a repellent. Parasites may attach before they die, so transmission of vector-borne infection cannot be completely excluded.
  • Avoid bathing or shampooing around treatment as directed by the exact label, keep the animal away from watercourses during the restricted period, and combine animal treatment with environmental flea control when needed.
  • Use only the correctly matched canine weight-band pipette. Do not use canine presentations in cats or ferrets because overdose may result; avoid use in puppies younger than 8 weeks or below 2 kg.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil67 mg (S)-Methoprene60.3 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფრონტლაინ კომბო სპოტ-ონ დოგ ეს
№ 180-11, 21-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
№ EPA 65331-4, 65331-5
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Frontline Combo 134 mg/120.6 mg, Spot-on

fipronil 134 mg + (S)-methoprene 120.6 mg, spot-on solution for dogs 10-20 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.1/10
Very good
vetman assessment

Frontline Combo

134 mg/120.6 mg, fipronil 134 mg + (S)-methoprene 120.6 mg, spot-on solution for dogs 10-20 kg
Assessed clinical scopeDog · Full canine label scope: flea infestation, alone or with labelled tick and biting-louse infestations, flea life-cycle suppression and use within a flea-allergy-dermatitis control strategy · On the skin
Care settingSingle correctly matched pipette applied to intact, dry skin after weighing and parasite assessment, alongside environmental flea control when infestation is established
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 183-11, 22-11 · Verified on 15 Oct 2026

A mature, well-documented and locally registered flea-centred ectoparasiticide with useful life-cycle control. It remains a strong option when the exact species and weight pipette is used, but is not a repellent and should not be treated as guaranteed prevention of vector attachment or transmission.

Regulatory and scientific credibility9.0/10

Every exact presentation is currently registered in Georgia and remains authorised in the UK, with current official product records, exact SPCs and more than two decades of regulatory history.

Clinical efficacy7.5/10

Controlled and household field studies support adult-flea control and the added inhibition of eggs and immature stages; labelled tick and biting-louse efficacy is established, but performance depends on correct skin application, parasite species, bathing and local susceptibility.

Safety and tolerability8.0/10

Systemic exposure is low and labelled-dose tolerability is generally favourable, but application-site reactions, transient hypersalivation after licking and rare reversible neurologic or systemic signs can occur. Rabbits must not be treated, and age, weight and illness restrictions apply.

Clinical practicality8.0/10

Monthly weight-band pipettes are straightforward and cover adult fleas plus environmental life stages, but the coat must be parted to reach skin, the site must stay dry, grooming and cross-licking must be prevented, and heavy household infestations require environmental management.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The combined label is flea-centred: use for fleas alone or when fleas occur with labelled ticks and/or biting lice. Do not use the fixed combination for a tick-only or louse-only problem when the added flea life-cycle component is not justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use on sick, febrile or convalescent animals, and observe the exact minimum age and weight limits.
  • Apply directly to intact skin where the animal cannot lick it; separate treated animals until dry. Licking can cause brief marked salivation, and accidental eye or human skin exposure should be rinsed promptly.
  • This product kills after exposure and is not a repellent. Parasites may attach before they die, so transmission of vector-borne infection cannot be completely excluded.
  • Avoid bathing or shampooing around treatment as directed by the exact label, keep the animal away from watercourses during the restricted period, and combine animal treatment with environmental flea control when needed.
  • Use only the correctly matched canine weight-band pipette. Do not use canine presentations in cats or ferrets because overdose may result; avoid use in puppies younger than 8 weeks or below 2 kg.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil134 mg (S)-Methoprene120.6 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფრონტლაინ კომბო სპოტ-ონ დოგ ემ
№ 183-11, 22-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
№ EPA 65331-4, 65331-5
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Frontline Combo 268 mg/241.2 mg, Spot-on

fipronil 268 mg + (S)-methoprene 241.2 mg, spot-on solution for dogs 20-40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.1/10
Very good
vetman assessment

Frontline Combo

268 mg/241.2 mg, fipronil 268 mg + (S)-methoprene 241.2 mg, spot-on solution for dogs 20-40 kg
Assessed clinical scopeDog · Full canine label scope: flea infestation, alone or with labelled tick and biting-louse infestations, flea life-cycle suppression and use within a flea-allergy-dermatitis control strategy · On the skin
Care settingSingle correctly matched pipette applied to intact, dry skin after weighing and parasite assessment, alongside environmental flea control when infestation is established
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 181-11, 23-11 · Verified on 15 Oct 2026

A mature, well-documented and locally registered flea-centred ectoparasiticide with useful life-cycle control. It remains a strong option when the exact species and weight pipette is used, but is not a repellent and should not be treated as guaranteed prevention of vector attachment or transmission.

Regulatory and scientific credibility9.0/10

Every exact presentation is currently registered in Georgia and remains authorised in the UK, with current official product records, exact SPCs and more than two decades of regulatory history.

Clinical efficacy7.5/10

Controlled and household field studies support adult-flea control and the added inhibition of eggs and immature stages; labelled tick and biting-louse efficacy is established, but performance depends on correct skin application, parasite species, bathing and local susceptibility.

Safety and tolerability8.0/10

Systemic exposure is low and labelled-dose tolerability is generally favourable, but application-site reactions, transient hypersalivation after licking and rare reversible neurologic or systemic signs can occur. Rabbits must not be treated, and age, weight and illness restrictions apply.

Clinical practicality8.0/10

Monthly weight-band pipettes are straightforward and cover adult fleas plus environmental life stages, but the coat must be parted to reach skin, the site must stay dry, grooming and cross-licking must be prevented, and heavy household infestations require environmental management.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The combined label is flea-centred: use for fleas alone or when fleas occur with labelled ticks and/or biting lice. Do not use the fixed combination for a tick-only or louse-only problem when the added flea life-cycle component is not justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use on sick, febrile or convalescent animals, and observe the exact minimum age and weight limits.
  • Apply directly to intact skin where the animal cannot lick it; separate treated animals until dry. Licking can cause brief marked salivation, and accidental eye or human skin exposure should be rinsed promptly.
  • This product kills after exposure and is not a repellent. Parasites may attach before they die, so transmission of vector-borne infection cannot be completely excluded.
  • Avoid bathing or shampooing around treatment as directed by the exact label, keep the animal away from watercourses during the restricted period, and combine animal treatment with environmental flea control when needed.
  • Use only the correctly matched canine weight-band pipette. Do not use canine presentations in cats or ferrets because overdose may result; avoid use in puppies younger than 8 weeks or below 2 kg.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil268 mg (S)-Methoprene241.2 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფრონტლაინ კომბო სპოტ-ონ დოგ ელ
№ 181-11, 23-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
№ EPA 65331-4, 65331-5
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Frontline Combo 402 mg/361.8 mg, Spot-on

fipronil 402 mg + (S)-methoprene 361.8 mg, spot-on solution for dogs over 40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
8.1/10
Very good
vetman assessment

Frontline Combo

402 mg/361.8 mg, fipronil 402 mg + (S)-methoprene 361.8 mg, spot-on solution for dogs over 40 kg
Assessed clinical scopeDog · Full canine label scope: flea infestation, alone or with labelled tick and biting-louse infestations, flea life-cycle suppression and use within a flea-allergy-dermatitis control strategy · On the skin
Care settingSingle correctly matched pipette applied to intact, dry skin after weighing and parasite assessment, alongside environmental flea control when infestation is established
vetman score 8.1/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 184-11, 115-11 · Verified on 15 Oct 2026

A mature, well-documented and locally registered flea-centred ectoparasiticide with useful life-cycle control. It remains a strong option when the exact species and weight pipette is used, but is not a repellent and should not be treated as guaranteed prevention of vector attachment or transmission.

Regulatory and scientific credibility9.0/10

Every exact presentation is currently registered in Georgia and remains authorised in the UK, with current official product records, exact SPCs and more than two decades of regulatory history.

Clinical efficacy7.5/10

Controlled and household field studies support adult-flea control and the added inhibition of eggs and immature stages; labelled tick and biting-louse efficacy is established, but performance depends on correct skin application, parasite species, bathing and local susceptibility.

Safety and tolerability8.0/10

Systemic exposure is low and labelled-dose tolerability is generally favourable, but application-site reactions, transient hypersalivation after licking and rare reversible neurologic or systemic signs can occur. Rabbits must not be treated, and age, weight and illness restrictions apply.

Clinical practicality8.0/10

Monthly weight-band pipettes are straightforward and cover adult fleas plus environmental life stages, but the coat must be parted to reach skin, the site must stay dry, grooming and cross-licking must be prevented, and heavy household infestations require environmental management.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • The combined label is flea-centred: use for fleas alone or when fleas occur with labelled ticks and/or biting lice. Do not use the fixed combination for a tick-only or louse-only problem when the added flea life-cycle component is not justified.
  • Never use on rabbits because serious reactions and death can occur. Do not use on sick, febrile or convalescent animals, and observe the exact minimum age and weight limits.
  • Apply directly to intact skin where the animal cannot lick it; separate treated animals until dry. Licking can cause brief marked salivation, and accidental eye or human skin exposure should be rinsed promptly.
  • This product kills after exposure and is not a repellent. Parasites may attach before they die, so transmission of vector-borne infection cannot be completely excluded.
  • Avoid bathing or shampooing around treatment as directed by the exact label, keep the animal away from watercourses during the restricted period, and combine animal treatment with environmental flea control when needed.
  • Use only the correctly matched canine weight-band pipette. Do not use canine presentations in cats or ferrets because overdose may result; avoid use in puppies younger than 8 weeks or below 2 kg.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil402 mg (S)-Methoprene361.8 mg
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Manufacturer (register)
Merial, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 81, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ფრონტლაინ კომბო სპოტ-ონ დოგ იქს ელ
№ 184-11, 115-11
Verified on: 15 Oct 2026
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
№ EPA 65331-4, 65331-5
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Frontline Spray 0.25%, Topical (unspecified)

fipronil 2.5 mg/ml, cutaneous spray 100 ml (0.5 ml per pump) for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full labelled canine scope: treatment and prevention of flea and tick infestations, control of species-specific biting lice, and use within a veterinarian-diagnosed flea-allergy-dermatitis strategy
8.2/10
Very good
vetman assessment

Frontline Spray

0.25%, fipronil 2.5 mg/ml, cutaneous spray 100 ml (0.5 ml per pump) for dogs and cats
Assessed clinical scopeDog · Full labelled canine scope: treatment and prevention of flea and tick infestations, control of species-specific biting lice, and use within a veterinarian-diagnosed flea-allergy-dermatitis strategy · On the skin
Care settingWhole-coat treatment after accurate weighing, with the exact pump output and coat length used to calculate dose; environmental flea control added when indicated
vetman score 8.2/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 84-11 · Verified on 15 Oct 2026

A mature, directly studied and locally registered whole-coat fipronil option with broad labelled ectoparasite coverage. Its main trade-off is demanding dose-by-coat application and greater handler exposure rather than weak efficacy.

Regulatory and scientific credibility9.0/10

Both exact pump presentations are currently registered in Georgia and the same 0.25% product remains authorised by the UK VMD, with an official SPC and a regulatory history dating to 1994.

Clinical efficacy8.5/10

Product-specific field and controlled studies support labelled flea and species-specific biting-louse control in dogs and cats, while the current label supports ticks and residual activity. Outcome still depends on complete coat-to-skin coverage, dose accuracy and environmental challenge.

Safety and tolerability8.0/10

Systemic absorption is negligible and labelled-dose tolerability is generally favourable, including puppies from 2 days of age. Whole-coat alcohol exposure, licking, rare skin or neurologic reactions, flammability and rabbit/aquatic toxicity still require strict precautions.

Clinical practicality6.5/10

Dose is weight- and coat-length dependent and requires full coat wetting: 6-12 pump actions/kg with the 100 ml bottle or 2-4/kg with the 250/500 ml bottle, plus gloves, ventilation, fire precautions and natural drying. This is materially more laborious than a pipette.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on rabbits; serious reactions and death can occur. Do not use on sick, febrile or convalescent animals.
  • The hydro-alcoholic spray is highly flammable. Apply outdoors or in a well-ventilated room, away from flame and heat; do not inhale it, and keep the animal away from heat until the coat is completely dry.
  • Weigh accurately, dampen the entire coat down to the skin and prevent licking or mutual grooming until dry. Avoid eyes and broken skin; head application should be made via a gloved hand.
  • Do not use simultaneously with another flea product applied directly to the animal. Treat in-contact animals with an appropriate product and manage bedding and the environment when infestation is established.
  • Single ticks may still attach and infection transmission cannot be completely excluded. The product is not a repellent and is not for direct environmental treatment.
  • Fipronil is hazardous to aquatic organisms. Keep treated dogs out of watercourses for 2 days and prevent product or containers from contaminating water.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full labelled feline scope: treatment and prevention of flea and tick infestations, control of species-specific biting lice, and use within a veterinarian-diagnosed flea-allergy-dermatitis strategy
8.0/10
Very good
vetman assessment

Frontline Spray

0.25%, fipronil 2.5 mg/ml, cutaneous spray 100 ml (0.5 ml per pump) for dogs and cats
Assessed clinical scopeCat · Full labelled feline scope: treatment and prevention of flea and tick infestations, control of species-specific biting lice, and use within a veterinarian-diagnosed flea-allergy-dermatitis strategy · On the skin
Care settingWhole-coat treatment after accurate weighing, with the exact pump output and coat length used to calculate dose; environmental flea control added when indicated
vetman score 8.0/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 84-11 · Verified on 15 Oct 2026

A mature, directly studied and locally registered whole-coat fipronil option with broad labelled ectoparasite coverage. It is useful even from a very young labelled age, but application is demanding and pregnancy/lactation data in queens are absent.

Regulatory and scientific credibility9.0/10

Both exact pump presentations are currently registered in Georgia and the same 0.25% product remains authorised by the UK VMD, with an official SPC and a regulatory history dating to 1994.

Clinical efficacy8.5/10

Product-specific field and controlled studies support labelled flea and species-specific biting-louse control in dogs and cats, while the current label supports ticks and residual activity. Outcome still depends on complete coat-to-skin coverage, dose accuracy and environmental challenge.

Safety and tolerability7.5/10

Systemic absorption is low and labelled-dose tolerability is generally favourable, including kittens from 2 days of age. Whole-coat alcohol exposure, licking, rare skin or neurologic reactions, flammability and rabbit/aquatic toxicity require strict precautions; data are unavailable for pregnant or nursing queens.

Clinical practicality6.5/10

Dose is weight- and coat-length dependent and requires full coat wetting: 6-12 pump actions/kg with the 100 ml bottle or 2-4/kg with the 250/500 ml bottle, plus gloves, ventilation, fire precautions and natural drying. This is materially more laborious than a pipette.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on rabbits; serious reactions and death can occur. Do not use on sick, febrile or convalescent animals.
  • The hydro-alcoholic spray is highly flammable. Apply outdoors or in a well-ventilated room, away from flame and heat; do not inhale it, and keep the animal away from heat until the coat is completely dry.
  • Weigh accurately, dampen the entire coat down to the skin and prevent licking or mutual grooming until dry. Avoid eyes and broken skin; head application should be made via a gloved hand.
  • Do not use simultaneously with another flea product applied directly to the animal. Treat in-contact animals with an appropriate product and manage bedding and the environment when infestation is established.
  • Single ticks may still attach and infection transmission cannot be completely excluded. The product is not a repellent and is not for direct environmental treatment.
  • Fipronil is hazardous to aquatic organisms. Keep treated dogs out of watercourses for 2 days and prevent product or containers from contaminating water.
  • Data are unavailable for treatment of pregnant or nursing queens; do not infer reproductive safety from the canine label.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil2.5 mg/ml
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer
Registration
Georgia Yes, veterinary
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
№ EPA 65331-1
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Frontline Spray 0.25%, Topical (unspecified)

fipronil 2.5 mg/ml, cutaneous spray 250 ml or 500 ml (1.5 ml per pump) for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full labelled canine scope: treatment and prevention of flea and tick infestations, control of species-specific biting lice, and use within a veterinarian-diagnosed flea-allergy-dermatitis strategy
8.2/10
Very good
vetman assessment

Frontline Spray

0.25%, fipronil 2.5 mg/ml, cutaneous spray 250 ml or 500 ml (1.5 ml per pump) for dogs and cats
Assessed clinical scopeDog · Full labelled canine scope: treatment and prevention of flea and tick infestations, control of species-specific biting lice, and use within a veterinarian-diagnosed flea-allergy-dermatitis strategy · On the skin
Care settingWhole-coat treatment after accurate weighing, with the exact pump output and coat length used to calculate dose; environmental flea control added when indicated
vetman score 8.2/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 121-11 · Verified on 15 Oct 2026

A mature, directly studied and locally registered whole-coat fipronil option with broad labelled ectoparasite coverage. Its main trade-off is demanding dose-by-coat application and greater handler exposure rather than weak efficacy.

Regulatory and scientific credibility9.0/10

Both exact pump presentations are currently registered in Georgia and the same 0.25% product remains authorised by the UK VMD, with an official SPC and a regulatory history dating to 1994.

Clinical efficacy8.5/10

Product-specific field and controlled studies support labelled flea and species-specific biting-louse control in dogs and cats, while the current label supports ticks and residual activity. Outcome still depends on complete coat-to-skin coverage, dose accuracy and environmental challenge.

Safety and tolerability8.0/10

Systemic absorption is negligible and labelled-dose tolerability is generally favourable, including puppies from 2 days of age. Whole-coat alcohol exposure, licking, rare skin or neurologic reactions, flammability and rabbit/aquatic toxicity still require strict precautions.

Clinical practicality6.5/10

Dose is weight- and coat-length dependent and requires full coat wetting: 6-12 pump actions/kg with the 100 ml bottle or 2-4/kg with the 250/500 ml bottle, plus gloves, ventilation, fire precautions and natural drying. This is materially more laborious than a pipette.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on rabbits; serious reactions and death can occur. Do not use on sick, febrile or convalescent animals.
  • The hydro-alcoholic spray is highly flammable. Apply outdoors or in a well-ventilated room, away from flame and heat; do not inhale it, and keep the animal away from heat until the coat is completely dry.
  • Weigh accurately, dampen the entire coat down to the skin and prevent licking or mutual grooming until dry. Avoid eyes and broken skin; head application should be made via a gloved hand.
  • Do not use simultaneously with another flea product applied directly to the animal. Treat in-contact animals with an appropriate product and manage bedding and the environment when infestation is established.
  • Single ticks may still attach and infection transmission cannot be completely excluded. The product is not a repellent and is not for direct environmental treatment.
  • Fipronil is hazardous to aquatic organisms. Keep treated dogs out of watercourses for 2 days and prevent product or containers from contaminating water.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full labelled feline scope: treatment and prevention of flea and tick infestations, control of species-specific biting lice, and use within a veterinarian-diagnosed flea-allergy-dermatitis strategy
8.0/10
Very good
vetman assessment

Frontline Spray

0.25%, fipronil 2.5 mg/ml, cutaneous spray 250 ml or 500 ml (1.5 ml per pump) for dogs and cats
Assessed clinical scopeCat · Full labelled feline scope: treatment and prevention of flea and tick infestations, control of species-specific biting lice, and use within a veterinarian-diagnosed flea-allergy-dermatitis strategy · On the skin
Care settingWhole-coat treatment after accurate weighing, with the exact pump output and coat length used to calculate dose; environmental flea control added when indicated
vetman score 8.0/10 Very good
Evidence confidence: High Georgia: Yes, veterinary · № 121-11 · Verified on 15 Oct 2026

A mature, directly studied and locally registered whole-coat fipronil option with broad labelled ectoparasite coverage. It is useful even from a very young labelled age, but application is demanding and pregnancy/lactation data in queens are absent.

Regulatory and scientific credibility9.0/10

Both exact pump presentations are currently registered in Georgia and the same 0.25% product remains authorised by the UK VMD, with an official SPC and a regulatory history dating to 1994.

Clinical efficacy8.5/10

Product-specific field and controlled studies support labelled flea and species-specific biting-louse control in dogs and cats, while the current label supports ticks and residual activity. Outcome still depends on complete coat-to-skin coverage, dose accuracy and environmental challenge.

Safety and tolerability7.5/10

Systemic absorption is low and labelled-dose tolerability is generally favourable, including kittens from 2 days of age. Whole-coat alcohol exposure, licking, rare skin or neurologic reactions, flammability and rabbit/aquatic toxicity require strict precautions; data are unavailable for pregnant or nursing queens.

Clinical practicality6.5/10

Dose is weight- and coat-length dependent and requires full coat wetting: 6-12 pump actions/kg with the 100 ml bottle or 2-4/kg with the 250/500 ml bottle, plus gloves, ventilation, fire precautions and natural drying. This is materially more laborious than a pipette.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Never use on rabbits; serious reactions and death can occur. Do not use on sick, febrile or convalescent animals.
  • The hydro-alcoholic spray is highly flammable. Apply outdoors or in a well-ventilated room, away from flame and heat; do not inhale it, and keep the animal away from heat until the coat is completely dry.
  • Weigh accurately, dampen the entire coat down to the skin and prevent licking or mutual grooming until dry. Avoid eyes and broken skin; head application should be made via a gloved hand.
  • Do not use simultaneously with another flea product applied directly to the animal. Treat in-contact animals with an appropriate product and manage bedding and the environment when infestation is established.
  • Single ticks may still attach and infection transmission cannot be completely excluded. The product is not a repellent and is not for direct environmental treatment.
  • Fipronil is hazardous to aquatic organisms. Keep treated dogs out of watercourses for 2 days and prevent product or containers from contaminating water.
  • Data are unavailable for treatment of pregnant or nursing queens; do not infer reproductive safety from the canine label.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil2.5 mg/ml
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer
Manufacturer (register)
Boehringer Ingelheim Animal Health France SCS, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 615, 19 Oct 2026.
Registration
Georgia Yes, veterinary
EU Yes, veterinary
Verified on: 15 Oct 2026
UK Yes, veterinary
Verified on: 15 Oct 2026
US Yes, veterinary
№ EPA 65331-1
Verified on: 15 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
4.7/10
Weak evidence support
vetman assessment

IN-UP Complex

100/50/4 mg/ml spot-on, 0.5 ml for dogs 1-5 kg
Assessed clinical scopeDog · Full labelled canine topical scope in the exact weight band: fleas, lice, biting lice and ixodid ticks; gastrointestinal nematodes and cestodes; heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite-risk and heartworm assessment, with diagnostic follow-up for established infection
vetman score 4.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000909 · Verified on 21 Oct 2026

The exact product is identifiable and locally registered, but its unusually broad topical claims are supported mainly by the current instruction and indirect, old or formulation-mismatched evidence. Prefer better-documented parasite-specific options when available; if selected, use the exact weight band with explicit heartworm assessment and follow-up.

Regulatory and scientific credibility4.0/10

The exact presentations are currently registered in Georgia and a current instruction plus a register-derived Russian record confirm identity, composition and labelled use. No EMA/FDA-style public assessment or transparent exact-product efficacy dossier was found; the available studies are old and use other aversectin combinations or routes, so the evidence gate applies.

Clinical efficacy4.0/10

Fipronil spot-on trials support ectoparasite activity and an older Avertel study supports the biological plausibility of aversectin C1 plus praziquantel against several endo- and ectoparasites. Neither source tests this exact topical triple combination, and the broad 6-7-week ectoparasite/helminth scope plus monthly heartworm prevention lacks robust independent exact-product trials.

Safety and tolerability4.5/10

The current instruction describes rare local reactions at the labelled dose but public target-animal safety data for the exact formulation are limited. Aversectin sensitivity, licking or overdose reactions, young/sick/debilitated patients, reproductive use, concurrent antiparasitics and environmental toxicity require explicit safeguards.

Clinical practicality7.5/10

A whole weight-banded pipette makes dose selection straightforward and administration is a single topical event. Correct skin placement, prevention of licking, 48 hours without washing or close human contact and different general-parasite versus heartworm intervals add meaningful treatment burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with known hypersensitivity, in animals below 2 months of age, in infectious disease or debilitation, or on wet or damaged skin.
  • Do not use concurrently with another antiparasitic because toxicity may be potentiated. Interaction information for other medicine classes is unavailable.
  • The instruction does not recommend use in Collies, Shelties or Bobtails because of avermectin sensitivity; resolve ABCB1 risk before considering use in any susceptible dog.
  • Prevent licking and observe until dry. Local erythema or pruritus may occur; overdose or oral exposure can cause depression, hypersalivation and vomiting—wash the product off and assess clinically.
  • During pregnancy or lactation, use only under veterinary supervision after an individual benefit-risk assessment; robust reproductive safety data for the exact combination were not found.
  • This is prevention against susceptible Dirofilaria larval stages, not treatment of adult heartworm disease. Assess exposure and infection status before prophylaxis and follow current heartworm guidance.
  • Apply the exact whole-pipette dose directly to dry intact skin where it cannot be licked. Do not wash with detergent for 48 hours; avoid stroking and contact with small children for 48 hours.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Praziquantel100 mg/ml Fipronil50 mg/ml Aversectin C14 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
AstraFarm · Russia
Manufacturer (register)
Scientific Innovative Enterprise Astrafarm Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1454, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 23 Mar 2028
Veterinary (National Food Agency)
In the register: ინ-აპ კომპლექსი®
№ 000909
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
4.6/10
Weak evidence support
vetman assessment

IN-UP Complex

100/50/4 mg/ml spot-on, 0.5 ml N2 for cats
Assessed clinical scopeCat · Full labelled feline topical scope for this 0.5 ml dose in cats 1-5 kg: fleas, lice, biting lice and ixodid ticks; gastrointestinal nematodes and cestodes; heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite-risk and heartworm assessment, with diagnostic follow-up for established infection
vetman score 4.6/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000905 · Verified on 21 Oct 2026

The exact product is identifiable and locally registered, but its unusually broad topical claims are supported mainly by the current instruction and indirect, old or formulation-mismatched evidence. Prefer better-documented parasite-specific options when available; if selected, use the exact weight band with explicit heartworm assessment and follow-up.

Regulatory and scientific credibility4.0/10

The exact presentations are currently registered in Georgia and a current instruction plus a register-derived Russian record confirm identity, composition and labelled use. No EMA/FDA-style public assessment or transparent exact-product efficacy dossier was found; the available studies are old and use other aversectin combinations or routes, so the evidence gate applies.

Clinical efficacy4.0/10

Fipronil spot-on trials support ectoparasite activity and an older Avertel study supports the biological plausibility of aversectin C1 plus praziquantel against several endo- and ectoparasites. Neither source tests this exact topical triple combination, and the broad 6-7-week ectoparasite/helminth scope plus monthly heartworm prevention lacks robust independent exact-product trials.

Safety and tolerability4.5/10

The current instruction describes rare local reactions at the labelled dose but public target-animal safety data for the exact formulation are limited. Aversectin sensitivity, licking or overdose reactions, young/sick/debilitated patients, reproductive use, concurrent antiparasitics and environmental toxicity require explicit safeguards.

Clinical practicality7.0/10

The two-pipette pack provides a clear 0.5 ml whole-pipette dose for cats 1-5 kg, but feline grooming makes placement and separation until dry important. The animal must remain unwashed for 48 hours, human contact is restricted for 48 hours and the prevention interval differs between general parasites and heartworm.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with known hypersensitivity, in animals below 2 months of age, in infectious disease or debilitation, or on wet or damaged skin.
  • Do not use concurrently with another antiparasitic because toxicity may be potentiated. Interaction information for other medicine classes is unavailable.
  • Prevent licking and observe until dry. Local erythema or pruritus may occur; overdose or oral exposure can cause depression, hypersalivation and vomiting—wash the product off and assess clinically.
  • During pregnancy or lactation, use only under veterinary supervision after an individual benefit-risk assessment; robust reproductive safety data for the exact combination were not found.
  • This is prevention against susceptible Dirofilaria larval stages, not treatment of adult heartworm disease. Assess exposure and infection status before prophylaxis and follow current heartworm guidance.
  • Apply the exact whole-pipette dose directly to dry intact skin where it cannot be licked. Do not wash with detergent for 48 hours; avoid stroking and contact with small children for 48 hours.
  • The broad exact-product efficacy claims are not supported by robust independent trials. Confirm the actual parasite problem and reassess response rather than treating the label breadth as proof of coverage.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Praziquantel100 mg/ml Fipronil50 mg/ml Aversectin C14 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
AstraFarm · Russia
Manufacturer (register)
Scientific Implementation Enterprise Astrafarm Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1449, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 23 Mar 2028
Veterinary (National Food Agency)
In the register: ინ-აპ კომპლექსი® 10-20კგ
№ 000905
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
4.7/10
Weak evidence support
vetman assessment

IN-UP Complex

100/50/4 mg/ml spot-on, 1 ml for dogs over 5-10 kg
Assessed clinical scopeDog · Full labelled canine topical scope in the exact weight band: fleas, lice, biting lice and ixodid ticks; gastrointestinal nematodes and cestodes; heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite-risk and heartworm assessment, with diagnostic follow-up for established infection
vetman score 4.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000908 · Verified on 21 Oct 2026

The exact product is identifiable and locally registered, but its unusually broad topical claims are supported mainly by the current instruction and indirect, old or formulation-mismatched evidence. Prefer better-documented parasite-specific options when available; if selected, use the exact weight band with explicit heartworm assessment and follow-up.

Regulatory and scientific credibility4.0/10

The exact presentations are currently registered in Georgia and a current instruction plus a register-derived Russian record confirm identity, composition and labelled use. No EMA/FDA-style public assessment or transparent exact-product efficacy dossier was found; the available studies are old and use other aversectin combinations or routes, so the evidence gate applies.

Clinical efficacy4.0/10

Fipronil spot-on trials support ectoparasite activity and an older Avertel study supports the biological plausibility of aversectin C1 plus praziquantel against several endo- and ectoparasites. Neither source tests this exact topical triple combination, and the broad 6-7-week ectoparasite/helminth scope plus monthly heartworm prevention lacks robust independent exact-product trials.

Safety and tolerability4.5/10

The current instruction describes rare local reactions at the labelled dose but public target-animal safety data for the exact formulation are limited. Aversectin sensitivity, licking or overdose reactions, young/sick/debilitated patients, reproductive use, concurrent antiparasitics and environmental toxicity require explicit safeguards.

Clinical practicality7.5/10

A whole weight-banded pipette makes dose selection straightforward and administration is a single topical event. Correct skin placement, prevention of licking, 48 hours without washing or close human contact and different general-parasite versus heartworm intervals add meaningful treatment burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with known hypersensitivity, in animals below 2 months of age, in infectious disease or debilitation, or on wet or damaged skin.
  • Do not use concurrently with another antiparasitic because toxicity may be potentiated. Interaction information for other medicine classes is unavailable.
  • The instruction does not recommend use in Collies, Shelties or Bobtails because of avermectin sensitivity; resolve ABCB1 risk before considering use in any susceptible dog.
  • Prevent licking and observe until dry. Local erythema or pruritus may occur; overdose or oral exposure can cause depression, hypersalivation and vomiting—wash the product off and assess clinically.
  • During pregnancy or lactation, use only under veterinary supervision after an individual benefit-risk assessment; robust reproductive safety data for the exact combination were not found.
  • This is prevention against susceptible Dirofilaria larval stages, not treatment of adult heartworm disease. Assess exposure and infection status before prophylaxis and follow current heartworm guidance.
  • Apply the exact whole-pipette dose directly to dry intact skin where it cannot be licked. Do not wash with detergent for 48 hours; avoid stroking and contact with small children for 48 hours.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Praziquantel100 mg/ml Fipronil50 mg/ml Aversectin C14 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
AstraFarm · Russia
Manufacturer (register)
Scientific Innovative Enterprise Astrafarm Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1453, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 23 Mar 2028
Veterinary (National Food Agency)
In the register: ინ-აპ კომპლექსი®
№ 000908
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

IN-UP Complex 100/50/4 mg/ml spot-on, Spot-on

2 ml for dogs over 10-20 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
4.7/10
Weak evidence support
vetman assessment

IN-UP Complex

100/50/4 mg/ml spot-on, 2 ml for dogs over 10-20 kg
Assessed clinical scopeDog · Full labelled canine topical scope in the exact weight band: fleas, lice, biting lice and ixodid ticks; gastrointestinal nematodes and cestodes; heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite-risk and heartworm assessment, with diagnostic follow-up for established infection
vetman score 4.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000920 · Verified on 21 Oct 2026

The exact product is identifiable and locally registered, but its unusually broad topical claims are supported mainly by the current instruction and indirect, old or formulation-mismatched evidence. Prefer better-documented parasite-specific options when available; if selected, use the exact weight band with explicit heartworm assessment and follow-up.

Regulatory and scientific credibility4.0/10

The exact presentations are currently registered in Georgia and a current instruction plus a register-derived Russian record confirm identity, composition and labelled use. No EMA/FDA-style public assessment or transparent exact-product efficacy dossier was found; the available studies are old and use other aversectin combinations or routes, so the evidence gate applies.

Clinical efficacy4.0/10

Fipronil spot-on trials support ectoparasite activity and an older Avertel study supports the biological plausibility of aversectin C1 plus praziquantel against several endo- and ectoparasites. Neither source tests this exact topical triple combination, and the broad 6-7-week ectoparasite/helminth scope plus monthly heartworm prevention lacks robust independent exact-product trials.

Safety and tolerability4.5/10

The current instruction describes rare local reactions at the labelled dose but public target-animal safety data for the exact formulation are limited. Aversectin sensitivity, licking or overdose reactions, young/sick/debilitated patients, reproductive use, concurrent antiparasitics and environmental toxicity require explicit safeguards.

Clinical practicality7.5/10

A whole weight-banded pipette makes dose selection straightforward and administration is a single topical event. Correct skin placement, prevention of licking, 48 hours without washing or close human contact and different general-parasite versus heartworm intervals add meaningful treatment burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with known hypersensitivity, in animals below 2 months of age, in infectious disease or debilitation, or on wet or damaged skin.
  • Do not use concurrently with another antiparasitic because toxicity may be potentiated. Interaction information for other medicine classes is unavailable.
  • The instruction does not recommend use in Collies, Shelties or Bobtails because of avermectin sensitivity; resolve ABCB1 risk before considering use in any susceptible dog.
  • Prevent licking and observe until dry. Local erythema or pruritus may occur; overdose or oral exposure can cause depression, hypersalivation and vomiting—wash the product off and assess clinically.
  • During pregnancy or lactation, use only under veterinary supervision after an individual benefit-risk assessment; robust reproductive safety data for the exact combination were not found.
  • This is prevention against susceptible Dirofilaria larval stages, not treatment of adult heartworm disease. Assess exposure and infection status before prophylaxis and follow current heartworm guidance.
  • Apply the exact whole-pipette dose directly to dry intact skin where it cannot be licked. Do not wash with detergent for 48 hours; avoid stroking and contact with small children for 48 hours.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Praziquantel100 mg/ml Fipronil50 mg/ml Aversectin C14 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
AstraFarm · Russia
Manufacturer (register)
Scientific Implementation Enterprise Astrafarm Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1465, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 23 Mar 2028
Veterinary (National Food Agency)
In the register: ინ-აპ კომპლექსი®
№ 000920
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

IN-UP Complex 100/50/4 mg/ml spot-on, Spot-on

3 ml for dogs over 20-30 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
4.7/10
Weak evidence support
vetman assessment

IN-UP Complex

100/50/4 mg/ml spot-on, 3 ml for dogs over 20-30 kg
Assessed clinical scopeDog · Full labelled canine topical scope in the exact weight band: fleas, lice, biting lice and ixodid ticks; gastrointestinal nematodes and cestodes; heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite-risk and heartworm assessment, with diagnostic follow-up for established infection
vetman score 4.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000922 · Verified on 21 Oct 2026

The exact product is identifiable and locally registered, but its unusually broad topical claims are supported mainly by the current instruction and indirect, old or formulation-mismatched evidence. Prefer better-documented parasite-specific options when available; if selected, use the exact weight band with explicit heartworm assessment and follow-up.

Regulatory and scientific credibility4.0/10

The exact presentations are currently registered in Georgia and a current instruction plus a register-derived Russian record confirm identity, composition and labelled use. No EMA/FDA-style public assessment or transparent exact-product efficacy dossier was found; the available studies are old and use other aversectin combinations or routes, so the evidence gate applies.

Clinical efficacy4.0/10

Fipronil spot-on trials support ectoparasite activity and an older Avertel study supports the biological plausibility of aversectin C1 plus praziquantel against several endo- and ectoparasites. Neither source tests this exact topical triple combination, and the broad 6-7-week ectoparasite/helminth scope plus monthly heartworm prevention lacks robust independent exact-product trials.

Safety and tolerability4.5/10

The current instruction describes rare local reactions at the labelled dose but public target-animal safety data for the exact formulation are limited. Aversectin sensitivity, licking or overdose reactions, young/sick/debilitated patients, reproductive use, concurrent antiparasitics and environmental toxicity require explicit safeguards.

Clinical practicality7.5/10

A whole weight-banded pipette makes dose selection straightforward and administration is a single topical event. Correct skin placement, prevention of licking, 48 hours without washing or close human contact and different general-parasite versus heartworm intervals add meaningful treatment burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with known hypersensitivity, in animals below 2 months of age, in infectious disease or debilitation, or on wet or damaged skin.
  • Do not use concurrently with another antiparasitic because toxicity may be potentiated. Interaction information for other medicine classes is unavailable.
  • The instruction does not recommend use in Collies, Shelties or Bobtails because of avermectin sensitivity; resolve ABCB1 risk before considering use in any susceptible dog.
  • Prevent licking and observe until dry. Local erythema or pruritus may occur; overdose or oral exposure can cause depression, hypersalivation and vomiting—wash the product off and assess clinically.
  • During pregnancy or lactation, use only under veterinary supervision after an individual benefit-risk assessment; robust reproductive safety data for the exact combination were not found.
  • This is prevention against susceptible Dirofilaria larval stages, not treatment of adult heartworm disease. Assess exposure and infection status before prophylaxis and follow current heartworm guidance.
  • Apply the exact whole-pipette dose directly to dry intact skin where it cannot be licked. Do not wash with detergent for 48 hours; avoid stroking and contact with small children for 48 hours.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Praziquantel100 mg/ml Fipronil50 mg/ml Aversectin C14 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
AstraFarm · Russia
Manufacturer (register)
Scientific Implementation Enterprise Astrafarm Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1467, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 23 Mar 2028
Veterinary (National Food Agency)
In the register: ინ-აპ კომპლექსი®
№ 000922
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

IN-UP Complex 100/50/4 mg/ml spot-on, Spot-on

5 ml for dogs over 30-50 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
4.7/10
Weak evidence support
vetman assessment

IN-UP Complex

100/50/4 mg/ml spot-on, 5 ml for dogs over 30-50 kg
Assessed clinical scopeDog · Full labelled canine topical scope in the exact weight band: fleas, lice, biting lice and ixodid ticks; gastrointestinal nematodes and cestodes; heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite-risk and heartworm assessment, with diagnostic follow-up for established infection
vetman score 4.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000904 · Verified on 21 Oct 2026

The exact product is identifiable and locally registered, but its unusually broad topical claims are supported mainly by the current instruction and indirect, old or formulation-mismatched evidence. Prefer better-documented parasite-specific options when available; if selected, use the exact weight band with explicit heartworm assessment and follow-up.

Regulatory and scientific credibility4.0/10

The exact presentations are currently registered in Georgia and a current instruction plus a register-derived Russian record confirm identity, composition and labelled use. No EMA/FDA-style public assessment or transparent exact-product efficacy dossier was found; the available studies are old and use other aversectin combinations or routes, so the evidence gate applies.

Clinical efficacy4.0/10

Fipronil spot-on trials support ectoparasite activity and an older Avertel study supports the biological plausibility of aversectin C1 plus praziquantel against several endo- and ectoparasites. Neither source tests this exact topical triple combination, and the broad 6-7-week ectoparasite/helminth scope plus monthly heartworm prevention lacks robust independent exact-product trials.

Safety and tolerability4.5/10

The current instruction describes rare local reactions at the labelled dose but public target-animal safety data for the exact formulation are limited. Aversectin sensitivity, licking or overdose reactions, young/sick/debilitated patients, reproductive use, concurrent antiparasitics and environmental toxicity require explicit safeguards.

Clinical practicality7.5/10

A whole weight-banded pipette makes dose selection straightforward and administration is a single topical event. Correct skin placement, prevention of licking, 48 hours without washing or close human contact and different general-parasite versus heartworm intervals add meaningful treatment burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with known hypersensitivity, in animals below 2 months of age, in infectious disease or debilitation, or on wet or damaged skin.
  • Do not use concurrently with another antiparasitic because toxicity may be potentiated. Interaction information for other medicine classes is unavailable.
  • The instruction does not recommend use in Collies, Shelties or Bobtails because of avermectin sensitivity; resolve ABCB1 risk before considering use in any susceptible dog.
  • Prevent licking and observe until dry. Local erythema or pruritus may occur; overdose or oral exposure can cause depression, hypersalivation and vomiting—wash the product off and assess clinically.
  • During pregnancy or lactation, use only under veterinary supervision after an individual benefit-risk assessment; robust reproductive safety data for the exact combination were not found.
  • This is prevention against susceptible Dirofilaria larval stages, not treatment of adult heartworm disease. Assess exposure and infection status before prophylaxis and follow current heartworm guidance.
  • Apply the exact whole-pipette dose directly to dry intact skin where it cannot be licked. Do not wash with detergent for 48 hours; avoid stroking and contact with small children for 48 hours.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Praziquantel100 mg/ml Fipronil50 mg/ml Aversectin C14 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
AstraFarm · Russia
Manufacturer (register)
Scientific Implementation Enterprise Astrafarm Ltd, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1448, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 23 Mar 2028
Veterinary (National Food Agency)
In the register: ინ-აპ კომპლექსი®
№ 000904
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

Insectostop, Spot-on

fipronil 100 mg/ml spot-on, 0.5 ml N6 for puppies and kittens
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal
3.8/10
Poor / unconvincing
vetman assessment

Insectostop

fipronil 100 mg/ml spot-on, 0.5 ml N6 for puppies and kittens
Assessed clinical scopeDog · Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal · auricular
Care settingVeterinary diagnosis after otoscopy and microscopy; clean the external canal, verify tympanic membrane integrity and reassess before repetition.
vetman score 3.8/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000614 · Verified on 21 Oct 2026

The exact label names otodectosis but omits the ear dose; this makes the regimen clinically non-reproducible despite Georgian registration. Do not infer a quantity from another fipronil product.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current ProVET instruction identifies the exact juvenile 0.5 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy3.5/10

The exact instruction names otodectosis and describes bilateral cleaning and application, but gives no amount. No exact-product controlled otic efficacy study was found, and spot-on flea/tick studies cannot validate an unstated ear-canal dose.

Safety and tolerability3.5/10

Exact-formulation ear-canal safety and ototoxicity data were not found. The absent quantity prevents a reproducible exposure assessment. Use only after confirming an intact tympanic membrane; stop for pain, neurologic signs, marked irritation or hearing change. Class safety from dermal spot-on use cannot be assumed to prove otic safety.

Clinical practicality3.0/10

Cleaning, bilateral application and 7-10 day microscopy-guided reassessment are described, but the instruction gives no number of drops or volume. A clinician cannot reproduce or calculate the regimen responsibly; use an explicitly dosed otic alternative.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Confirm otodectosis by otoscopy/microscopy and verify an intact tympanic membrane before use. Do not apply into a perforated, unvisualised, severely inflamed or neurologically abnormal ear.
  • The exact instruction gives no auricular quantity. Do not infer drops or volume from another fipronil product; select an explicitly dosed alternative.
  • Spot-on flea/tick efficacy and dermal safety studies do not establish efficacy or ototoxicity safety for this exact repeated ear-canal regimen. Evidence confidence is low.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The public exact instruction does not establish reproductive safety. Use in pregnancy, breeding or lactation only when a veterinarian documents a favourable benefit-risk and no better-characterised option is suitable.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Dog Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them
5.4/10
Weak evidence support
vetman assessment

Insectostop

fipronil 100 mg/ml spot-on, 0.5 ml N6 for puppies and kittens
Assessed clinical scopeDog · Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them · On the skin
Care settingHome topical administration after veterinary selection of parasite target, weight band and retreatment interval; environmental control and household coverage as clinically indicated.
vetman score 5.4/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000614 · Verified on 21 Oct 2026

A weak exact-presentation option: fipronil class efficacy is credible, but dose design, broad claims or formulation-specific evidence are less convincing than current regulator-reviewed comparators. Use only within the exact label and reassess control rather than assuming class equivalence.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current ProVET instruction identifies the exact juvenile 0.5 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy5.5/10

The 100 mg/ml concentration and core flea/tick role are close to authorised comparators, and controlled dog/cat studies support the class/formulation. Exact-product outcomes and the broader sarcoptic/trombidiform claim are unverified; the manufacturer states about four weeks for fleas and three weeks for ticks.

Safety and tolerability4.5/10

The instruction excludes animals under 10 weeks and sick, exhausted, weak or hypersensitive patients. Reproductive safety, exact-formulation adverse-event frequency and overdose margin are not stated in a public regulator dossier; juvenile and small-patient use therefore requires conservative selection.

Clinical practicality7.5/10

A single 0.5 ml pipette for a 1-3 kg patient is straightforward and the six-pipette pack supports repeat control. Accurate weight and the ten-week minimum age remain essential in small juvenile patients.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only on dry, intact skin in an area the animal cannot lick. Weigh the patient, select the exact label band and do not extrapolate between products, concentrations or pipette sizes.
  • Fipronil does not reliably prevent tick attachment or pathogen transmission. Examine the patient after exposure and use an integrated parasite plan based on local epidemiology and lifestyle.
  • The exact product has no independent controlled outcome trial or public regulator assessment dossier. Class evidence supports fipronil, not every broader mite, repellent or persistence claim on this formulation.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The public exact instruction does not establish reproductive safety. Use in pregnancy, breeding or lactation only when a veterinarian documents a favourable benefit-risk and no better-characterised option is suitable.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal
3.8/10
Poor / unconvincing
vetman assessment

Insectostop

fipronil 100 mg/ml spot-on, 0.5 ml N6 for puppies and kittens
Assessed clinical scopeCat · Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal · auricular
Care settingVeterinary diagnosis after otoscopy and microscopy; clean the external canal, verify tympanic membrane integrity and reassess before repetition.
vetman score 3.8/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000614 · Verified on 21 Oct 2026

The exact label names otodectosis but omits the ear dose; this makes the regimen clinically non-reproducible despite Georgian registration. Do not infer a quantity from another fipronil product.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current ProVET instruction identifies the exact juvenile 0.5 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy3.5/10

The exact instruction names otodectosis and describes bilateral cleaning and application, but gives no amount. No exact-product controlled otic efficacy study was found, and spot-on flea/tick studies cannot validate an unstated ear-canal dose.

Safety and tolerability3.5/10

Exact-formulation ear-canal safety and ototoxicity data were not found. The absent quantity prevents a reproducible exposure assessment. Use only after confirming an intact tympanic membrane; stop for pain, neurologic signs, marked irritation or hearing change. Class safety from dermal spot-on use cannot be assumed to prove otic safety.

Clinical practicality3.0/10

Cleaning, bilateral application and 7-10 day microscopy-guided reassessment are described, but the instruction gives no number of drops or volume. A clinician cannot reproduce or calculate the regimen responsibly; use an explicitly dosed otic alternative.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Confirm otodectosis by otoscopy/microscopy and verify an intact tympanic membrane before use. Do not apply into a perforated, unvisualised, severely inflamed or neurologically abnormal ear.
  • The exact instruction gives no auricular quantity. Do not infer drops or volume from another fipronil product; select an explicitly dosed alternative.
  • Spot-on flea/tick efficacy and dermal safety studies do not establish efficacy or ototoxicity safety for this exact repeated ear-canal regimen. Evidence confidence is low.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The public exact instruction does not establish reproductive safety. Use in pregnancy, breeding or lactation only when a veterinarian documents a favourable benefit-risk and no better-characterised option is suitable.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them
5.8/10
Weak evidence support
vetman assessment

Insectostop

fipronil 100 mg/ml spot-on, 0.5 ml N6 for puppies and kittens
Assessed clinical scopeCat · Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them · On the skin
Care settingHome topical administration after veterinary selection of parasite target, weight band and retreatment interval; environmental control and household coverage as clinically indicated.
vetman score 5.8/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000614 · Verified on 21 Oct 2026

A usable fipronil spot-on presentation for its exact weight and age band, supported by established class efficacy but not by an independent exact-product dossier. Keep broader claims, retreatment interval and formulation-specific safety within the limits of the manufacturer instruction.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current ProVET instruction identifies the exact juvenile 0.5 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy6.0/10

The 100 mg/ml concentration and core flea/tick role are close to authorised comparators, and controlled dog/cat studies support the class/formulation. Exact-product outcomes and the broader sarcoptic/trombidiform claim are unverified; the manufacturer states about four weeks for fleas and three weeks for ticks.

Safety and tolerability5.5/10

The instruction excludes animals under 10 weeks and sick, exhausted, weak or hypersensitive patients. Reproductive safety, exact-formulation adverse-event frequency and overdose margin are not stated in a public regulator dossier; juvenile and small-patient use therefore requires conservative selection.

Clinical practicality7.5/10

A single 0.5 ml pipette for a 1-3 kg patient is straightforward and the six-pipette pack supports repeat control. Accurate weight and the ten-week minimum age remain essential in small juvenile patients.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only on dry, intact skin in an area the animal cannot lick. Weigh the patient, select the exact label band and do not extrapolate between products, concentrations or pipette sizes.
  • Fipronil does not reliably prevent tick attachment or pathogen transmission. Examine the patient after exposure and use an integrated parasite plan based on local epidemiology and lifestyle.
  • The exact product has no independent controlled outcome trial or public regulator assessment dossier. Class evidence supports fipronil, not every broader mite, repellent or persistence claim on this formulation.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The public exact instruction does not establish reproductive safety. Use in pregnancy, breeding or lactation only when a veterinarian documents a favourable benefit-risk and no better-characterised option is suitable.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil100 mg/ml Fipronil100 mg/ml
Formulation Type
Spot-on
Administration route
On the skin, auricular
Manufacturer
Suziria / ProVET · Ukraine
Manufacturer (register)
LLC scientific production enterprise Suziria, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1095, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 23 May 2029
Veterinary (National Food Agency)
In the register: ინსექტოსტოპი
№ 000614
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Insectostop, Spot-on

fipronil 100 mg/ml spot-on, 0.8 ml N6 for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal
3.8/10
Poor / unconvincing
vetman assessment

Insectostop

fipronil 100 mg/ml spot-on, 0.8 ml N6 for dogs and cats
Assessed clinical scopeDog · Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal · auricular
Care settingVeterinary diagnosis after otoscopy and microscopy; clean the external canal, verify tympanic membrane integrity and reassess before repetition.
vetman score 3.8/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000613 · Verified on 21 Oct 2026

The exact label names otodectosis but omits the ear dose; this makes the regimen clinically non-reproducible despite Georgian registration. Do not infer a quantity from another fipronil product.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current ProVET instruction identifies the exact 0.8 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy3.5/10

The exact instruction names otodectosis and describes bilateral cleaning and application, but gives no amount. No exact-product controlled otic efficacy study was found, and spot-on flea/tick studies cannot validate an unstated ear-canal dose.

Safety and tolerability3.5/10

Exact-formulation ear-canal safety and ototoxicity data were not found. The absent quantity prevents a reproducible exposure assessment. Use only after confirming an intact tympanic membrane; stop for pain, neurologic signs, marked irritation or hearing change. Class safety from dermal spot-on use cannot be assumed to prove otic safety.

Clinical practicality3.0/10

Cleaning, bilateral application and 7-10 day microscopy-guided reassessment are described, but the instruction gives no number of drops or volume. A clinician cannot reproduce or calculate the regimen responsibly; use an explicitly dosed otic alternative.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Confirm otodectosis by otoscopy/microscopy and verify an intact tympanic membrane before use. Do not apply into a perforated, unvisualised, severely inflamed or neurologically abnormal ear.
  • The exact instruction gives no auricular quantity. Do not infer drops or volume from another fipronil product; select an explicitly dosed alternative.
  • Spot-on flea/tick efficacy and dermal safety studies do not establish efficacy or ototoxicity safety for this exact repeated ear-canal regimen. Evidence confidence is low.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The public exact instruction does not establish reproductive safety. Use in pregnancy, breeding or lactation only when a veterinarian documents a favourable benefit-risk and no better-characterised option is suitable.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Dog Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them
5.8/10
Weak evidence support
vetman assessment

Insectostop

fipronil 100 mg/ml spot-on, 0.8 ml N6 for dogs and cats
Assessed clinical scopeDog · Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them · On the skin
Care settingHome topical administration after veterinary selection of parasite target, weight band and retreatment interval; environmental control and household coverage as clinically indicated.
vetman score 5.8/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000613 · Verified on 21 Oct 2026

A usable fipronil spot-on presentation for its exact weight and age band, supported by established class efficacy but not by an independent exact-product dossier. Keep broader claims, retreatment interval and formulation-specific safety within the limits of the manufacturer instruction.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current ProVET instruction identifies the exact 0.8 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy6.0/10

The 100 mg/ml concentration and core flea/tick role are close to authorised comparators, and controlled dog/cat studies support the class/formulation. Exact-product outcomes and the broader sarcoptic/trombidiform claim are unverified; the manufacturer states about four weeks for fleas and three weeks for ticks.

Safety and tolerability5.5/10

The instruction excludes animals under 10 weeks and sick, exhausted, weak or hypersensitive patients. Reproductive safety, exact-formulation adverse-event frequency and overdose margin are not stated in a public regulator dossier; juvenile and small-patient use therefore requires conservative selection.

Clinical practicality7.0/10

Single 0.8 ml pipettes match the first dog/cat band, while larger dogs require two to four pipettes. Monthly flea and roughly three-week tick protection is workable, but repeated multi-pipette application and environmental control add burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only on dry, intact skin in an area the animal cannot lick. Weigh the patient, select the exact label band and do not extrapolate between products, concentrations or pipette sizes.
  • Fipronil does not reliably prevent tick attachment or pathogen transmission. Examine the patient after exposure and use an integrated parasite plan based on local epidemiology and lifestyle.
  • The exact product has no independent controlled outcome trial or public regulator assessment dossier. Class evidence supports fipronil, not every broader mite, repellent or persistence claim on this formulation.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The public exact instruction does not establish reproductive safety. Use in pregnancy, breeding or lactation only when a veterinarian documents a favourable benefit-risk and no better-characterised option is suitable.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal
3.8/10
Poor / unconvincing
vetman assessment

Insectostop

fipronil 100 mg/ml spot-on, 0.8 ml N6 for dogs and cats
Assessed clinical scopeCat · Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal · auricular
Care settingVeterinary diagnosis after otoscopy and microscopy; clean the external canal, verify tympanic membrane integrity and reassess before repetition.
vetman score 3.8/10 Poor / unconvincing
Evidence confidence: Low Georgia: Yes, veterinary · № 000613 · Verified on 21 Oct 2026

The exact label names otodectosis but omits the ear dose; this makes the regimen clinically non-reproducible despite Georgian registration. Do not infer a quantity from another fipronil product.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current ProVET instruction identifies the exact 0.8 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy3.5/10

The exact instruction names otodectosis and describes bilateral cleaning and application, but gives no amount. No exact-product controlled otic efficacy study was found, and spot-on flea/tick studies cannot validate an unstated ear-canal dose.

Safety and tolerability3.5/10

Exact-formulation ear-canal safety and ototoxicity data were not found. The absent quantity prevents a reproducible exposure assessment. Use only after confirming an intact tympanic membrane; stop for pain, neurologic signs, marked irritation or hearing change. Class safety from dermal spot-on use cannot be assumed to prove otic safety.

Clinical practicality3.0/10

Cleaning, bilateral application and 7-10 day microscopy-guided reassessment are described, but the instruction gives no number of drops or volume. A clinician cannot reproduce or calculate the regimen responsibly; use an explicitly dosed otic alternative.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Confirm otodectosis by otoscopy/microscopy and verify an intact tympanic membrane before use. Do not apply into a perforated, unvisualised, severely inflamed or neurologically abnormal ear.
  • The exact instruction gives no auricular quantity. Do not infer drops or volume from another fipronil product; select an explicitly dosed alternative.
  • Spot-on flea/tick efficacy and dermal safety studies do not establish efficacy or ototoxicity safety for this exact repeated ear-canal regimen. Evidence confidence is low.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The public exact instruction does not establish reproductive safety. Use in pregnancy, breeding or lactation only when a veterinarian documents a favourable benefit-risk and no better-characterised option is suitable.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them
5.6/10
Weak evidence support
vetman assessment

Insectostop

fipronil 100 mg/ml spot-on, 0.8 ml N6 for dogs and cats
Assessed clinical scopeCat · Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them · On the skin
Care settingHome topical administration after veterinary selection of parasite target, weight band and retreatment interval; environmental control and household coverage as clinically indicated.
vetman score 5.6/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000613 · Verified on 21 Oct 2026

A weak exact-presentation option: fipronil class efficacy is credible, but dose design, broad claims or formulation-specific evidence are less convincing than current regulator-reviewed comparators. Use only within the exact label and reassess control rather than assuming class equivalence.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The current ProVET instruction identifies the exact 0.8 ml presentation, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy6.0/10

The 100 mg/ml concentration and core flea/tick role are close to authorised comparators, and controlled dog/cat studies support the class/formulation. Exact-product outcomes and the broader sarcoptic/trombidiform claim are unverified; the manufacturer states about four weeks for fleas and three weeks for ticks.

Safety and tolerability5.0/10

The instruction excludes animals under 10 weeks and sick, exhausted, weak or hypersensitive patients. Reproductive safety, exact-formulation adverse-event frequency and overdose margin are not stated in a public regulator dossier; juvenile and small-patient use therefore requires conservative selection.

Clinical practicality7.0/10

Single 0.8 ml pipettes match the first dog/cat band, while larger dogs require two to four pipettes. Monthly flea and roughly three-week tick protection is workable, but repeated multi-pipette application and environmental control add burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only on dry, intact skin in an area the animal cannot lick. Weigh the patient, select the exact label band and do not extrapolate between products, concentrations or pipette sizes.
  • Fipronil does not reliably prevent tick attachment or pathogen transmission. Examine the patient after exposure and use an integrated parasite plan based on local epidemiology and lifestyle.
  • The exact product has no independent controlled outcome trial or public regulator assessment dossier. Class evidence supports fipronil, not every broader mite, repellent or persistence claim on this formulation.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The public exact instruction does not establish reproductive safety. Use in pregnancy, breeding or lactation only when a veterinarian documents a favourable benefit-risk and no better-characterised option is suitable.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil100 mg/ml Fipronil100 mg/ml
Formulation Type
Spot-on
Administration route
On the skin, auricular
Manufacturer
Suziria / ProVET · Ukraine
Manufacturer (register)
LLC scientific production enterprise Suziria, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1093, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 21 May 2029
Veterinary (National Food Agency)
In the register: ინსექტოსტოპი
№ 000613
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Inspector Quadro C 0.4 ml, Spot-on

spot-on solution for dogs 1-4 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.0/10
Situational / acceptable
vetman assessment

Inspector Quadro C

0.4 ml, spot-on solution for dogs 1-4 kg
Assessed clinical scopeDog · Labelled canine topical scope for the exact weight band: ectoparasites, gastrointestinal nematodes and cestodes, and heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite and heartworm assessment, with diagnosis-specific follow-up
vetman score 7.0/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 000151 · Verified on 21 Oct 2026

Registered exact canine spot-on supported by a public SPC and small exact-product studies. Do not treat every broad combination claim as equally proven; use the exact dog weight band after parasite and heartworm assessment.

Regulatory and scientific credibility7.5/10

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

Clinical efficacy7.0/10

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

Safety and tolerability6.5/10

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

Clinical practicality7.0/10

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, infectious disease or debilitation, on wet or damaged skin, or outside the exact labelled species, age and weight band.
  • Do not combine with another antiparasitic unless a veterinarian has checked ingredients, intervals and cumulative toxicity.
  • During pregnancy or lactation and below 1 kg, use only after an individual veterinary benefit-risk assessment.
  • For ear-directed use, confirm tympanic-membrane integrity; with a perforated eardrum the product must not enter the ear canal.
  • Prevent licking and monitor for local irritation, depression, hypersalivation, tremor or vomiting; wash off and assess after overdose.
  • Keep treated animals away from rabbits, bees, fish and surface water; prevent environmental transfer until dry.
  • Heartworm use prevents susceptible larval stages; it is not adulticide treatment. Assess infection and exposure first.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil107 mg/ml Praziquantel42.8 mg/ml Moxidectin26.75 mg/ml Pyriproxyfen21.4 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 650, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 May 2027
Veterinary (National Food Agency)
In the register: ინსპექტორ კვადრო C
№ 000151
Verified on: 21 Oct 2026
EU Yes, veterinary
№ 0022-3129
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Inspector Quadro C 1 ml, Spot-on

spot-on solution for dogs 4-10 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.0/10
Situational / acceptable
vetman assessment

Inspector Quadro C

1 ml, spot-on solution for dogs 4-10 kg
Assessed clinical scopeDog · Labelled canine topical scope for the exact weight band: ectoparasites, gastrointestinal nematodes and cestodes, and heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite and heartworm assessment, with diagnosis-specific follow-up
vetman score 7.0/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 000159 · Verified on 21 Oct 2026

Registered exact canine spot-on supported by a public SPC and small exact-product studies. Do not treat every broad combination claim as equally proven; use the exact dog weight band after parasite and heartworm assessment.

Regulatory and scientific credibility7.5/10

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

Clinical efficacy7.0/10

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

Safety and tolerability6.5/10

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

Clinical practicality7.0/10

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, infectious disease or debilitation, on wet or damaged skin, or outside the exact labelled species, age and weight band.
  • Do not combine with another antiparasitic unless a veterinarian has checked ingredients, intervals and cumulative toxicity.
  • During pregnancy or lactation and below 1 kg, use only after an individual veterinary benefit-risk assessment.
  • For ear-directed use, confirm tympanic-membrane integrity; with a perforated eardrum the product must not enter the ear canal.
  • Prevent licking and monitor for local irritation, depression, hypersalivation, tremor or vomiting; wash off and assess after overdose.
  • Keep treated animals away from rabbits, bees, fish and surface water; prevent environmental transfer until dry.
  • Heartworm use prevents susceptible larval stages; it is not adulticide treatment. Assess infection and exposure first.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil107 mg/ml Praziquantel42.8 mg/ml Moxidectin26.75 mg/ml Pyriproxyfen21.4 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 675, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 May 2027
Veterinary (National Food Agency)
In the register: ინსპექტორ კვადრო C
№ 000159
Verified on: 21 Oct 2026
EU Yes, veterinary
№ 0022-3129
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Inspector Quadro C 2.5 ml, Spot-on

spot-on solution for dogs 10-25 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.0/10
Situational / acceptable
vetman assessment

Inspector Quadro C

2.5 ml, spot-on solution for dogs 10-25 kg
Assessed clinical scopeDog · Labelled canine topical scope for the exact weight band: ectoparasites, gastrointestinal nematodes and cestodes, and heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite and heartworm assessment, with diagnosis-specific follow-up
vetman score 7.0/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 000160 · Verified on 21 Oct 2026

Registered exact canine spot-on supported by a public SPC and small exact-product studies. Do not treat every broad combination claim as equally proven; use the exact dog weight band after parasite and heartworm assessment.

Regulatory and scientific credibility7.5/10

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

Clinical efficacy7.0/10

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

Safety and tolerability6.5/10

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

Clinical practicality7.0/10

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, infectious disease or debilitation, on wet or damaged skin, or outside the exact labelled species, age and weight band.
  • Do not combine with another antiparasitic unless a veterinarian has checked ingredients, intervals and cumulative toxicity.
  • During pregnancy or lactation and below 1 kg, use only after an individual veterinary benefit-risk assessment.
  • For ear-directed use, confirm tympanic-membrane integrity; with a perforated eardrum the product must not enter the ear canal.
  • Prevent licking and monitor for local irritation, depression, hypersalivation, tremor or vomiting; wash off and assess after overdose.
  • Keep treated animals away from rabbits, bees, fish and surface water; prevent environmental transfer until dry.
  • Heartworm use prevents susceptible larval stages; it is not adulticide treatment. Assess infection and exposure first.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil107 mg/ml Praziquantel42.8 mg/ml Moxidectin26.75 mg/ml Pyriproxyfen21.4 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 676, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 May 2027
Veterinary (National Food Agency)
In the register: ინსპექტორ კვადრო C
№ 000160
Verified on: 21 Oct 2026
EU Yes, veterinary
№ 0022-3129
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Inspector Quadro C 4 ml, Spot-on

spot-on solution for dogs 25-40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.0/10
Situational / acceptable
vetman assessment

Inspector Quadro C

4 ml, spot-on solution for dogs 25-40 kg
Assessed clinical scopeDog · Labelled canine topical scope for the exact weight band: ectoparasites, gastrointestinal nematodes and cestodes, and heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite and heartworm assessment, with diagnosis-specific follow-up
vetman score 7.0/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 000158 · Verified on 21 Oct 2026

Registered exact canine spot-on supported by a public SPC and small exact-product studies. Do not treat every broad combination claim as equally proven; use the exact dog weight band after parasite and heartworm assessment.

Regulatory and scientific credibility7.5/10

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

Clinical efficacy7.0/10

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

Safety and tolerability6.5/10

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

Clinical practicality7.0/10

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, infectious disease or debilitation, on wet or damaged skin, or outside the exact labelled species, age and weight band.
  • Do not combine with another antiparasitic unless a veterinarian has checked ingredients, intervals and cumulative toxicity.
  • During pregnancy or lactation and below 1 kg, use only after an individual veterinary benefit-risk assessment.
  • For ear-directed use, confirm tympanic-membrane integrity; with a perforated eardrum the product must not enter the ear canal.
  • Prevent licking and monitor for local irritation, depression, hypersalivation, tremor or vomiting; wash off and assess after overdose.
  • Keep treated animals away from rabbits, bees, fish and surface water; prevent environmental transfer until dry.
  • Heartworm use prevents susceptible larval stages; it is not adulticide treatment. Assess infection and exposure first.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil107 mg/ml Praziquantel42.8 mg/ml Moxidectin26.75 mg/ml Pyriproxyfen21.4 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 672, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 May 2027
Veterinary (National Food Agency)
In the register: ინსპექტორ კვადრო C
№ 000158
Verified on: 21 Oct 2026
EU Yes, veterinary
№ 0022-3129
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Inspector Quadro C 6 ml, Spot-on

spot-on solution for dogs 40-60 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.0/10
Situational / acceptable
vetman assessment

Inspector Quadro C

6 ml, spot-on solution for dogs 40-60 kg
Assessed clinical scopeDog · Labelled canine topical scope for the exact weight band: ectoparasites, gastrointestinal nematodes and cestodes, and heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite and heartworm assessment, with diagnosis-specific follow-up
vetman score 7.0/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 000157 · Verified on 21 Oct 2026

Registered exact canine spot-on supported by a public SPC and small exact-product studies. Do not treat every broad combination claim as equally proven; use the exact dog weight band after parasite and heartworm assessment.

Regulatory and scientific credibility7.5/10

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

Clinical efficacy7.0/10

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

Safety and tolerability6.5/10

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

Clinical practicality7.0/10

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, infectious disease or debilitation, on wet or damaged skin, or outside the exact labelled species, age and weight band.
  • Do not combine with another antiparasitic unless a veterinarian has checked ingredients, intervals and cumulative toxicity.
  • During pregnancy or lactation and below 1 kg, use only after an individual veterinary benefit-risk assessment.
  • For ear-directed use, confirm tympanic-membrane integrity; with a perforated eardrum the product must not enter the ear canal.
  • Prevent licking and monitor for local irritation, depression, hypersalivation, tremor or vomiting; wash off and assess after overdose.
  • Keep treated animals away from rabbits, bees, fish and surface water; prevent environmental transfer until dry.
  • Heartworm use prevents susceptible larval stages; it is not adulticide treatment. Assess infection and exposure first.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil107 mg/ml Praziquantel42.8 mg/ml Moxidectin26.75 mg/ml Pyriproxyfen21.4 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 674, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 May 2027
Veterinary (National Food Agency)
In the register: ინსპექტორ კვადრო C
№ 000157
Verified on: 21 Oct 2026
EU Yes, veterinary
№ 0022-3129
Verified on: 22 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Inspector Quadro K 0.4 ml, Spot-on

spot-on solution for cats 1-4 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
6.0/10
Situational / acceptable
vetman assessment

Inspector Quadro K

0.4 ml, spot-on solution for cats 1-4 kg
Assessed clinical scopeCat · Labelled feline topical scope for the exact weight band: ectoparasites, gastrointestinal nematodes and cestodes, and heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite and heartworm assessment, with diagnosis-specific follow-up
vetman score 6.0/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 000155 · Verified on 21 Oct 2026

Registered exact feline spot-on with manufacturer instructions and small exact-product studies, but the Bulgarian register links the wrong product SPC. Use only in cats within the exact weight band, with explicit parasite selection and follow-up.

Regulatory and scientific credibility5.5/10

Exact strengths have current Georgian registrations and an indefinite Bulgarian register entry. Confidence is reduced because the Quadro K page links to the Quadro C dog SPC rather than a K-specific feline SPC; the exact K instruction is available from the manufacturer.

Clinical efficacy6.0/10

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

Safety and tolerability6.0/10

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

Clinical practicality7.0/10

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, infectious disease or debilitation, on wet or damaged skin, or outside the exact labelled species, age and weight band.
  • Do not combine with another antiparasitic unless a veterinarian has checked ingredients, intervals and cumulative toxicity.
  • During pregnancy or lactation and below 1 kg, use only after an individual veterinary benefit-risk assessment.
  • For ear-directed use, confirm tympanic-membrane integrity; with a perforated eardrum the product must not enter the ear canal.
  • Prevent licking and monitor for local irritation, depression, hypersalivation, tremor or vomiting; wash off and assess after overdose.
  • Keep treated animals away from rabbits, bees, fish and surface water; prevent environmental transfer until dry.
  • Heartworm use prevents susceptible larval stages; it is not adulticide treatment. Assess infection and exposure first.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil107 mg/ml Praziquantel42.8 mg/ml Moxidectin10.7 mg/ml Pyriproxyfen21.4 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 657, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 10 May 2027
Veterinary (National Food Agency)
In the register: ინსპექტორ კვადრო K
№ 000155
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Inspector Quadro K 0.8 ml, Spot-on

spot-on solution for cats 4-8 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
6.0/10
Situational / acceptable
vetman assessment

Inspector Quadro K

0.8 ml, spot-on solution for cats 4-8 kg
Assessed clinical scopeCat · Labelled feline topical scope for the exact weight band: ectoparasites, gastrointestinal nematodes and cestodes, and heartworm-larval prevention · On the skin
Care settingVeterinary-selected home application to dry intact skin after parasite and heartworm assessment, with diagnosis-specific follow-up
vetman score 6.0/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 000798 · Verified on 21 Oct 2026

Registered exact feline spot-on with manufacturer instructions and small exact-product studies, but the Bulgarian register links the wrong product SPC. Use only in cats within the exact weight band, with explicit parasite selection and follow-up.

Regulatory and scientific credibility5.5/10

Exact strengths have current Georgian registrations and an indefinite Bulgarian register entry. Confidence is reduced because the Quadro K page links to the Quadro C dog SPC rather than a K-specific feline SPC; the exact K instruction is available from the manufacturer.

Clinical efficacy6.0/10

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

Safety and tolerability6.0/10

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

Clinical practicality7.0/10

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, infectious disease or debilitation, on wet or damaged skin, or outside the exact labelled species, age and weight band.
  • Do not combine with another antiparasitic unless a veterinarian has checked ingredients, intervals and cumulative toxicity.
  • During pregnancy or lactation and below 1 kg, use only after an individual veterinary benefit-risk assessment.
  • For ear-directed use, confirm tympanic-membrane integrity; with a perforated eardrum the product must not enter the ear canal.
  • Prevent licking and monitor for local irritation, depression, hypersalivation, tremor or vomiting; wash off and assess after overdose.
  • Keep treated animals away from rabbits, bees, fish and surface water; prevent environmental transfer until dry.
  • Heartworm use prevents susceptible larval stages; it is not adulticide treatment. Assess infection and exposure first.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil107 mg/ml Praziquantel42.8 mg/ml Moxidectin10.7 mg/ml Pyriproxyfen21.4 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Manufacturer (register)
JSC SPF EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1313, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 11 May 2027
Veterinary (National Food Agency)
In the register: ინსპექტორ კვადრო K
№ 000798
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.8/10
Weak evidence support
vetman assessment

LEGA

98 mg/ml spot-on solution, 4 x 2 ml for dogs
Assessed clinical scopeDog · Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them · On the skin
Care settingHome topical administration after veterinary selection of parasite target, weight band and retreatment interval; environmental control and household coverage as clinically indicated.
vetman score 5.8/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000785 | 000882 · Verified on 21 Oct 2026

A usable fipronil spot-on presentation for its exact weight and age band, supported by established class efficacy but not by an independent exact-product dossier. Keep broader claims, retreatment interval and formulation-specific safety within the limits of the manufacturer instruction.

Regulatory and scientific credibility5.0/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The instruction is Georgian and product-specific, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found.

Clinical efficacy6.0/10

Fipronil spot-on has controlled canine evidence against fleas, ticks and chewing lice, but LEGA itself has no independent outcome study. The mosquito-repellent claim and exact 98 mg/ml schedule are not established by the cited comparator evidence; the label itself shortens tick prevention to every two weeks.

Safety and tolerability5.5/10

The label lists hypersensitivity/allergy, excludes dogs under 2 kg, puppies under 10 days, pregnancy/lactation, illness/debilitation and concurrent insecticides. The very young age threshold and exact excipient/formulation margin lack an independent public safety dossier; avoid licking and human contact until dry.

Clinical practicality7.5/10

Weight bands are simple, but a 2 ml bottle may require one or two bottles per dose and tick prevention is every two weeks rather than monthly. Multiple application points, lick prevention and a 24-hour handling restriction add burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only on dry, intact skin in an area the animal cannot lick. Weigh the patient, select the exact label band and do not extrapolate between products, concentrations or pipette sizes.
  • Fipronil does not reliably prevent tick attachment or pathogen transmission. Examine the patient after exposure and use an integrated parasite plan based on local epidemiology and lifestyle.
  • The exact product has no independent controlled outcome trial or public regulator assessment dossier. Class evidence supports fipronil, not every broader mite, repellent or persistence claim on this formulation.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The exact instruction excludes pregnancy and lactation. Record reproductive status and choose another product for pregnant, breeding or nursing animals.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil98 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Davati LLC · Georgia
Registration
Georgia Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

LEGA Spray, Aerosol / spray

external solution, 100 ml
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Registered external fipronil and benzyl benzoate spray; labelled dog indication and dose not verified
Not rateable
No numerical score assigned
vetman assessment

LEGA Spray

external solution, 100 ml
Assessed clinical scopeDog · Registered external fipronil and benzyl benzoate spray; labelled dog indication and dose not verified · On the skin
Care settingNot assessable until the exact Georgian label is available
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, veterinary · № 000114 · Verified on 22 Oct 2026 Off-label use
Not rateable

The fipronil and benzyl benzoate concentrations, the spray dose and the dog label could not be verified: the only source page repeats spot-on directions that do not fit a 100 ml spray.

Not rated: the composition strength and spray dose are unknown. Use a fipronil spray with a verified label instead.

Important safety and use flags

  • Do not dose from the 2 ml spot-on directions shown on the distributor page; they do not belong to this spray.
  • Concentration denominators of fipronil and benzyl benzoate are missing from the register entry.
  • Ask the distributor for the approved Georgian instruction before use.
  • Prevent licking until dry and watch for local irritation.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Registered external fipronil and benzyl benzoate spray; no verified cat label
Not rateable
No numerical score assigned
vetman assessment

LEGA Spray

external solution, 100 ml
Assessed clinical scopeCat · Registered external fipronil and benzyl benzoate spray; no verified cat label · On the skin
Care settingNot assessable for cats; avoid until a verified feline label exists
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, veterinary · № 000114 · Verified on 22 Oct 2026 Off-label use
Not rateable

Concentrations, spray dose and any feline instruction could not be verified, and the spray contains benzyl benzoate, which is toxic to cats.

Not rated for cats: strength, dose and feline safety instruction are unknown, and benzyl benzoate is a known feline toxin. Prefer a cat-authorised fipronil product.

Important safety and use flags

  • Benzyl benzoate is toxic to cats; do not use this spray on cats without a verified feline label.
  • Do not dose from the 2 ml spot-on directions shown on the distributor page.
  • Concentration denominators are missing from the register entry.
  • Ask the distributor for the approved Georgian instruction.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Fipronil Benzyl benzoate
Formulation Type
Aerosol / spray
Administration route
On the skin
Manufacturer
Davati LLC · Georgia
Manufacturer (register)
Davati Ltd, Georgia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 686, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 Jun 2027
Veterinary (National Food Agency)
In the register: ლეგა სპრეი
№ 000114
Verified on: 22 Oct 2026
Controlled in Georgia
Unknown
Information not fully verified The Georgian NFA register lists this spray for dogs and cats and reports fipronil 5 mg plus benzyl benzoate 56 mg, but the denominator/concentration unit and spray dose could not be verified. The distributor page incorrectly places a 2 ml dog spot-on instruction under the spray title. No dose is published until the exact spray leaflet is available. LEGA page conflict

LEGA Spray, Aerosol / spray

external solution, 180 ml
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Registered external fipronil and benzyl benzoate spray; labelled dog indication and dose not verified
Not rateable
No numerical score assigned
vetman assessment

LEGA Spray

external solution, 180 ml
Assessed clinical scopeDog · Registered external fipronil and benzyl benzoate spray; labelled dog indication and dose not verified · On the skin
Care settingNot assessable until the exact Georgian label is available
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, veterinary · № 000147 · Verified on 22 Oct 2026 Off-label use
Not rateable

The fipronil and benzyl benzoate concentrations, the spray dose and the dog label could not be verified: the only source page repeats spot-on directions that do not fit a 180 ml spray.

Not rated: the composition strength and spray dose are unknown. Use a fipronil spray with a verified label instead.

Important safety and use flags

  • Do not dose from the 2 ml spot-on directions shown on the distributor page; they do not belong to this spray.
  • Concentration denominators of fipronil and benzyl benzoate are missing from the register entry.
  • Ask the distributor for the approved Georgian instruction before use.
  • Prevent licking until dry and watch for local irritation.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Cat Registered external fipronil and benzyl benzoate spray; no verified cat label
Not rateable
No numerical score assigned
vetman assessment

LEGA Spray

external solution, 180 ml
Assessed clinical scopeCat · Registered external fipronil and benzyl benzoate spray; no verified cat label · On the skin
Care settingNot assessable for cats; avoid until a verified feline label exists
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, veterinary · № 000147 · Verified on 22 Oct 2026 Off-label use
Not rateable

Concentrations, spray dose and any feline instruction could not be verified, and the spray contains benzyl benzoate, which is toxic to cats.

Not rated for cats: strength, dose and feline safety instruction are unknown, and benzyl benzoate is a known feline toxin. Prefer a cat-authorised fipronil product.

Important safety and use flags

  • Benzyl benzoate is toxic to cats; do not use this spray on cats without a verified feline label.
  • Do not dose from the 2 ml spot-on directions shown on the distributor page.
  • Concentration denominators are missing from the register entry.
  • Ask the distributor for the approved Georgian instruction.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Fipronil Benzyl benzoate
Formulation Type
Aerosol / spray
Administration route
On the skin
Manufacturer
Davati LLC · Georgia
Manufacturer (register)
Davati Ltd, Georgia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 701, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 Jun 2027
Veterinary (National Food Agency)
In the register: ლეგა სპრეი
№ 000147
Verified on: 22 Oct 2026
Controlled in Georgia
Unknown
Information not fully verified The Georgian NFA register lists this spray for dogs and cats and reports fipronil 5 mg plus benzyl benzoate 56 mg, but the denominator/concentration unit and spray dose could not be verified. The distributor page incorrectly places a 2 ml dog spot-on instruction under the spray title. No dose is published until the exact spray leaflet is available. LEGA page conflict
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
5.8/10
Weak evidence support
vetman assessment

Perfect Trio

100/15/20 mg/ml spot-on, 0.6 ml N3 for cats 2-4 kg
Assessed clinical scopeCat · Full labelled feline topical scope in the exact weight band: fleas, lice, biting lice, ticks and mites; gastrointestinal nematodes; Dirofilaria larval prevention · On the skin
Care settingVeterinary-selected home spot-on use after parasite identification and heartworm-risk assessment, with follow-up for established infestation or infection
vetman score 5.8/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000802 · Verified on 21 Oct 2026

Locally registered exact spot-on with a positive but small exact-product field study. It may be a situational broad-spectrum option after parasite selection, but its wide claims and safety margin are less securely documented than better-studied alternatives; prevent licking and use only in cats over 3 months and 2 kg.

Regulatory and scientific credibility6.0/10

The exact presentation is actively registered in Georgia, current official manufacturer instructions verify its composition and labelled use, and an exact-product peer-reviewed field study is available. However, no EMA/FDA-style public assessment, regulator-hosted SPC or transparent full dossier for this formulation was found.

Clinical efficacy6.0/10

A 2024 exact-product field study reported high efficacy in naturally infested dogs and cats against selected fleas, lice and mites, plus feline Uncinaria, with one-month follow-up. Each parasite group contained only seven animals, the comparator and blinding are inadequately reported, and many broad label targets and prevention claims were not tested.

Safety and tolerability5.0/10

The small field study reported no adverse effects, but it cannot establish a broad safety margin or detect uncommon events. The label prohibits use in pregnancy, lactation, kittens under 3 months, cats at or below 2 kg, and sick or convalescent animals; licking, overdose and concurrent macrocyclic-lactone exposure remain important concerns.

Clinical practicality6.5/10

A whole weight-banded pipette makes routine dosing straightforward, but treatment varies by target: one application, repeated 7-10-day courses for some mites, or monthly heartworm prevention. Correct skin placement, prevention of licking, bathing restrictions, ear examination when relevant and follow-up add meaningful clinical and adherence burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, in animals under 3 months or at or below 2 kg, or in sick, convalescent, debilitated or emaciated patients.
  • Do not use during pregnancy or lactation; the exact combination does not have an established reproductive safety margin.
  • Do not combine with another macrocyclic lactone or antiparasitic unless a veterinarian has checked active ingredients, intervals and cumulative neurotoxicity.
  • Prevent licking and separate treated animals until dry. Monitor for local irritation, hypersalivation, vomiting, depression, ataxia, tremor or other neurologic signs; wash off and assess promptly if they occur.
  • Apply the entire exact pipette directly to dry intact skin. Do not bathe for 3 days before or after treatment and avoid handling or contact with small children for 48 hours.
  • For ear-mite treatment, examine and clean the ear first and confirm tympanic-membrane integrity; complicated otitis requires separate diagnosis and treatment.
  • Heartworm use is prevention against susceptible larval stages, not adulticide treatment. Assess exposure and infection status and follow current species-specific guidance.
  • The exact-product study is small and does not validate every broad label claim. Confirm the parasite and reassess response rather than treating label breadth as proof of coverage.
  • Fipronil is highly toxic to aquatic invertebrates and the label states toxicity to fish and bees; prevent entry into surface water and dispose of pipettes responsibly.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil100 mg/ml Ivermectin15 mg/ml Pyriproxyfen20 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Vetsintez LLC · Ukraine
Manufacturer (register)
Vetsintez LLC, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1320, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 11 Nov 2029
Veterinary (National Food Agency)
In the register: პერფექტ ტრიო
№ 000802
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
5.8/10
Weak evidence support
vetman assessment

Perfect Trio

100/15/20 mg/ml spot-on, 0.8 ml N3 for cats 4-10 kg
Assessed clinical scopeCat · Full labelled feline topical scope in the exact weight band: fleas, lice, biting lice, ticks and mites; gastrointestinal nematodes; Dirofilaria larval prevention · On the skin
Care settingVeterinary-selected home spot-on use after parasite identification and heartworm-risk assessment, with follow-up for established infestation or infection
vetman score 5.8/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000803 · Verified on 21 Oct 2026

Locally registered exact spot-on with a positive but small exact-product field study. It may be a situational broad-spectrum option after parasite selection, but its wide claims and safety margin are less securely documented than better-studied alternatives; prevent licking and use only in cats over 3 months and 2 kg.

Regulatory and scientific credibility6.0/10

The exact presentation is actively registered in Georgia, current official manufacturer instructions verify its composition and labelled use, and an exact-product peer-reviewed field study is available. However, no EMA/FDA-style public assessment, regulator-hosted SPC or transparent full dossier for this formulation was found.

Clinical efficacy6.0/10

A 2024 exact-product field study reported high efficacy in naturally infested dogs and cats against selected fleas, lice and mites, plus feline Uncinaria, with one-month follow-up. Each parasite group contained only seven animals, the comparator and blinding are inadequately reported, and many broad label targets and prevention claims were not tested.

Safety and tolerability5.0/10

The small field study reported no adverse effects, but it cannot establish a broad safety margin or detect uncommon events. The label prohibits use in pregnancy, lactation, kittens under 3 months, cats at or below 2 kg, and sick or convalescent animals; licking, overdose and concurrent macrocyclic-lactone exposure remain important concerns.

Clinical practicality6.5/10

A whole weight-banded pipette makes routine dosing straightforward, but treatment varies by target: one application, repeated 7-10-day courses for some mites, or monthly heartworm prevention. Correct skin placement, prevention of licking, bathing restrictions, ear examination when relevant and follow-up add meaningful clinical and adherence burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, in animals under 3 months or at or below 2 kg, or in sick, convalescent, debilitated or emaciated patients.
  • Do not use during pregnancy or lactation; the exact combination does not have an established reproductive safety margin.
  • Do not combine with another macrocyclic lactone or antiparasitic unless a veterinarian has checked active ingredients, intervals and cumulative neurotoxicity.
  • Prevent licking and separate treated animals until dry. Monitor for local irritation, hypersalivation, vomiting, depression, ataxia, tremor or other neurologic signs; wash off and assess promptly if they occur.
  • Apply the entire exact pipette directly to dry intact skin. Do not bathe for 3 days before or after treatment and avoid handling or contact with small children for 48 hours.
  • For ear-mite treatment, examine and clean the ear first and confirm tympanic-membrane integrity; complicated otitis requires separate diagnosis and treatment.
  • Heartworm use is prevention against susceptible larval stages, not adulticide treatment. Assess exposure and infection status and follow current species-specific guidance.
  • The exact-product study is small and does not validate every broad label claim. Confirm the parasite and reassess response rather than treating label breadth as proof of coverage.
  • Fipronil is highly toxic to aquatic invertebrates and the label states toxicity to fish and bees; prevent entry into surface water and dispose of pipettes responsibly.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil100 mg/ml Ivermectin15 mg/ml Pyriproxyfen20 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Vetsintez LLC · Ukraine
Manufacturer (register)
Vetsintez LLC, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1322, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 11 Nov 2029
Veterinary (National Food Agency)
In the register: პერფექტ ტრიო
№ 000803
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.7/10
Weak evidence support
vetman assessment

Perfect Trio

100/15/20 mg/ml spot-on, 0.8 ml N3 for dogs 4-10 kg
Assessed clinical scopeDog · Full labelled canine topical scope in the exact weight band: fleas, lice, biting lice, mosquitoes, ticks and mites; gastrointestinal nematodes; Dirofilaria larval prevention · On the skin
Care settingVeterinary-selected home spot-on use after parasite identification and heartworm-risk assessment, with follow-up for established infestation or infection
vetman score 5.7/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000804 · Verified on 21 Oct 2026

Locally registered exact spot-on with a positive but small exact-product field study. It may be a situational broad-spectrum option after parasite selection, but its wide claims and safety margin are less securely documented than better-studied alternatives; avoid MDR1-susceptible dogs and use the exact weight band.

Regulatory and scientific credibility6.0/10

The exact presentation is actively registered in Georgia, current official manufacturer instructions verify its composition and labelled use, and an exact-product peer-reviewed field study is available. However, no EMA/FDA-style public assessment, regulator-hosted SPC or transparent full dossier for this formulation was found.

Clinical efficacy6.0/10

A 2024 exact-product field study reported high efficacy in naturally infested dogs and cats against selected fleas, lice and mites, plus feline Uncinaria, with one-month follow-up. Each parasite group contained only seven animals, the comparator and blinding are inadequately reported, and many broad label targets and prevention claims were not tested.

Safety and tolerability4.5/10

The small field study reported no adverse effects, but it cannot establish a broad safety margin or detect uncommon events. The label prohibits use in pregnancy, lactation, young, underweight, sick or convalescent animals and specifically warns against use in MDR1-mutant breeds because of possible neurotoxicity.

Clinical practicality6.5/10

A whole weight-banded pipette makes routine dosing straightforward, but treatment varies by target: one application, repeated 7-10-day courses for some mites, or monthly heartworm prevention. Correct skin placement, prevention of licking, bathing restrictions, ear examination when relevant and follow-up add meaningful clinical and adherence burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, in animals under 3 months or at or below 2 kg, or in sick, convalescent, debilitated or emaciated patients.
  • Do not use during pregnancy or lactation; the exact combination does not have an established reproductive safety margin.
  • Do not combine with another macrocyclic lactone or antiparasitic unless a veterinarian has checked active ingredients, intervals and cumulative neurotoxicity.
  • The label does not recommend use in Collies, Shetland Sheepdogs, Old English Sheepdogs, Scottish Shepherds or their crosses because of possible MDR1-associated neurotoxicity.
  • Prevent licking and separate treated animals until dry. Monitor for local irritation, hypersalivation, vomiting, depression, ataxia, tremor or other neurologic signs; wash off and assess promptly if they occur.
  • Apply the entire exact pipette directly to dry intact skin. Do not bathe for 3 days before or after treatment and avoid handling or contact with small children for 48 hours.
  • For ear-mite treatment, examine and clean the ear first and confirm tympanic-membrane integrity; complicated otitis requires separate diagnosis and treatment.
  • Heartworm use is prevention against susceptible larval stages, not adulticide treatment. Assess exposure and infection status and follow current species-specific guidance.
  • The exact-product study is small and does not validate every broad label claim. Confirm the parasite and reassess response rather than treating label breadth as proof of coverage.
  • Fipronil is highly toxic to aquatic invertebrates and the label states toxicity to fish and bees; prevent entry into surface water and dispose of pipettes responsibly.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil100 mg/ml Ivermectin15 mg/ml Pyriproxyfen20 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Vetsintez LLC · Ukraine
Manufacturer (register)
Vetsintez LLC, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1323, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 11 Nov 2029
Veterinary (National Food Agency)
In the register: პერფექტ ტრიო
№ 000804
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

Perfect Trio 100/15/20 mg/ml spot-on, Spot-on

1.6 ml N3 for dogs 10-20 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.7/10
Weak evidence support
vetman assessment

Perfect Trio

100/15/20 mg/ml spot-on, 1.6 ml N3 for dogs 10-20 kg
Assessed clinical scopeDog · Full labelled canine topical scope in the exact weight band: fleas, lice, biting lice, mosquitoes, ticks and mites; gastrointestinal nematodes; Dirofilaria larval prevention · On the skin
Care settingVeterinary-selected home spot-on use after parasite identification and heartworm-risk assessment, with follow-up for established infestation or infection
vetman score 5.7/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000801 · Verified on 21 Oct 2026

Locally registered exact spot-on with a positive but small exact-product field study. It may be a situational broad-spectrum option after parasite selection, but its wide claims and safety margin are less securely documented than better-studied alternatives; avoid MDR1-susceptible dogs and use the exact weight band.

Regulatory and scientific credibility6.0/10

The exact presentation is actively registered in Georgia, current official manufacturer instructions verify its composition and labelled use, and an exact-product peer-reviewed field study is available. However, no EMA/FDA-style public assessment, regulator-hosted SPC or transparent full dossier for this formulation was found.

Clinical efficacy6.0/10

A 2024 exact-product field study reported high efficacy in naturally infested dogs and cats against selected fleas, lice and mites, plus feline Uncinaria, with one-month follow-up. Each parasite group contained only seven animals, the comparator and blinding are inadequately reported, and many broad label targets and prevention claims were not tested.

Safety and tolerability4.5/10

The small field study reported no adverse effects, but it cannot establish a broad safety margin or detect uncommon events. The label prohibits use in pregnancy, lactation, young, underweight, sick or convalescent animals and specifically warns against use in MDR1-mutant breeds because of possible neurotoxicity.

Clinical practicality6.5/10

A whole weight-banded pipette makes routine dosing straightforward, but treatment varies by target: one application, repeated 7-10-day courses for some mites, or monthly heartworm prevention. Correct skin placement, prevention of licking, bathing restrictions, ear examination when relevant and follow-up add meaningful clinical and adherence burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use with hypersensitivity, in animals under 3 months or at or below 2 kg, or in sick, convalescent, debilitated or emaciated patients.
  • Do not use during pregnancy or lactation; the exact combination does not have an established reproductive safety margin.
  • Do not combine with another macrocyclic lactone or antiparasitic unless a veterinarian has checked active ingredients, intervals and cumulative neurotoxicity.
  • The label does not recommend use in Collies, Shetland Sheepdogs, Old English Sheepdogs, Scottish Shepherds or their crosses because of possible MDR1-associated neurotoxicity.
  • Prevent licking and separate treated animals until dry. Monitor for local irritation, hypersalivation, vomiting, depression, ataxia, tremor or other neurologic signs; wash off and assess promptly if they occur.
  • Apply the entire exact pipette directly to dry intact skin. Do not bathe for 3 days before or after treatment and avoid handling or contact with small children for 48 hours.
  • For ear-mite treatment, examine and clean the ear first and confirm tympanic-membrane integrity; complicated otitis requires separate diagnosis and treatment.
  • Heartworm use is prevention against susceptible larval stages, not adulticide treatment. Assess exposure and infection status and follow current species-specific guidance.
  • The exact-product study is small and does not validate every broad label claim. Confirm the parasite and reassess response rather than treating label breadth as proof of coverage.
  • Fipronil is highly toxic to aquatic invertebrates and the label states toxicity to fish and bees; prevent entry into surface water and dispose of pipettes responsibly.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil100 mg/ml Ivermectin15 mg/ml Pyriproxyfen20 mg/ml
Formulation Type
Spot-on
Administration route
On the skin
Manufacturer
Vetsintez LLC · Ukraine
Manufacturer (register)
Vetsintez LLC, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1319, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 11 Nov 2029
Veterinary (National Food Agency)
In the register: პერფექტ ტრიო
№ 000801
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

Rex and Musya, Aerosol / spray

fipronil 3 mg/ml cutaneous spray, 150 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Full dog label from 10 weeks and 1 kg: flea, tick, louse, biting-louse and mange mite treatment with a fipronil 0.3% spray on the coat, plus ear-mite treatment by ear
5.8/10
Weak evidence support
vetman assessment

Rex and Musya

fipronil 3 mg/ml cutaneous spray, 150 ml for dogs and cats
Assessed clinical scopeDog · Full dog label from 10 weeks and 1 kg: flea, tick, louse, biting-louse and mange mite treatment with a fipronil 0.3% spray on the coat, plus ear-mite treatment by ear · topical,otic
Care settingClinic or owner spray treatment outdoors or in a ventilated area; ear use after veterinary confirmation of ear mites
vetman score 5.8/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000490 · Verified on 21 Oct 2026

A weak option: the fipronil dose matches proven sprays, but extra mange and ear claims are unsupported and the exact product has no independent evidence.

Regulatory and scientific credibility5.0/10

The exact 150 ml spray is registered in Georgia (000490, valid to 2028) with a current Ukrainian manufacturer instruction; fipronil sprays are EU-authorised, but this product has no EU, UK or US dossier.

Clinical efficacy6.0/10

At 2-5 ml/kg the dog receives 6-15 mg/kg fipronil, close to proven fipronil sprays; the mange and ear-mite claims rest only on manufacturer material.

Safety and tolerability6.5/10

Fipronil is well tolerated by dogs; the label excludes sick dogs, pregnancy, lactation, puppies under 10 weeks and dogs below 1 kg, and spraying into the ear is an unusual route.

Clinical practicality5.5/10

Wetting the whole coat at 2-5 ml/kg needs a ventilated area, 48 hours without bathing or petting, and 2-3 repeats for mange or lice.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in sick or debilitated dogs, during pregnancy or lactation, in puppies under 10 weeks or dogs below 1 kg.
  • Never use on rabbits: fipronil is toxic to them.
  • Before spraying into the ear, check that the eardrum is intact; clean the canal and treat both ears.
  • For sarcoptic mange or demodicosis, prefer a systemic isoxazoline with proven efficacy.
  • Do not bathe or pet for 48 hours; keep the dog in a ventilated area until dry.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Full cat label from 10 weeks: flea, tick, louse, biting-louse and mange mite treatment with a fipronil 0.3% spray on the coat, plus ear-mite treatment by ear
5.7/10
Weak evidence support
vetman assessment

Rex and Musya

fipronil 3 mg/ml cutaneous spray, 150 ml for dogs and cats
Assessed clinical scopeCat · Full cat label from 10 weeks: flea, tick, louse, biting-louse and mange mite treatment with a fipronil 0.3% spray on the coat, plus ear-mite treatment by ear · topical,otic
Care settingClinic or owner spray treatment in a ventilated area with licking prevented; ear use after veterinary confirmation of ear mites
vetman score 5.7/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000490 · Verified on 21 Oct 2026

A weak option for cats: a correctly dosed fipronil spray, but hard to apply and without independent product evidence for its wider claims.

Regulatory and scientific credibility5.0/10

The exact 150 ml spray is registered in Georgia for cats and dogs (000490, valid to 2028) with a current Ukrainian manufacturer instruction, but it has no EU, UK or US dossier.

Clinical efficacy6.0/10

At 2-5 ml/kg the cat receives 6-15 mg/kg fipronil, close to proven fipronil sprays; the mange and ear-mite claims rest only on manufacturer material.

Safety and tolerability6.5/10

Fipronil is safe in cats, but grooming a wet coat raises oral exposure; the label excludes sick cats, pregnancy, lactation and kittens under 10 weeks.

Clinical practicality5.0/10

Spraying a cat to the skin and keeping it in a ventilated area until dry is difficult, and 48 hours without bathing or petting are required.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not use in sick or debilitated cats, during pregnancy or lactation, or in kittens under 10 weeks.
  • Never use on rabbits: fipronil is toxic to them.
  • Prevent licking until dry; hypersalivation can follow if the cat licks the wet coat.
  • Before spraying into the ear, check that the eardrum is intact; clean the canal and treat both ears.
  • Do not bathe or pet for 48 hours.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil3 mg/ml
Formulation Type
Aerosol / spray
Administration route
On the skin, Into the ear
Manufacturer
Manufacturer (register)
O.L.KAR-Agrozoovet-service, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 940, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 06 Nov 2028
Veterinary (National Food Agency)
In the register: რექსი და მუსია - ინსექტო-აკარიციდული სპრეი ძაღლებისა და კატებისთვის
№ 000490
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

Rex and Musya, Spot-on

fipronil 80 mg/ml spot-on solution, 4 x 1 ml for dogs and cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal
4.6/10
Weak evidence support
vetman assessment

Rex and Musya

fipronil 80 mg/ml spot-on solution, 4 x 1 ml for dogs and cats
Assessed clinical scopeDog · Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal · auricular
Care settingVeterinary diagnosis after otoscopy and microscopy; clean the external canal, verify tympanic membrane integrity and reassess before repetition.
vetman score 4.6/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000466 · Verified on 21 Oct 2026

A weak, low-confidence label-supported otic option: the regimen is stated, but exact-formulation efficacy and ototoxicity evidence are absent. Prefer a product with regulator-reviewed otic data and always confirm an intact tympanum.

Regulatory and scientific credibility4.5/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The instruction is product-specific, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found; several dose bands are ranges rather than fixed pipette units.

Clinical efficacy4.0/10

The exact instruction provides an otic regimen, but no exact-product controlled auricular efficacy study was found. Evidence for fipronil spot-on control of fleas and ticks is not direct evidence for this solvent, concentration and repeated ear-canal regimen.

Safety and tolerability4.0/10

Exact-formulation ear-canal safety and ototoxicity data were not found. Use only after confirming an intact tympanic membrane; stop for pain, neurologic signs, marked irritation or hearing change. Class safety from dermal spot-on use cannot be assumed to prove otic safety.

Clinical practicality6.5/10

The 4-6 drops per ear regimen is measurable and the remaining ampoule is applied to the back, but canal cleaning, bilateral dosing, massage, restraint and reassessment are required. The single-use 1 ml ampoule limits storage ambiguity.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Confirm otodectosis by otoscopy/microscopy and verify an intact tympanic membrane before use. Do not apply into a perforated, unvisualised, severely inflamed or neurologically abnormal ear.
  • Clean both external canals, treat both ears even with unilateral signs and massage the ear base as directed. Stop and reassess for pain, head tilt, nystagmus, ataxia, hearing change or marked irritation.
  • Spot-on flea/tick efficacy and dermal safety studies do not establish efficacy or ototoxicity safety for this exact repeated ear-canal regimen. Evidence confidence is low.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The exact instruction excludes pregnancy and lactation. Record reproductive status and choose another product for pregnant, breeding or nursing animals.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Dog Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them
4.8/10
Weak evidence support
vetman assessment

Rex and Musya

fipronil 80 mg/ml spot-on solution, 4 x 1 ml for dogs and cats
Assessed clinical scopeDog · Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them · On the skin
Care settingHome topical administration after veterinary selection of parasite target, weight band and retreatment interval; environmental control and household coverage as clinically indicated.
vetman score 4.8/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000466 · Verified on 21 Oct 2026

A weak exact-presentation option: fipronil class efficacy is credible, but dose design, broad claims or formulation-specific evidence are less convincing than current regulator-reviewed comparators. Use only within the exact label and reassess control rather than assuming class equivalence.

Regulatory and scientific credibility4.5/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The instruction is product-specific, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found; several dose bands are ranges rather than fixed pipette units.

Clinical efficacy5.0/10

Fipronil has applicable dog/cat spot-on evidence, but the exact product has no independent outcome study. Broad itch-mite and flea-allergic-dermatitis claims, variable dose ranges and product-specific persistence are supported mainly by the manufacturer instruction.

Safety and tolerability4.5/10

The label excludes animals under 10 weeks, dogs under 1 kg, pregnancy/lactation, illness and hypersensitivity, and restricts bathing/handling for 48 hours. Exact-formulation safety is not independently characterised, while wide topical ranges and a 1.5 ml feline dose increase dose-control uncertainty.

Clinical practicality5.5/10

One-millilitre ampoules are easy to open, but several bands are ranges, cats may require counting 10-20 drops or 1.5 ampoules, and larger dogs require multiple ampoules. A clear routine retreatment schedule is not stated in the structured label rows.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only on dry, intact skin in an area the animal cannot lick. Weigh the patient, select the exact label band and do not extrapolate between products, concentrations or pipette sizes.
  • Fipronil does not reliably prevent tick attachment or pathogen transmission. Examine the patient after exposure and use an integrated parasite plan based on local epidemiology and lifestyle.
  • The exact product has no independent controlled outcome trial or public regulator assessment dossier. Class evidence supports fipronil, not every broader mite, repellent or persistence claim on this formulation.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The exact instruction excludes pregnancy and lactation. Record reproductive status and choose another product for pregnant, breeding or nursing animals.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal
4.6/10
Weak evidence support
vetman assessment

Rex and Musya

fipronil 80 mg/ml spot-on solution, 4 x 1 ml for dogs and cats
Assessed clinical scopeCat · Label-concordant adjunctive treatment of Otodectes cynotis infestation in the external ear canal · auricular
Care settingVeterinary diagnosis after otoscopy and microscopy; clean the external canal, verify tympanic membrane integrity and reassess before repetition.
vetman score 4.6/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 000466 · Verified on 21 Oct 2026

A weak, low-confidence label-supported otic option: the regimen is stated, but exact-formulation efficacy and ototoxicity evidence are absent. Prefer a product with regulator-reviewed otic data and always confirm an intact tympanum.

Regulatory and scientific credibility4.5/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The instruction is product-specific, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found; several dose bands are ranges rather than fixed pipette units.

Clinical efficacy4.0/10

The exact instruction provides an otic regimen, but no exact-product controlled auricular efficacy study was found. Evidence for fipronil spot-on control of fleas and ticks is not direct evidence for this solvent, concentration and repeated ear-canal regimen.

Safety and tolerability4.0/10

Exact-formulation ear-canal safety and ototoxicity data were not found. Use only after confirming an intact tympanic membrane; stop for pain, neurologic signs, marked irritation or hearing change. Class safety from dermal spot-on use cannot be assumed to prove otic safety.

Clinical practicality6.5/10

The 4-6 drops per ear regimen is measurable and the remaining ampoule is applied to the back, but canal cleaning, bilateral dosing, massage, restraint and reassessment are required. The single-use 1 ml ampoule limits storage ambiguity.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Confirm otodectosis by otoscopy/microscopy and verify an intact tympanic membrane before use. Do not apply into a perforated, unvisualised, severely inflamed or neurologically abnormal ear.
  • Clean both external canals, treat both ears even with unilateral signs and massage the ear base as directed. Stop and reassess for pain, head tilt, nystagmus, ataxia, hearing change or marked irritation.
  • Spot-on flea/tick efficacy and dermal safety studies do not establish efficacy or ototoxicity safety for this exact repeated ear-canal regimen. Evidence confidence is low.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The exact instruction excludes pregnancy and lactation. Record reproductive status and choose another product for pregnant, breeding or nursing animals.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Cat Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them
4.7/10
Weak evidence support
vetman assessment

Rex and Musya

fipronil 80 mg/ml spot-on solution, 4 x 1 ml for dogs and cats
Assessed clinical scopeCat · Label-concordant treatment and prevention of susceptible flea, tick and louse infestations; broader mite or repellent claims are included only where the exact instruction states them · On the skin
Care settingHome topical administration after veterinary selection of parasite target, weight band and retreatment interval; environmental control and household coverage as clinically indicated.
vetman score 4.7/10 Weak evidence support
Evidence confidence: Medium Georgia: Yes, veterinary · № 000466 · Verified on 21 Oct 2026

A weak exact-presentation option: fipronil class efficacy is credible, but dose design, broad claims or formulation-specific evidence are less convincing than current regulator-reviewed comparators. Use only within the exact label and reassess control rather than assuming class equivalence.

Regulatory and scientific credibility4.5/10

The exact presentation is actively registered in Georgia and has a current official manufacturer instruction. The instruction is product-specific, but no regulator-hosted public assessment dossier or independent exact-formulation trial was found; several dose bands are ranges rather than fixed pipette units.

Clinical efficacy5.0/10

Fipronil has applicable dog/cat spot-on evidence, but the exact product has no independent outcome study. Broad itch-mite and flea-allergic-dermatitis claims, variable dose ranges and product-specific persistence are supported mainly by the manufacturer instruction.

Safety and tolerability4.0/10

The label excludes animals under 10 weeks, dogs under 1 kg, pregnancy/lactation, illness and hypersensitivity, and restricts bathing/handling for 48 hours. Exact-formulation safety is not independently characterised, while wide topical ranges and a 1.5 ml feline dose increase dose-control uncertainty.

Clinical practicality5.5/10

One-millilitre ampoules are easy to open, but several bands are ranges, cats may require counting 10-20 drops or 1.5 ampoules, and larger dogs require multiple ampoules. A clear routine retreatment schedule is not stated in the structured label rows.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Use only on dry, intact skin in an area the animal cannot lick. Weigh the patient, select the exact label band and do not extrapolate between products, concentrations or pipette sizes.
  • Fipronil does not reliably prevent tick attachment or pathogen transmission. Examine the patient after exposure and use an integrated parasite plan based on local epidemiology and lifestyle.
  • The exact product has no independent controlled outcome trial or public regulator assessment dossier. Class evidence supports fipronil, not every broader mite, repellent or persistence claim on this formulation.
  • Respect every product-specific minimum age and weight. Do not transfer the eight-week/weight thresholds, pipette volumes or overdose margins of an authorised comparator to this presentation.
  • The exact instruction excludes pregnancy and lactation. Record reproductive status and choose another product for pregnant, breeding or nursing animals.
  • Do not use in sick, convalescent, exhausted or debilitated animals where the exact label excludes them. Avoid use in a patient with known fipronil or excipient hypersensitivity.
  • Prevent oral exposure and mutual grooming until the application site is dry. Brief hypersalivation can follow licking; vomiting, depression, tremor, marked salivation or other neurologic signs require prompt veterinary assessment.
  • Do not combine with another directly applied ectoparasiticide unless the compatibility and interval are explicitly established. Follow the exact bathing, handling and retreatment restrictions rather than shortening the interval after apparent failure.
  • Fipronil is hazardous to aquatic organisms. Keep treated animals away from water during the label restriction, prevent contamination of ponds and waterways, and dispose of pipettes and residue through the appropriate medicine-waste route.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil80 mg/ml Fipronil80 mg/ml
Formulation Type
Spot-on
Administration route
On the skin, auricular
Manufacturer
Manufacturer (register)
Private Enterprise O.L.KAR-AgroZoovet-Service, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 921, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 20 Oct 2028
Veterinary (National Food Agency)
In the register: რექსი და მუსია - ინსექტო-აკარიციდული წვეთები ძაღლებისა და კატებისთვის
№ 000466
Verified on: 21 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

RolfClub 3D 5%/5%/2%, Topical (unspecified)

collar 75 cm for large dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
5.4/10
Weak evidence support
vetman assessment

RolfClub 3D

5%/5%/2%, collar 75 cm for large dogs
Assessed clinical scopeDog · Complete dog label: treatment/prevention of flea, lice/biting-lice and ixodid-tick infestation, short-term protection from blood-sucking dipterans and linked babesiosis, borreliosis and dirofilariasis prevention claims · On the skin
Care settingOwner-fitted continuous-wear dog collar after veterinarian/product selection, with fit/skin checks, household-species separation and environmental controls
vetman score 5.4/10 Weak evidence support
Evidence confidence: Low Georgia: Yes, veterinary · № 002683 · Verified on 23 Oct 2026

A highly convenient, current locally authorised dog collar whose components are plausible, but whose exact six-month efficacy and vector-borne-disease claims lack a public formulation-specific outcome dossier. Convenience cannot erase the evidence gap, cat-contact pyrethroid risk or aquatic/handling controls, so the complete-label value remains weak.

Regulatory and scientific credibility6.0/10

The exact 75 cm product has a current time-limited Georgian authorisation, an approved manufacturer instruction and a current Russian register-derived identity record. It has no exact EU/GB/US authorisation or public regulator assessment comparable with current long-acting collar controls.

Clinical efficacy4.0/10

The three actives have plausible and partly studied ectoparasite activity, and other formulation-specific collars prove multi-month control is possible. However, no public controlled trial of this exact polymer collar, six-month flea/tick/lice claim, five-day dipteran claim or pathogen-transmission endpoints was found; spot-on studies cannot be transferred.

Safety and tolerability4.5/10

The exact label reports mainly individual erythema/pruritus, but does not provide quantified target-animal safety or continuous-exposure pharmacovigilance. Dog-only cyphenothrin creates potentially severe feline-contact risk; chewing/ingestion, dermatitis, neurologic signs, child contact and aquatic toxicity require explicit controls.

Clinical practicality8.0/10

One continuously worn collar can cover the exact label flea/tick/lice period for up to six months and avoids monthly dosing. A 75 cm presentation is easy to fit and trim for a large dog, but correct 1.0-1.5 cm clearance, growth/skin checks, water precautions, household-cat separation and replacement after loss/damage remain necessary.

Full-course cost-effectiveness-

Current Georgian per-protection-period price was unavailable; price is excluded from the denominator.

Important safety and use flags

  • Complete-scope boundary: this score covers the exact dog collar label—fleas, lice/biting lice, ixodid ticks, blood-sucking dipterans and the linked babesiosis, borreliosis and dirofilariasis claims. Component plausibility does not validate every pest, duration or pathogen endpoint.
  • Evidence ceiling: no public controlled exact RolfClub collar trial or regulator assessment was found. Seresto/Scalibor collar data and fipronil/cyphenothrin spot-on studies use different formulations, release kinetics and doses; do not transfer their quantified efficacy or safety.
  • Duration boundary: the exact instruction claims up to six months for fleas, lice/biting lice and ixodid ticks, but only up to five days for flying blood-sucking insects. Record fitting/replacement date and reassess parasites rather than assuming uniform six-month repellency.
  • Disease-prevention boundary: a flea/tick/insect collar lowers exposure but cannot guarantee prevention of babesiosis, borreliosis or dirofilariasis. The five-day flying-insect claim cannot replace an authorised heartworm preventive, testing and geographic risk plan.
  • Dog only—cat hazard: D-cyphenothrin is a pyrethroid and relevant US EPA dog-product mitigation warns cat exposure may be fatal. Never fit this collar to a cat; prevent licking, chewing and prolonged close contact by household cats and choose a cat-safe household protocol.
  • Fit/physical safety: leave 1.0-1.5 cm between neck and collar, secure and trim excess, then recheck skin and fit as the dog grows or coat/weight changes. Prevent chewing/ingestion and snagging; replace a lost, damaged or excessively loose collar rather than improvising repairs.
  • Stop and remove for important erythema, pruritus, alopecia, salivation, vomiting, weakness, ataxia, twitching, tremor or seizure; wash exposed skin with mild detergent/water and obtain veterinary/poison advice. Do not add another insectoacaricide without a product-specific veterinarian plan.
  • Do not use under 3 months, during infectious disease or convalescence, or with hypersensitivity. Pregnancy/lactation require veterinarian benefit-risk consultation; the exact instruction does not provide a quantified reproductive safety dossier.
  • Aquatic/environmental control: fipronil and pyrethroids are hazardous to aquatic organisms. Keep the dog/collar from watercourses, follow bathing/swimming restrictions or remove as directed, and dispose of the used collar and trimmed pieces safely—not in wastewater or fire.
  • Handler/household control: keep the sealed and fitted collar, offcuts and removed collar away from children, food and feed. Wash hands after fitting or touching it, avoid sleeping/prolonged skin contact with the collar and do not allow small children close contact with the collared dog.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil5 % D-cyphenothrin5 % Pyriproxyfen2 %
Formulation Type
Topical (unspecified)
Administration route
On the skin
Manufacturer
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 584, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 12 Apr 2027
Veterinary (National Food Agency)
In the register: როლფკლუბ 3D 5%/5%/2%, 75 სმ საყელო დიდი ძაღლებისთვის
№ 002683
Verified on: 23 Oct 2026
EU No
UK No
US No
Controlled in Georgia
Unknown
Information not fully verified Dog only. Fit one 75 cm collar continuously with 1.0-1.5 cm clearance and trim the excess. The exact instruction claims up to 6 months against fleas, lice/biting lice and ixodid ticks, but only up to 5 days against blood-sucking flying insects. No public exact-product controlled efficacy dossier was found; vector-borne-disease prevention is not equivalent to guaranteed pathogen protection.

RolfClub 3D 5/5/2% collar

40 cm for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
Not rateable
No numerical score assigned
vetman assessment

RolfClub 3D

5/5/2% collar, 40 cm for cats
Assessed clinical scopeCat · Full cat label from 3 months: flea and tick protection for up to 8 months with a fipronil 5%, pyrethroid 5% and pyriproxyfen 2% collar · On the skin
Care settingNot recommended until the pyrethroid in the Georgian product is confirmed; if used, a healthy adult cat with close owner monitoring
vetman score Not rateable No numerical score assigned
Evidence confidence: Low Georgia: Yes, veterinary · № 002684 · Verified on 21 Oct 2026 Off-label use
Not rateable

Not rateable until the exact Georgian pack resolves the active-ingredient conflict: the register states D-cyphenothrin and the manufacturer states etofenprox.

No numerical score until the exact active composition and strength are verified from the Georgian pack or an authoritative exact-product leaflet.

Important safety and use flags

  • Composition conflict: the Georgian register lists D-cyphenothrin, a pyrethroid used in dog-only products, while the manufacturer states etofenprox. Check the pack before fitting it to a cat.
  • Remove the collar and seek urgent care if hypersalivation, tremor, twitching or seizures appear, or if the collar is chewed by the cat, another pet or a child.
  • Do not use in kittens under 3 months, infectious or convalescent cats, with hypersensitivity, or with another insectoacaricide; pregnancy and lactation need veterinary advice.
  • No breakaway release is described: check the fit regularly so a jaw or leg cannot get caught.
  • The 8-month claim has no independent support; check for fleas and ticks during wear.
Assessment sources
Assessed: 23 Oct 2026No axis or overall score is shown when the available evidence does not support a responsible numerical assessment.
Composition / strength
Fipronil5 % Etofenprox5 % Pyriproxyfen2 %
Administration route
On the skin
Manufacturer
Ekoprom · Russia
Manufacturer (register)
JSC SPC EKOPROM, Russia
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 585, 19 Oct 2026.
Registration
Georgia Yes, veterinary
In force until 12 Apr 2027
Veterinary (National Food Agency)
In the register: როლფკლუბი 3D კატებისტვის
№ 002684
Verified on: 21 Oct 2026
Controlled in Georgia
Unknown

WOW!, Spot-on

Bay! 70/450 mg/ml spot-on, 2 ml for dogs over 10-20 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
6.5/10
Situational / acceptable
vetman assessment

WOW!

Bay! 70/450 mg/ml spot-on, 2 ml for dogs over 10-20 kg
Assessed clinical scopeDog · Labelled monthly control of susceptible fleas, ticks, lice and flying biting insects in dogs within this presentation's explicit weight band · TOPICAL
Care settingVeterinary-selected home spot-on use after weighing the dog, confirming the target ectoparasite and separating treated dogs from cats until dry
vetman score 6.5/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 001088 · Verified on 21 Oct 2026

A locally registered monthly dog spot-on whose active combination is supported by good comparator evidence, but not by an independent study of this exact product. It is acceptable when repellency is specifically needed and strict cat-exposure prevention is feasible.

Regulatory and scientific credibility6.5/10

The exact presentation is actively registered in Georgia and has a current manufacturer leaflet. Comparable fipronil-permethrin spot-ons have transparent UK/EU regulatory records, but no public assessment dossier or independent exact-WOW formulation review was found.

Clinical efficacy7.0/10

Randomised and field studies of closely comparable fipronil-permethrin spot-ons support flea, tick, mosquito and sand-fly activity over the monthly interval. None tested this exact WOW concentration, excipients or manufacturing process, so broad label transfer remains indirect.

Safety and tolerability5.5/10

Correctly used fipronil-permethrin spot-ons are generally tolerated by dogs, but transient skin or neurologic/gastrointestinal signs can occur. Permethrin exposure can cause fatal convulsions in cats, making household separation, application control and rapid decontamination critical.

Clinical practicality7.5/10

A single 2 ml tube and monthly interval are convenient, but the full dose must reach intact skin at several dorsal points and the treated dog must be kept from cats until completely dry.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • DOGS ONLY. Never use on cats or rabbits. Permethrin can cause potentially fatal convulsions in cats; prevent cats from licking treated dogs and keep them separated until the site is completely dry.
  • If a cat is exposed, immediately wash the skin with mild soap or shampoo and seek urgent veterinary care; do not wait for tremor, salivation, ataxia or seizures.
  • Do not use below 2 months of age or 2 kg, in sick, debilitated or convalescent dogs, on damaged skin, or with known fipronil/permethrin hypersensitivity.
  • Pregnancy and lactation require an individual veterinary benefit-risk decision; the exact leaflet does not establish routine unrestricted use.
  • Apply the entire correct tube directly to dry intact skin at the labelled dorsal points. Prevent licking, eye or mucosal contact and do not bathe for 24 hours.
  • Monitor for local irritation, pruritus, nausea, vomiting, weakness, tremor or incoordination. If intolerance develops, wash the application site and contact a veterinarian.
  • Repellency and killing reduce but do not eliminate attachment, bites or vector-borne pathogen transmission. Diagnose illness independently and use region-appropriate vector prevention.
  • Independent evidence concerns closely comparable fipronil-permethrin spot-ons, not this exact WOW formulation. Reassess product choice if expected monthly control fails.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil70 mg/ml Permethrin450 mg/ml
Formulation Type
Spot-on
Administration route
TOPICAL
Manufacturer
Manufacturer (register)
Private enterprise firm Farmaton, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1680, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

WOW!, Spot-on

Bay! 70/450 mg/ml spot-on, 4 ml for dogs over 20-40 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
6.4/10
Situational / acceptable
vetman assessment

WOW!

Bay! 70/450 mg/ml spot-on, 4 ml for dogs over 20-40 kg
Assessed clinical scopeDog · Labelled monthly control of susceptible fleas, ticks, lice and flying biting insects in dogs within this presentation's explicit weight band · TOPICAL
Care settingVeterinary-selected home spot-on use after weighing the dog, confirming the target ectoparasite and separating treated dogs from cats until dry
vetman score 6.4/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 001087 · Verified on 21 Oct 2026

A locally registered monthly dog spot-on with useful fipronil-permethrin class evidence but no independent exact-product trial. The larger application volume and potentially fatal feline exposure make careful household selection essential.

Regulatory and scientific credibility6.5/10

The exact presentation is actively registered in Georgia and has a current manufacturer leaflet. Comparable fipronil-permethrin spot-ons have transparent UK/EU regulatory records, but no public assessment dossier or independent exact-WOW formulation review was found.

Clinical efficacy7.0/10

Randomised and field studies of closely comparable fipronil-permethrin spot-ons support flea, tick, mosquito and sand-fly activity over the monthly interval. None tested this exact WOW concentration, excipients or manufacturing process, so broad label transfer remains indirect.

Safety and tolerability5.5/10

Correctly used fipronil-permethrin spot-ons are generally tolerated by dogs, but transient skin or neurologic/gastrointestinal signs can occur. Permethrin exposure can cause fatal convulsions in cats, making household separation, application control and rapid decontamination critical.

Clinical practicality7.0/10

A single 4 ml tube avoids arithmetic, but distributing the full volume over several dorsal points, preventing licking and separating household cats increases owner burden.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • DOGS ONLY. Never use on cats or rabbits. Permethrin can cause potentially fatal convulsions in cats; prevent cats from licking treated dogs and keep them separated until the site is completely dry.
  • If a cat is exposed, immediately wash the skin with mild soap or shampoo and seek urgent veterinary care; do not wait for tremor, salivation, ataxia or seizures.
  • Do not use below 2 months of age or 2 kg, in sick, debilitated or convalescent dogs, on damaged skin, or with known fipronil/permethrin hypersensitivity.
  • Pregnancy and lactation require an individual veterinary benefit-risk decision; the exact leaflet does not establish routine unrestricted use.
  • Apply the entire correct tube directly to dry intact skin at the labelled dorsal points. Prevent licking, eye or mucosal contact and do not bathe for 24 hours.
  • Monitor for local irritation, pruritus, nausea, vomiting, weakness, tremor or incoordination. If intolerance develops, wash the application site and contact a veterinarian.
  • Repellency and killing reduce but do not eliminate attachment, bites or vector-borne pathogen transmission. Diagnose illness independently and use region-appropriate vector prevention.
  • Independent evidence concerns closely comparable fipronil-permethrin spot-ons, not this exact WOW formulation. Reassess product choice if expected monthly control fails.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil70 mg/ml Permethrin450 mg/ml
Formulation Type
Spot-on
Administration route
TOPICAL
Manufacturer
Manufacturer (register)
Private enterprise firm Farmaton, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1679, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

WOW!, Spot-on

Bay! 70/450 mg/ml spot-on, 6 ml for dogs over 40-60 kg
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
6.4/10
Situational / acceptable
vetman assessment

WOW!

Bay! 70/450 mg/ml spot-on, 6 ml for dogs over 40-60 kg
Assessed clinical scopeDog · Labelled monthly control of susceptible fleas, ticks, lice and flying biting insects in dogs within this presentation's explicit weight band · TOPICAL
Care settingVeterinary-selected home spot-on use after weighing the dog, confirming the target ectoparasite and separating treated dogs from cats until dry
vetman score 6.4/10 Situational / acceptable
Evidence confidence: Medium Georgia: Yes, veterinary · № 001064 · Verified on 21 Oct 2026

A locally registered monthly dog spot-on with supportive combination-class evidence but no independent exact-product trial. Its 6 ml application burden and potentially fatal feline exposure limit it to carefully controlled households.

Regulatory and scientific credibility6.5/10

The exact presentation is actively registered in Georgia and has a current manufacturer leaflet. Comparable fipronil-permethrin spot-ons have transparent UK/EU regulatory records, but no public assessment dossier or independent exact-WOW formulation review was found.

Clinical efficacy7.0/10

Randomised and field studies of closely comparable fipronil-permethrin spot-ons support flea, tick, mosquito and sand-fly activity over the monthly interval. None tested this exact WOW concentration, excipients or manufacturing process, so broad label transfer remains indirect.

Safety and tolerability5.5/10

Correctly used fipronil-permethrin spot-ons are generally tolerated by dogs, but transient skin or neurologic/gastrointestinal signs can occur. Permethrin exposure can cause fatal convulsions in cats, making household separation, application control and rapid decontamination critical.

Clinical practicality6.5/10

The 6 ml tube avoids calculation but has the highest application-volume burden; complete skin delivery over several dorsal points and strict cat separation are essential.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • DOGS ONLY. Never use on cats or rabbits. Permethrin can cause potentially fatal convulsions in cats; prevent cats from licking treated dogs and keep them separated until the site is completely dry.
  • If a cat is exposed, immediately wash the skin with mild soap or shampoo and seek urgent veterinary care; do not wait for tremor, salivation, ataxia or seizures.
  • Do not use below 2 months of age or 2 kg, in sick, debilitated or convalescent dogs, on damaged skin, or with known fipronil/permethrin hypersensitivity.
  • Pregnancy and lactation require an individual veterinary benefit-risk decision; the exact leaflet does not establish routine unrestricted use.
  • Apply the entire correct tube directly to dry intact skin at the labelled dorsal points. Prevent licking, eye or mucosal contact and do not bathe for 24 hours.
  • Monitor for local irritation, pruritus, nausea, vomiting, weakness, tremor or incoordination. If intolerance develops, wash the application site and contact a veterinarian.
  • Repellency and killing reduce but do not eliminate attachment, bites or vector-borne pathogen transmission. Diagnose illness independently and use region-appropriate vector prevention.
  • Independent evidence concerns closely comparable fipronil-permethrin spot-ons, not this exact WOW formulation. Reassess product choice if expected monthly control fails.
Assessment sources
Assessed: 22 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Fipronil70 mg/ml Permethrin450 mg/ml
Formulation Type
Spot-on
Administration route
TOPICAL
Manufacturer
Manufacturer (register)
Private enterprise firm Farmaton, Ukraine
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1655, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.